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 As the number and age of human couples turning to assisted reproductive 
technology (ART) continues to increase, it is essential for clinicians to understand 
infertility threats related to both female and male patients. The objective of this 
study was to evaluate the association between age, environment, and 
reproductive success in male patients having participated in assisted 
reproductive technology. In corresponding experiments, male infertility variables 
such as; age, lifestyle exposures, body mass index (BMI), and infertility length 
with current partner (ILCP) were investigated. A retrospective collection of clinical 
male patient data from 2011 to 2014 was evaluated. Thirty-five variables were 
collected from an original sample of 132 patients and correlated for relationships 
related to male fertility. A negative relationship was observed between pregnancy 
and male age, IVF pregnancy and male age, male age and semen volume, and 
male age and semen progressive motility. A negative correlation was also 
revealed among alcohol usage and semen volume and alcohol usage and total 
motile sperm/specimen. Additionally, a positive correlation was observed 
between ILCP and percent normal semen.  
 The goal of the following study, the clinician survey, was to evaluate and 
compare differences in opinions. Questions pertained to male infertility factors 
and fertility clinic practices. Clinicians responded with the following opinion rates; 
67.9% felt semen analysis was an effective predictor, 32.7% reported no idea if 
DNA fragmentation was a predictor, 58.5% were in agreement that male age had 
somewhat significance, 80.1% responded that genetics and/or epigenetics 
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displayed somewhat or significant influence (41.5% and 39.6%), 58.5% believed 
male exposure/environmental factors displayed significance, 53.9% felt access to 
more male information would enable better care. The most commonly seen 
descriptive variable clinicians reported was ILCP (70.8%), the most important 
semen characteristic was sperm count (84.6%), the most commonly seen 
urological variable was vasectomy (77.8%), smoking was the most commonly 
seen environmental exposure (74.5%), and medication use was the most 
commonly seen medical variable (84.8%). Clinicians described that 39.1% of 
patient charts were <25.0% completed and 63.0% of clinicians acknowledged 





CHAPTER I:  INTRODUCTION 
Rationale 
As the 20th century transformed into the 21st, a cultural shift in society 
identified a need and an occasion for increased research on the effect of 
reproductive threats associated with advanced paternal age and paternal 
environmental exposure factors. Both of which may contribute negatively to male 
reproductive success. Despite a number of maternal studies in the second half of 
the 20th century, research investigating the role of paternal age in adverse birth 
outcome is limited. Consideration and identification of specific paternal factors 
will aid in increased semen quality, increased fertility rates, increased pregnancy 
rates, and decreased number of still births and fetal abnormalities.  
 The past few decades have revealed an increase in the amount of human 
couples turning to assisted reproductive technology (ART) procedures. Research 
has shown that this increase is due in large part to the newly established trend of 
postponing childbirth. Couples in the United State have progressively delayed 
starting families because of societal changes, cultural expectations, career 
aspirations, and financial situations.  
This rise in ART patients can largely be attributed to the increased number 
of infertility treatments in older patients. The use of infertility treatments has risen 
dramatically in the past 20 years; between 1996 and 2003, the number of human 
ART cycles performed in the United States nearly doubled from 64,681 to 
122,872 (Institute of Medicine (US) Committee on Understanding Premature 
Birth and Assuring Healthy Outcomes, 2007). In 2013, Chandra and colleagues 
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clarified that, although treatment use has been raised, infertility rates have 
actually decreased from 8.5 to 6.0% of married women between 1982 and 2010. 
The authors explained that because couples are waiting longer to start families, 
fertility issues or delays may be involved with the increase in infertility treatments 
but should not be associated with a rise in infertility rate.  
 Regardless of the cause of this influx in infertility treatments, the 
association of increased maternal age and the risk of higher reproductive failure 
has been well established. Conversely, the link between paternal age and birth 
outcome has received far less attention. There are several factors at fault for the 
hindrance of studying paternal age.  
A large amount of attention has traditionally been focused on maternal 
influences on fetal growth. In 2008, Chen and colleagues pointed out that, to 
date, maternal influence has universally been considered of more importance 
than paternal influence. Additionally, research has demonstrated that the 
biological father is unknown in some cases, further hindering the investigation of 
paternal effects. In the 2006, paternal age was missing from the U.S. vital 
statistic records for 39.0% of unmarried women, but only 0.4% of married women 
(Basso and Wilcox, 2006). Furthermore, from an epidemiological standpoint, it is 
more convenient to study the effects of maternal factors on birth outcomes. 
Pregnant women generally make frequent prenatal care visits to their physician 
or hospital, thereby facilitating the collection of information on maternal 
characteristics that may affect birth outcomes (Chen et al., 2008).  
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Recent research has revealed that as males age and are exposed to 
detrimental factors semen quality can decrease. Although it is possible for men to 
father children into old age, the genetic quality of sperm, as well as its volume 
and motility, typically decrease with age and negative environmental factors. 
Therefore, it is important to note that currently semen quality is the primary 
measurement of the ability of sperm to accomplish fertilization. It is the sperm 
cells in the semen that are of importance, and therefore semen quality involves 
both sperm quantity and quality. Decreased semen quality is a major factor of 
male infertility. 
Notably, fifty percent of the embryonic genome is derived from paternal 
deoxyribonucleic acids (DNA) in the sperm cell. In contrast to paternal DNA 
contribution to successful fertilization, increased sperm DNA damage can 
adversely affect embryo quality. These detrimental effects can be observed 
starting at day-2 of early embryonic development and can continue to be 
detected following embryo transfer; resulting in reduced implantation and 
pregnancy rates (Simon et al., 2014).  
Statement of the Problem 
Regardless of age, human sperm samples are very heterogeneous and 
include a low amount of truly functional gametes (Sousa et al., 2011). Although 
all sperm may look the same to a casual observer, human ejaculates are varied, 
and subpopulations of sperm with distinct biochemical and physiological 
characteristics can be identified in every sample (Sousa et al., 2011). It is 
actually believed that only a very small percentage of sperm is able to achieve 
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fertilization (Holt and Van Look, 2004; Holt, 2005). This produces a challenge for 
the accumulation of substantial and consistent data on human male sperm 
parameters. Exposing the heterogeneous nature of human sperm as one of the 
major challenges researchers are facing in the industry today when trying to 
better characterize and isolate a particular useable subpopulation.  
Although researchers, such as Sousa et al. (2011), have demonstrated 
advanced fractionation techniques to obtain subpopulations with improvements in 
certain sperm parameters, a subpopulation including only fertile sperm has never 
been isolated. This is mainly due to the fact that we are still not able to 
completely describe what makes a competent spermatozoon (Sousa et al., 
2011). 
Research has shown that paternal semen influences on reproduction are 
quite important. It is believed that approximately half of the couples that turn to 
assisted reproductive techniques do so because of male infertility factors. 
Therefore, due to the increasing proportion of couples participating in ART 
procedures, predicting outcomes is of ever increasing importance. Although 
researchers have established a number of unfavorable factors from maternal 
influence, male factor infertility is still relatively understudied. Scientists have 
increasingly acknowledged that male factors provide a significant amount to the 
successful treatment of an infertility couple. Since pregnancy rates following in 
vitro fertilization (IVF) are still quite low, prognostic information for both the male 
and female is very helpful in making clinical decisions (Brincat et al., 2014).   
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In 1993, Giwercman et al. reported data that clearly indicated semen 
quality had markedly decreased during the period 1938-1990, and concurrently 
the incidence of some genitourinary abnormalities including hypospadias, 
maldescent, and cancer had increased. Researchers explained that such a 
significant increase in the occurrence of gonadal abnormalities over a relatively 
short period of time was more likely to be due to environmental factors rather 
than genetic factors.   
Generally, it has been believed that pollution, smoking, alcohol, and 
sexually transmitted diseases play a role in male infertility. In addition, 
researchers have proposed that increased male age, body mass index, previous 
illnesses, medication, steroidal and hormonal usage, and trauma to the testicles 
have also contributed to the decrease in quality of a man’s sperm. As more 
information is being established on how the effect of male age and the 
environment have contributed to sperm quality, many patients want to know how 
to ‘fix’ this problem.  
While it is still assumed that the medical risks may be smaller for older 
fathers, the increase in couples becoming parents later in life emphasizes the 
issue that male age and exposure should be taken seriously. According to a 
2014 Centers for Disease Control and Prevention report, approximately six 
million couples in the United States are infertile. Research has shown that in 
about one third to one half of these couples, a male sperm factor is partially or 
completely responsible.  
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In 2004, it was reported that 24 in every 1,000 men aged 40 to 44 fathered 
a child (Centers for Disease Control and Prevention, 2014). That number was up 
almost 18.0% from the decade before. Meanwhile, only three out of every 1,000 
men aged 55 and older had fathered live births. As men are attempting 
fatherhood later in life, 1.2 million men seek help for infertility, and those are just 
the cases that are reported. Fifteen percent of these men are accurately 
diagnosed with male factor infertility using a semen analysis (Guzick et al., 
2001).  
Chandra and colleagues (2013) reported that among men from 2006 to 
2010, some form of infertility was reported by 9.4% of men aged 15 to 44 and by 
12.0% of men aged 25 to 45. These statistics demonstrate that as couples are 
waiting longer to conceive advanced age should be a concern for both parents. 
These findings demonstrate the importance of knowing the mutual contributions 
of both the male and female patient. However, that information is not yet widely 
recognized outside of the human infertility industry. To date, statistics for 
‘infertility’, listed online by the CDC have overwhelmingly contained female 
fertility problems and only minimally addressed male factors.  
The last century endured witness to science curriculums educating 
millions of students that there is not an identified specific male age associated 
with the senescence of reproduction. In recent years, researchers have found 
some success in demonstrating a gradual decline in male fertility as age 
increased. Different from the acute onset of menopause in females, male 
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infertility research demonstrated a gradual change in the reproductive system 
associated with advanced age.  
Exact biological mechanisms of reproductive alterations in older males 
have been difficult for researchers to identify and vary among individuals. 
Consequently, there is little being done to replace the previous ideas of limited 
male reproductive influence with the education of this advanced theory. In fact, 
extreme cases of advanced male reproductive success are actually being more 
highly publicized; not just from media outlets but from boasting physicians as 
well. As a result, the small amount of data on the detrimental effects of advanced 
male reproductive age, have been unsuccessful in protecting outrages cases 
from continually being pursued by some male patients and some physicians.  
In addition to male age, infertility patients should receive just as much 
information on the further risks of male factors as they receive on female factors. 
Many research studies show that this is not the case. Two obvious explanations 
for this problem are the lack of male patient data reported to be properly 
addressed and the lack of patient knowledge and/or minimization of the male role 
on human reproductive success. 
When most people hear the term preconception health, they only think of 
the female. However, preconception health is important for the male, as well. 
There are things men can do to improve their own health, as well as the health 
benefits of their female partner and future children. Ethically, it is in the best 
interest of the industry and the patients to give as much information as possible 
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on male infertility factors. Additionally, patients need to be educated on the 
benefits of participating in male preconception health. 
Just as overall health, lifestyle, and age can affect female reproductive 
success, the same factors have been shown to affect male semen quality and 
reproductive success. Male gametes are extremely delicate and susceptible to 
factors that affect normal semen production. By reducing the health and/or 
number of sperm male reproduction can be affected. Also reported to impact 
sperm production is; heavy alcohol use, drug use, advanced age, and 
environmental toxins. Health problems such as mumps, serious conditions like 
kidney disease or hormone problems, medications, and radiation treatment 
and/or chemotherapy for cancer (Office on Women’s Health, 2012) can initiate 
abnormal sperm production. In addition, obesity among men has been 
associated directly with increasing male infertility (Sallmén et al., 2006; Frey et 
al., 2008). 
Adding to the problem, a 2014 Center for Disease Control and Prevention 
consensus illustrated that the percentage of male data reported to analyze was 
much less than the amount of female data available. The group suggested that 
the lower number of available data was a reflection of the difference in reporting 
from the male perspective. Clinicians are currently observing the same problem 
in their private practices. Lack of completed male data reports can hinder 
treatment practices.  
Regardless of the lower percentages of infertility service usage actually 
reported among men, similar infertility associations have been identified as those 
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seen in women, such as; advanced male age, marital status, and other 
demographic characteristics (Centers for Disease Control and Prevention, 2014). 
This further demonstrates the need to convey male infertility factors to ART 
couples and encourage proper male patient record documentation.   
For both male and female patients, advanced age is a reality when having 
children later in life. As with most things in life, there are pros and cons of being 
older parents. However, many professionals in the industry believe that a double 
standard has come into play for male versus female patients. History shows that 
on average females live longer and that the burden of most treatment and follow 
up care is carried by the female patient.  
When examining the ethics surrounding the gain in new data connected to 
male infertility, other issues have begun to arise. Many infertility clinics implement 
female cutoff ages. However, this same standard does not apply for a 
comparable percentage of male patients. Even as knowledge in this area is 
increased, the medical and ethical concerns should remain the same. The overall 
welfare of the offspring and the proper treatment of both the male and female 
patient are of top concern.      
 The results of the online clinician survey, created by the researcher, 
further demonstrated the various discrepancies in human fertility treatment. Since 
there is little regulation beyond quality control in fertility laboratory settings, there 
is currently a considerable amount of treatment variations. Although much may 
be miniscule, when it comes to determining the best application practices any 
differences can create controversial results and recommendations.  
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Significance of the Study 
The researcher, in conjunction with an outside private facility, has the 
technology and resources to establish specific factors which will then become 
indicators for further research. This study will create new, available data to be 
used by the human fertility industry.  
Over the past decades, the majority of infertility research data obtained 
has mainly been focused on female factors. As previously mentioned and to be 
discussed in further depth in Chapter II, couples are waiting longer to start their 
families. This trend has created an increased need to focus additional research 
on male infertility factors. As we gain more knowledge on the significance of male 
factors it is necessary to present these findings and to further the research in 
these areas to provide better treatment for infertility couples.  
Data obtained from the completion of this study is intended to provide 
useful information to physicians, physiologists, clinical staff, administrators, policy 
makers, health care providers, sperm donors, and infertility couples. The findings 
can be beneficial to researchers and human infertility professionals, as well. The 
data can serve as a resource for both the clinical and investigative systems as 
they adapt their practices to meet the personal needs of individual infertility 
couples. Finally, couples facing infertility can gain meaningful knowledge on 
lifestyle factors and lifestyle changes that can improve their fertility success rates 
and enhance their infertility treatment.    
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CHAPTER II:  REVIEW OF LITERATURE 
Reproductive Physiology 
For the human species to continue surviving, it is necessary to produce 
fertile offspring. This is necessary to continue the existence of the species and to 
pass on genetic information from generation to generation. The process is 
accomplished through normal reproduction. Organisms generate new individuals 
of the same kind through a sexual or asexual process. Human reproduction is 
any form of sexual reproduction resulting in the conception of a child.  
In Homo sapiens, the natural capability to produce offspring is 
characterized as fertility. Under both genetic and environmental control, fertility is 
influenced by male and female gamete production, fertilization, and gestational 
term. The natural capability of a couple to produce live offspring is considered 
successful reproduction; therefore a lack of success is considered infertility.  
Research has demonstrated a number of biological and environmental 
factors that can possibly lead to the infertility of females, males, or both members 
of the couple. In humans and other similar mammalian species, to become 
pregnant is a complex processes that requires many balancing parts. Any step 
that is disrupted throughout the process may lead to an unsuccessful 
reproductive experience.  
Assisted Reproductive Technology, known as ART, are techniques used 
to aid in achieving reproductive success. Artificial methods to obtain human 
pregnancy involve the treatment of human oocytes, sperm, and/or embryos. 
However, the availability of this assisted therapy has not always existed and is 
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considered a young field in the discipline of science. There is much research left 
to be done and an endless amount of additional knowledge to be gained.  
History of Reproductive Physiology 
The birth of modern reproductive and developmental biology took place as 
early as the 17th century. Spermatozoa were first reportedly discovered, by Anton 
Leeuwenhoek (1632-1723), using a homemade lens magnified 300 fold. In 1780 
scientist Lazzaro Spallazani performed the first recorded successful artificial 
insemination (AI) by developing a technique to artificially inseminate a dog.  
By the 19th century, significant progress in the scientific knowledge of 
mammalian reproduction and development was being reported. Important 
contributions to this progress were the discovery of the ovum by Karl von Baer 
(1792-1876). His observations of the stages of embryogenesis, led to the 
remarkable descriptions made by Edouard Van Benden (1845-1910) of oocyte 
development in rabbits and bats (see Alexandre, 2001) half of a century later. 
Albert Brachet furthered these advancements by his report of keeping a rabbit 
blastocyst alive and developing in blood plasma for 48 hours outside of the 
mother’s body (1912, 1913).   
The second half of the 20th century saw an advancement in mammalian 
embryology when a handful of scientists such as; Biggers, McLaren, and Whitten 
reported the development of murine oocytes in a chemically defined culture 
medium (McLaren and Biggers, 1958; Whitten, 1957). The successful production 
of murine offspring, after the transfer of in vitro cultured embryos was reported by 
13 
 
McLaren and Biggers (1958). This development led to first the successful in vitro 
offspring of several species, including humans.  
Mid-decade, Austin (1951) and Chang and Pincus (1951) reported a major 
technological barrier to in vitro fertilization (IVF); the process of sperm 
capacitation. Sperm capacitation normally occurs in the female reproductive tract 
and renders sperm cells capable of fertilizing ova. However, in 1954, Thibault 
and colleagues successfully accomplished IVF by using sperm cells recovered 
from the uterine milieu of mated does.  
In 1959, Chang reported the birth of the first live mammalian, a rabbit, 
following in vitro fertilization, thus opening the way to assisted procreation. 
Finally, by 1975, it became evident that ejaculated rabbit spermatozoa could in 
fact be in vitro capacitated, enabling in vitro fertilization, and the development of 
resulting embryos into live offspring (Bracket and Oliphant, 1975).    
In 1978, biologist Robert G. Edwards and gynecologist Patrick Steptoe 
produced the first human baby by in vitro fertilization (Steptoe and Edwards, 
1978). In February of 1979, the researchers presented their results to the Royal 
College of Obstetricians and Gynecologists in London. With their study finally 
published in 1980, Edwards and colleagues described that the intentions of their 
research were to recover pre-ovulatory oocytes by laparoscopy, fertilize them in 
vitro using spermatozoa from the husband, grow the embryos in culture three or 
four cleavage divisions, and then place them in the mother’s uterus (Edwards et 
al., 1980). This paper was the first of its kind in a series of papers presenting the 
researchers’ observations, methods of treatment, and results. Many of the 
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applied human embryo culture protocols and resulting implantation rates have 
remained relatively the same as those described by Edwards and collaborators in 
1980. 
Human Reproduction 
In humans, the processes of ovulation and fertilization must occur within a 
specific time frame inside of the female reproductive tract to achieve conception. 
The female ovaries cyclically develop and release a mature, competent oocyte 
through ovulation. A complicated process that involves purposeful destruction of 
follicular tissue, ovulation is initiated by a hormonal surge to expel an unfertilized 
oocyte (Senger, 1999). In 1981, Wright and Bondioli described the series of 
fertilization events in specific order; (1) contact with and penetration of the 
cellular investments of an ovulated oocyte by a spermatozoon; (2) penetration of 
the oocyte’s zona pellucida; (3) fusion of the spermatozoon and oocyte external 
membranes; pronuclei fusion (syngamy); and (4) alignment of their respective 
chromosomes on the first cleavage spindle. Ultrastructure studies have 
documented each of these physiological events (Austin, 1968; Bedford, 1970; 
Zamboni, 1971; Gould, 1975; Gwatkin, 1977).  
The primary structures of in the human female reproductive tract include 
the ovaries, oviducts, uterus, cervix, vagina, and external genitalia, all of which 
play a vital role in maintaining and sustaining gestation. These structures are 
described in great detail in P. L. Senger’s 1999 textbook, Pathways to Pregnancy 
and Parturition. In the same publication, Senger (1999) outlined the primary 
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components of the male reproduction system as well. These male reproductive 
structures will be described in detail in the next section of this review of literature.  
In humans, the moment of conception begins at fertilization, with the 
fusion of viable male and female gametes to produce a new organism. Human 
fertility is dependent on a number of factors; age, nutrition, sexual behavior, 
culture, instinct, endocrinology, timing, economics, way of life, and emotions, to 
achieve each successful conception.  
Male Reproduction 
 Concern has increased on the impact of the environment on public health, 
including reproductive ability (Carlsen et al., 1992). Arising controversy from 
separate reviews have claimed that the quality of human semen has declined 
(Nelson and Bunge, 1974; James, 1980; Leto and Frensilli, 1981; Bostofte et al., 
1983; Osser et al., 1984; Menkveld et al., 1986; Murature et al., 1987; Bendvold, 
1989; Li et al., 1991; Swan et al., 1997; Swan et al., 2000). However, only little 
attention has been invested in these warnings, possibly because the suggestions 
were based on data from selected groups of men recruited from infertility clinics 
(Bostofte et al., 1983; Osser et al., 1984; Menkveld et al., 1986; Bendvold, 1989), 
from among semen donors (Leto and Frensilli, 1981), or from candidates for 
vasectomy (Nelson and Bunge, 1974).  
However, this specific selection of male samples is intentional because of 
the lack of availability on male infertility information in other areas. The limited 
sample groups mentioned in the previous studies are actually the most 
assessable groups from which to gain research on male infertility, even though 
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that information is still incomplete as compared to available research on female 
infertility. It is worthy to note, however, that in 1987 the World Health 
Organization reported that the lower reference value for a ‘normal’ sperm count 
has changed from 60x106/ml in the 1940’s (Hammen, 1944; MacLeod and Heim, 
1945) to the percent value of 20x106/ml (World Health Organization, 1987). 
 In 1992, Carlsen and collaborators concluded that data on semen quality 
collected systematically from reports published worldwide indicated clearly that 
sperm density has declined significantly during 1938-1990, although they could 
not conclude whether or not the decline is continuing. Simultaneously, the group 
pointed out that the incidence of some genitourinary abnormalities; including 
testicular cancer and possibly maldescent and hypospadias have increased. The 
researchers (Carlsen et al., 1992) inferred that such remarkable changes in 
semen quality and the occurrence of genitourinary abnormalities over a relatively 
short period were probably due to environmental rather than genetic factors. 
Furthermore, the researchers proposed that some common paternal influences 
are assumed to be responsible both for the decline in sperm density and for the 
increase in cancer of the testis, hypospadias, and cryptorchidism (Carlsen et al., 
1992). 
The male reproductive system is regulated by interplay between the 
nervous system, the endocrine system and the reproductive gonads. The 
hypothalamus is the neural control center for reproductive hormones and the 
endocrine system relies on these hormones to cause responses in target tissues. 
An important regulator of the spermatogenic process, involving the interplay 
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between the hypothalamus, pituitary and testicles, is the hypothalamus pituitary-
axis (HTP). The presence of specialized neurons in the hypothalamus release 
the gonadotropin-releasing hormone (GnRH) in a pulsatile manner, stimulating 
the production of the two pituitary hormones, luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH), which are the functional link between the 
brain and the testes. FSH targets the Sertoli cells which play a major role on 
sperm germ cell development and LH acts on the Leydig cells stimulating 
testosterone production.  
 To understand the importance of semen quality, it is essential to 
understand that the male reproductive system is made up of a number of 
components that must all be activated at the appropriate time. In addition, at any 
step along the spermatogenesis process, harmful factors can hinder normal 
sperm production. The key components of the male reproductive system 
described by Senger (1999) are as follows: 
Spermatic Cord 
The function of the spermatic cord is to provide vascular, lymphatic and 
neural connection to the body, to provide the countercurrent heat exchanger and 
to house the cremaster muscle (Senger, 1999). All of these components are 
essential in the production of viable spermatozoa by preventing disruptions from 
affecting the function of the testes.  
The spermatic cord extends from the body cavity into the scrotum and 
attaches to the dorsal pole of the testes, suspending the testes in the scrotum. 
Abnormal sperm production or sperm function is correlated with the anatomical 
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function of the spermatic cord and can account for a majority of male infertility 
problems. Undescended testicles, genetic defects, health problems including 
diabetes, prior infections such as mumps, trauma or prior surgeries on the 
testicles or groin inguinal region can all affect sperm production (Mayo Clinic, 
2014).  
The design of the spermatic cord is to create an environment that lowers 
the temperature of the venous blood traveling through the testicular veins, and 
subsequently the testicular arteries. As previously mentioned, the spermatic cord 
suspends the testis in the scrotum, allowing for venous blood to be cooled by 
direct heat loss through the skin of the scrotum. Within the spermatic cord a 
network of veins are tightly intermingled with a highly coiled spermatic artery. 
Through countercurrent heat exchange, the warmer arterial blood temperature is 
cooled by the lower venous blood temperature, maintaining testicular 
temperature at about 4 to 6ºC cooler than the rest of the male body (Senger, 
1999).  
Maintenance of low testicular temperature is imperative for 
spermatogenesis to occur. Any disruption or modification of this cooling system 
will severely compromise; if not completely suppress sperm production. A 
number of male infertility problems can originate from increased testicular 
temperatures, whether it is from the male’s occupation, a sedentary lifestyle or a 
high fever, increased testicular temperature can damage sperm cells. 
In his textbook, Senger (1999) explained that researchers reported 
exposure of the scrotum to hot temperatures for periods of 16 hours a day did not 
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influence the number of spermatozoa. However, a reduction in motility and 
percentage of live spermatozoa occurred when the testes were heated for only 
eight hours per day.  
In addition, frequent exposure to heat, such as in saunas or hot tubs, has 
been shown to elevate testicular temperature and impair sperm production (Shefi 
et al., 2007). The groups’ findings also demonstrated that after heat exposure 
semen quality varied biologically among individuals and could actually be 
reversed in some infertile men (Shefi et al., 2007). Unfortunately, the results of 
common male exposure studies, such as this one, remain unknown to the 
majority of the population. This critically support the fact that it is important for 
male partners to understand the effects of heat exposure as it relates to 
successful pregnancy rates.    
Testes  
The human male gonads have two important functions: (1) they produce 
the hormone testosterone, which produces the deep male voice, beard, and sex 
drive; and (2) they produce sperm (National Institute for Occupational Safety and 
Health, 1996). Serving as the manufacturing and assembly site for the process of 
spermatogenesis, it is in the testes where male gamete production takes place. 
The process of spermatogenesis summarizes all events that transform basic 
spermatogonia into highly specialized mature spermatozoa within the male 
gonads (Wistuba et al., 2007). Before a gamete can leave the testis, it passes 
through several stages of maturation. The process includes mitotic multiplication 
and propagation of the spermatogonial stem cells (SSCs), meiotic recombination 
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of genetic material and testicular maturation of spermatozoa (Ehmcke et al., 
2006).  
Mammalian testes interplay between three systems within the male body, 
the reproductive system, the nervous system and the endocrine system. 
Considered the primary reproductive organ in the male, producing both 
spermatozoa and the androgen testosterone, the testes consist of two major 
compartments, the seminiferous tubules and the interstitium.  
The seminiferous tubules are the place of spermatogenesis and are part 
of the tubular compartment of the parenchyma, a cellular mass of connective 
tissue, of the testicles. The seminiferous tubules also produce a fluid, which 
serving as a vehicle in which spermatozoa are suspended and facilitating in their 
removal from the testes (Senger, 1999). The interstitium is responsible for blood 
supply, immunological responses and contains Leydig cells that mediate 
endocrine signals of the pituitary to the testis and back to other body functions 
(Wistuba et al., 2007).  
In the fully developed mammalian testis, the majority of undifferentiated 
cells of the germ line are type A spermatogonia (Wistuba et al., 2007). This 
population of cells also includes the SSCs. Wistuba et al. (2007) described these 
as the most important cells for spermatogenesis because their task is to provide 
both self-renewal of the SSCs and type B spermatogonia . Type B 
spermatogonia differentiate and develop into primary spermatocytes. The 
primary oocytes undergo meiosis and secondary spermatocytes are produced 
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with reduced genomic content. Another genomic reducing step next leads to the 
development of haploid spermatids (Wistuba et al., 2007).  
In addition to the structural mechanisms of the testes, which produce a 
protein called testes determining factor, the convoluted seminiferous tubules are 
responsible for the production of Sertoli cells. The basic function of the Sertoli 
cells is to nourish the developing sperm through the various stages of 
spermatogenesis. Activated by FSH, Sertoli cells are specifically located in the 
only place in the testes where spermatozoa are produced. Anchored to the basal 
compartment of the seminiferous epithelium, Sertoli cells surround the 
developing population of germ cells. Here a blood-testis barrier is formed from 
the peritubular cells surrounding the seminiferous tubule and the Sertoli cell 
junctional complexes to prevent immunologic destruction of developing germ 
cells. 
Considering the primary role that the testes play in male reproduction, 
there are a number of associated malfunctions that can contribute to infertility. 
Enlarged veins in the testes can increase blood flow and heat, affecting the 
number and shape of sperm. National Institute of Occupational Safety and Health 
(2006) described how reproductive hazards can actually reduce the number of 
sperm produced and/or cause damage to sperm morphology and motility. Just 
this year, Lotti and colleagues (2015) published a study in which infertile males 
smokers showed lower ejaculate and ultrasound-derived seminal vesicles 
volume in the testes, despite higher testosterone levels, when compared with 
non-smokers. Similarly to women, damage related to cancer and its 
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treatments, including radiation or chemotherapy can be detrimental to male 
fertility. In a bi-gender evaluation, Mϋller (2003) described the impact of cancer 
therapy on not only the female but the male reproductive axis.   
Epididymis 
 After an approximate 72 day process, sperm cells exit the Sertoli cell 
junction of the seminiferous tubule and enter into the outer structure of the 
testicles, the epididymis (National Institute of Occupational Safety and Health, 
2006). This environment is necessary for spermatozoa to acquire motility and 
potential fertility. If the sperm are not ejaculated from the epididymis they 
eventually die and are absorbed by the body. 
While controlling their exit from the male reproductive system the 
epididymis also serves a storage reservoir for spermatozoa. Organized into three 
distinct regions known as the head (caput), the body (corpus) and the tail 
(cauda), the epididymal duct is responsible for rhythmic contractions, forcing 
spermatozoa into the tail. The number of sperm in the distal tail can be altered 
dramatically by the frequency of ejaculation. Therefore, spermatozoa spending 
an unusually long time in the epididymal tail may be of poor quality when 
compared to sperm from males ejaculated routinely, contributing to their lack of 
viability (Senger, 1999).   
In 2006, researchers described a male infertility factor associated with this 
site (National Institute of Occupational Safety and Health, 2006). The group 
explained that hazardous chemicals may collect in the epididymis, seminal 
vesicles, or prostate. These chemicals can kill the sperm, change the way in 
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which they swim, or attach to the sperm and be carried to the oocyte or unborn 
child (National Institute of Occupational Safety and Health, 2006). 
Further research supported that insufficient sperm delivery could usually 
be traced back to male infertility issues of the epididymis. Premature or 
retrograde ejaculation, semen entering the bladder instead of emerging through 
the penis during orgasm, certain genetic diseases, such as cystic fibrosis, 
structural problems, such as blockage of the sperm containing epididymis, or 
damage or injury to the reproductive organs are common examples of male 
infertility related to compromised sperm delivery (Mayo Clinic, 2014).  
The vas deferens of the epididymis are the site of vasectomy procedures 
in males who want to be unproductive. Medical data has demonstrated that in the 
cases of men who have previously undergone a vasectomy and desire a return 
of fertility, can undergo a surgical procedure known as a vasectomy reversal for 
sperm to be used in assisted reproductive techniques. Similarly, in the cases of 
men with ejaculatory problems, fertile spermatozoa can be removed from the 
epididymis and used for artificial insemination (Nagler and Jung, 2009).    
Accessory Sex Glands 
When a man ejaculates, the mature sperm cells move through the vas 
deferens, past the seminal vesicles, and the prostate gland (National Institute of 
Occupational Safety and Health, 1996). During this time the accessory sex 
glands are responsible for the final altering, packaging, addition of metabolic 
substrates, and surface coatings for transport of the spermatozoa. Senger (1999) 
explained that with the help of the epididymis, accessory sex glands produce 
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secretions which contribute to the liquid, non-cellular portion of semen known as 
the seminal plasma. Seminal plasma is not required for fertility, but is important in 
natural insemination where a fluid vehicle for delivery of the sperm is needed. 
Male Semen Characteristics 
In one of many reviews, Wistuba and colleagues (2007) echoed that 
spermatogenesis is a highly organized process that requires complex endocrine 
as well as genomic regulation. This process is supported and mediated by 
somatic cell types, the Sertoli cells in the tubules and the peritubular myoid cells, 
and the Leydig cells in the testicular interstitium (Wistuba et al., 2007). During the 
process of spermatogenesis, the initial cells created are called spermatogonia, 
following mitosis they become primary spermatocytes that divide meiotically into 
two secondary spermatocytes. Through Meiosis II each secondary spermatocyte 
divides into two spermatids that develop into mature spermatozoa, known as 
sperm cells. 
The mammalian sperm cell is composed of a head, a midpiece, and a tail.  
The head contains the nucleus, the genetic material that contributes the paternal 
deoxyribonucleic acid (DNA), and is surrounded by the acrosome. Sperm cells 
come in two types, ‘female’ and ‘male’. Sperm cells that give rise to female (XX) 
offspring after fertilization differ in that they carry an X-chromosome, while sperm 
cells that give rise to male (XY) offspring carry a Y-chromosome.  
The acrosome contains enzymes that play a key role in the fertilization of 
the oocyte. Sperm is unable to fertilize an oocyte by natural means if the 
acrosomal cap and/or the enzymes are not produced. The cap consistently 
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comes off during the acrosome reaction just prior to fertilization, releasing 
enzymes that help dissolve the zona pellucida of the oocyte and expose sperm 
receptors that can then bind the sperm to the oocyte.  
Behind the chromosome containing head is a thickened region 
encompassing the cellular mitochondria called the midpiece. In the case of 
sperm, the mitochondria are the engines that drive the propeller-like tail to give 
the sperm its forward motion or motility. The tail flagellates, which propels the 
sperm cell, at about 1 to 3 mm/minute in humans, by whipping in an elliptical 
cone movement (Ishijima et al., 1986). In a 2011 study, Sousa and colleagues 
suggested that one of the differences in sperm fertilization ability between 
ejaculates may be attributed to the number of sperm in the ejaculate with 
functioning mitochondria.  
For the purposes of this literature review, the characteristics of 
spermatozoa will be described in common averages, despite the specific 
variability found among human male samples in the available literature. 
Research has demonstrated that the mean values for human sperm head 
dimensions in length are 4.3 μm, width 2.9 μm, area 10.3 μm2, and perimeter 
12.5 μm (Bellastella et al., 2010). These averages are closely related to the 2010 
WHO criteria described for normal semen which are as follows; head length 
4.1μm, width 2.8 μm, and ratio 1.5 (World Health Organization, 2010). 
To claim that there has been controversy over the years in generating a 
specific normal human spermatozoa reference range would be one of the biggest 
understatements of the infertility industry. Selecting for normal spermatozoa is 
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plagued with difficulties, the assessment of 'oval', 'smooth', 'irregular', and 
'asymmetric' is extremely subjective (Menkveld, 2010; Auger, 2010). In a 2010 
report, Bellastella and collaborators added to the list of researchers who have 
described that semen samples from different men containing spermatozoa of 
different sizes.  
Researchers proposed that these differences reflect the stresses affecting 
the spermatozoa, during smearing and air drying of the semen sample that are 
known to produce swelling of immature sperm heads (Yeung, et al., 1997; Soler 
et al., 2000), apparent loss of cytoplasmic droplets (Cooper et al., 2004), and cell 
shrinkage (Katz et al., 1986). The group of researchers explained that the 
response of the cells to these stresses may be characteristic of each individual 
male. Under evaluation circumstances, spermatozoa with expanded post-
acrosomal regions were also detected in human semen (Ludwig and Frick, 
1990). Bellastella et al. (2010) emphasized that if these samples are less mature 
spermatozoa, detecting them would be of value in diagnosing epididymal 
dysfunction. 
Another factor hindering the evaluation of semen in vitro is that, due to its 
alkaline nature, a sperm cell does not gain full hypermotility until it reaches the 
female vagina where the alkaline pH is neutralized by acidic vaginal fluids. This 
gradual process takes 20 to 30 minutes inside the female reproductive tract. In 
assisted reproductive technology the challenge has been for researchers to 
create the same final development environment in vitro.  
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The sensitivity of the sperm production process is magnified due to the 
characterization of the sperm cell. The spermatozoon contains a minimum 
amount of cytoplasm and has the most densely packed DNA known in 
eukaryotes. Compared to mitotic chromosomes in somatic cells, sperm DNA is at 
least six fold more highly condensed (Ward and Coffey, 1991). As previously 
mentioned the production and storage of sperm cells inside the male gonads 
takes 70 to 74 days from start to finish. Therefore, at any point during this time 
the testicular assembly line can produce sperm with defects from a number of 
factors. 
Male Semen Evaluation 
In 1929, Macomber and Sanders published one of the earliest 
assessments of sperm concentration in human semen and reported a median of 
approximately 100 million spermatozoa per milliliter, using blood pipettes and an 
unidentified counting chamber. In the following decades, systematic studies were 
undertaken with the examination of semen from men whose partners were 
interesting discrepancy between results of different centers that surfaced since 
then has been reviewed by Zukerman et al. (1977) and MacLeod and Wang 
(1979), especially concerning what should be taken as discriminating values for 
fertility.  
In most normal domestic animals, the evaluation of sperm reveals a 
generally homogeneous population in individual species. Man, however, is in a 
small group of species generating semen specimens that exhibit extreme 
heterogeneity or pleomorphism of sperm morphology between (Menkveld et al., 
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1990; Menkveld, 1991; Mortimer, 1994) and even within (Hartmann et al., 1964) 
specific individuals. Just as the sperm homogeneity observed in animals 
simplifies the process of determining and defining normality of spermatozoa, the 
opposite is the case with human spermatozoa. Researchers have unsuccessfully 
tried to define a ‘fertile’ group or ‘fertile’ individual among human populations 
(Freund, 1966; Mortimer, 1994). However, inaccurate drawings and increased 
emphasis on the description of abnormal spermatozoa more than normal 
spermatozoa (Freund, 1966; Hellinga, 1976; Comhaire et al., 1994) consequently 
led to an unclear definition of morphologically normal sperm cells with no 
definitive criteria (Page and Holding, 1951). 
In the 1980s, Menkveld (1987) introduced a new concept for the 
evaluation of sperm morphology, ‘normal spermatozoan’. However, investigators 
continued to recognize that the morphological data of semen being reported was 
center-dependent, and highly dependent on the method used to determine the 
percentage of normal forms, indicating that these differences were procedural 
(World Health Organization, 1999). This continued to emphasize the need of 
having clear sperm categorization guidelines applied consistently throughout the 
industry.  
In 1995, Menkveld and Kruger stressed that for a spermatozoon to be 
considered as morphologically normal by ‘strict’ criteria, the normal biological 
variations should be kept as small as possible to ensure repeatable evaluation. 
Thus, the ‘complete’ spermatozoon must be normal as described by the 
standards of Menkveld (1987, 1991) and Menkveld et al. (1990). This strict 
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criteria is in contrast with other liberal evaluation systems (Freund, 1966; 
Eliasson, 1971; Mortimer, 1985; Comhaire et al., 1994) that use lower reference 
limits to categorize abnormal sperm. The researchers pointed out that in these 
more generous liberal evaluations, all spermatozoa that are not classified as 
abnormal will be regarded as normal, resulting in two sperm populations 
(Menkveld and Kruger, 1995). Therefore, just because a sperm is not abnormal, 
considering it normal may lead to a faulty classification of the fertility potential of 
a specific male.  
In the same study, Menkveld and Kruger (1995) described the 
characteristics that a sperm cell must exhibit to be considered morphologically 
normal by strict criteria. The sperm head must have a smooth oval configuration 
with a well-defined acrosome comprising 40.0 to 70.0% of the anterior sperm 
head. Normal head dimensions are head length and width between 3.0 to 5.0 µm 
and 2.0 to 3.0 µm, respectively, as suggested by Eliasson (1971). No neck, 
midpiece, and/or tail defects must be present. The midpiece must be slender, 
axially attached, ≤ 1μm in width, and approximately 1.5 times the head length 
(Menkveld and Kruger, 1995). Tails must be straight, uniform, slightly thinner 
than the midpiece, uncoiled, and ± 45 μm long (Menkveld and Kruger, 1995).  
 In their report, Menkveld and Kruger (1995) reaffirmed that most 
researchers are in agreement when describing morphological evaluation of 
human spermatozoa as one of the most controversial semen parameters. The 
importance of morphology is seen in terms of its role in establishing male fertility 
potential, and its role as a prognostic parameter for fertilizing ability in vivo 
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(Menkveld et al., 1990) or in assisted reproduction (Fraser and DasGupta, 1993; 
Kruger, 1994). Adding to the controversy, sperm reference ranges continue to 
change from decade to decade and vary from one publication to another.  
Therefore, although semen analysis is routinely used to evaluate the male 
partner in infertile couples, sperm measurements that discriminate between 
fertile and infertile men are not well defined (Guzick et al., 2001). A typical semen 
analysis is used to grade the quality of a sperm sample; the number of sperm per 
milliliter of ejaculate, as well as the morphology and motility of the sperm are 
measured. Common morphological defects observed are double heads, double 
tails, abnormally sized acrosomes, missing acrosomes, kinked tails, missing 
heads, missing acrosomes, short tails, and abnormally sized heads.  
Currently the majority of sperm samples are graded under one of two 
grading criteria: Kruger’s Strict criteria, as described above, or The World Health 
Organization criteria. In a 2010 report titled, ‘World Health Organization reference 
values for human semen characteristics’, Cooper et al. described the updated 
WHO guidelines. The following lower one-sided reference limits, with 95.0% 
confidence, were generated from men whose partners had been trying to get 
pregnant less than or equal to 12 months: semen volume, 1.5 ml; total sperm 
number, 39 million per ejaculate; sperm concentration, 15 million per ml; vitality, 
58.0% live; progressive motility, 32.0%; total motility, 40.0%; and morphologically 
normal forms, 4.0% (Cooper et al., 2010).  
Research has shown that a number of factors may influence the accuracy 
of a semen analysis results; in addition results for a single man can have a large 
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amount of natural variation over time. Advanced research has clarified that male 
age and reproductive threats can contribute to the malformation of sperm cells, 
hindering the capability of fertilization, and male reproduction (Moline et al., 
2000). For this reason, Weschler (2002) had previously suggested that a 
subfertile result must be confirmed with at least two further analyses.  
As couples wait longer to have children, it is important to acknowledge 
that paternal factors provide an equal emphasis on reproductive success. 
Essentially, it is just as important to understand the characteristics of the semen 
in these infertile men and how to correctly distinguish and treat them for 
increased fertility.  
Human Infertility 
 Infertility is an increasing public health issue in the United States that 
affects women, men, and couples. In a 2014 national report, the Centers for 
Disease Control and Prevention (CDC) explained that, depending upon the 
underlying cause, infertility can be treated by gynecologists, urologists, and 
reproductive endocrinologists using a range of medical options, including advice 
on the timing of intercourse, drugs to stimulate ovulation, surgery, and ART 
procedures (Centers for Disease Control and Prevention, 2014).  
In the past two decades, there has been an explosion of interest in the 
scientific advancement of human reproduction and assisted conception. It has 
been theorized that the increase in assisted reproductive technology rates is due 
to the present societal trend of parents delaying childbirth. There is an ongoing 
debate among researchers over the fact that human fertility is actually declining 
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or that fertility treatments are increasing because couples are waiting longer to 
conceive, needing more assistance at an advanced age. 
As opposed to our parents’ generation, a majority of individuals today are 
focused more on their careers in their 20’s and 30’s, while waiting to start families 
later in life. As a result men and women are attempting to conceive at an older 
age with increased years of possible exposure. For couples who do end up 
experiencing infertility, a collective progression of medical treatments is available 
through assisted reproductive technology and research continues to evolve daily. 
For a human pregnancy to occur, every part of the complex reproductive 
process has to take place at just the right time. Females release at least one 
mature oocyte from one or both ovaries to be picked up by the fallopian tube. 
Males produce mature, viable spermatozoa that swim up the female cervix, 
through the uterus and into the fallopian tube to fertilize the newly released 
oocyte(s). The fertilized oocyte then travels down the fallopian tube to the uterus, 
where it implants and grows into a fetus. History has shown that a number of 
known and unknown factors can disrupt this process at any step.  
Infertility is defined by the World Health Organization (2014) as a disease 
of the reproductive system characterized by the failure to achieve a clinical 
pregnancy after 12 months or more of regular, unprotected sexual intercourse, 
excluding reasons such as breastfeeding or postpartum amenorrhea. In the U.S., 
a commonly used definition of infertility is when a woman under 35 has not 
conceived after 12 months of contraceptive-free sexual intercourse and a woman 
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over 35 has not conceived after 6 months of contraceptive-free sexual 
intercourse (Cooper et al., 2010).  
The reasons for infertility can involve one or both partners and can be 
congenital and present from birth and/or from environmental or lifestyle factors. 
In some instances, a cause for infertility is never found and it is possible that a 
combination of several minor factors in both partners underlie these unexplained 
fertility problems. Therefore, the more knowledge we gain on the factors that 
affect human fertility, the more tools we will have to decipher the problem.   
Prior studies have shown a strong paternal effect of sperm DNA damage 
on in vitro fertilization outcome, including reduced fertilization, reduced embryo 
quality and cleavage rates, reduced numbers of embryos developing into 
blastocysts, increased percentage of embryos undergoing developmental arrest, 
and reduced implantation and pregnancy rates (Simon et al., 2014). The quality 
of the semen sample is also responsible for the advancement of certain maternal 
gestational factors, such as the development of the placenta. In addition, recent 
research has shown that damaged or aged sperm possibly poses later health 
risks for the offspring of older fathers. 
Understanding male sperm production is important in appreciating the 
vulnerability of the sperm to environmental and chemical exposures. One 
common misunderstanding is that the male manufactures millions of sperm daily, 
therefore, activities engaged in weeks or months earlier do not have an effect 
upon the sperm quality. Although the human male does produce millions of 
sperm daily, it takes approximately 72 days to actually create and store the 
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sperm within the testicles. Therefore, there is over two months of time before 
conception that the male can be exposed to environmental circumstances that 
could slow or harm the healthy genetic development of the sperm cell 
(Pressinger, 1997). In addition, as the reproductive age of the human male 
increases, researchers have become less confident in the well accepted theory 
of an infinite male fertility period.  
Closer evaluation has suggested a number of hypotheses as to why male 
reproductive senescence occurs. For example, some researchers have 
speculated that programed gene expression changes are responsible. While 
others have proposed it is due to cumulative damages caused by biological 
processes. However, whether senescence as a biological process can be slowed 
down, halted, or even reversed; is a subject of current speculation and research.  
Rather than becoming aged, as the term cellular senescence suggests, it is 
hypothesized that these specific sperm cells are representative of a change in 
cell state.     
Unlike virtually every other cell in the body, sperm cells have no defense 
mechanism. Any toxin that damages a sperm cell causes it to generate high 
levels of free radicals that can damage surrounding cells as well. Determining the 
factors that lead to increased semen damage will help to initiate more effective 
treatment plans that may include: taking supplemental antioxidants, improved 
healthier lifestyle, varicocele repair, medication revaluation, and avoidance of 
various types of heat and chemical exposure.  
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Recommendations already include suggestions for males to avoid 
exposure to some common work and environmental toxins like: organic solvents, 
oil products, processed foods, chlorinated and fluorinated water, paint, 
photographic supplies, irradiation, heat, combustion engine exhaust fumes, and 
heavy metals. The past 10 years have shown an increase in studies linking weak 
or defective sperm to employment in occupations with exposure to chemicals and 
pesticides (Strohmer et al., 1993). 
Dependent upon patient diagnosis, couples may start fertility treatment 
with partially assisted reproductive techniques and progress to more advanced 
methods as treatment progresses. One of the first methods commonly 
implemented is ovarian stimulation, a hormonally controlled procedure in which 
females receive drug treatments to induce ovulation through the production of 
multiple follicles. At the time of ovulation, either sexual intercourse is performed 
by the couple or the use of additional assisted reproductive techniques, such as 
artificial insemination, are implemented. AI can be performed through intrauterine 
insemination (IUI) of the sperm into the female reproductive tract using artificial 
means other than sexual intercourse.  
The next level of treatment is the most frequently used procedure in 
assisted reproductive technology. In vitro fertilization, or IVF, is the joining of 
sperm and oocytes outside of the body in production of a fertilized zygote. 
Following three to five days of in vitro culture, the embryo(s) are transferred into 
the female reproductive tract. Embryo transfer (ET) is performed on a 
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corresponding date with the cyclic female uterus by using artificial means to 
implant the fertilized embryo.  
In some instances, a further assisted reproductive technique may be 
implemented. Intracytoplasmic sperm injection (ICSI), most commonly used for 
male infertility problems, is an in vitro fertilization procedure that occurs outside 
of the body where micromanipulation of a single sperm cell is injected into the 
oocyte. As with IVF, the developing embryo is transferred through artificial means 
into the female reproductive tract after three to five days of development.        
The Use of Assisted Reproductive Technology 
The Society for Assisted Reproductive Technology (SART) reported that 
in 2012, of the group’s 379 member clinics in the United States, 165,172 assisted 
reproductive cycles were performed (Society of Assisted Reproductive 
Technology, 2013). These procedures resulted in the birth of 61,740 babies, an 
increase of more than 2000 infants from 2011. Although the use of ART is still 
relatively rare as compared to the potential demand, its use has double over the 
past decade. In 2012, the American Society of Reproductive Medicine reported 
an estimated 3.9 million babies born in the U.S., the number of IVF babies 
constituting over 1.5% of all births in the U.S. (American Society of Reproductive 
Medicine, 2014). This was the largest number of cycles, of babies and 
percentage of babies born through IVF ever reported (American Society of 
Reproductive Medicine, 2014). 
Numerous previous analyses have shown that women in the United States 
who make use of medical help for fertility problems are a highly selective group 
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among those who have fertility problems. Data from nationally representative 
surveys, primarily the National Survey of Family Growth, but also clinic-based 
studies, have shown that fertility-impaired women who use infertility services are 
significantly more likely to be married, non-Hispanic white, older, more highly 
educated and more affluent than nonusers (Chandra and Stephen, 2008; Greil et 
al., 2011; Hirsch and Mosher, 1987; Kalmuss, 1987; Nachtigall, 2006; Staniec 
and Webb, 2007; Stephen and Chandra, 2000; Wilcox and Mosher, 1993).  
Reasons for the disparities in use of infertility services may include access 
barriers such as the significant cost of medical services for infertility and the lack 
of adequate health insurance to afford the necessary diagnostic or treatment 
services (William, 1997; Smith et al., 2011). Unlike the extensive infertility 
healthcare in other countries, such as Denmark, currently only 15 U.S. states 
have passed insurance mandates to cover ART. Unfortunately, there is evidence 
to suggest that these mandates have done nothing to better the difference in 
rates of infertility treatment by race or ethnicity and socioeconomic status (Bitler, 
2012).  
After a 1995 review, Schmidt and colleagues assumed that about 50.0% 
of all Danish couples experiencing infertility seek ART treatment. In Denmark, the 
number of initiated treatments with IVF and ICSI performed at public and private 
fertility clinics has increased by 83.0%, from approximately 6,000 per year to 
more than 11,000 per year, within the last 10 years (Schmidt, 2006; The Danish 
Fertility Society, 2009). However, infertility treatment is widely available in 
Denmark within both the public and private healthcare systems (Nyboe Anderson 
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et al., 2005). The public system has offered all infertile couples up to three in vitro 
fertilization treatments free of charge. 
However, Aitken (2014) explained that ART treatments are often delivered 
without critically considering the underlying causes of the condition or seriously 
contemplating the long-term consequences of the current enthusiasm for such 
therapy. Critical factors supporting the need of couples to engage in ART can 
range from advanced maternal age to a variety of lifestyle factors, such as 
smoking and obesity, which are known to compromise the developmental 
potential of the oocyte and DNA integrity in the spermatozoa.  
Advanced Age and Human Infertility 
As the societal trend for older parents to have children increases, health 
concern about age-associated risks of infertility, abnormal pregnancies, and birth 
defects remain a top concern. In a 2008 publication, Maheshwari claimed that 
since the 1980’s infertility rates in humans have increased by 4.0%, mostly from 
problems with fecundity due to an increase in age.  
Conversely, in a national survey conducted from 1982 to 2010, Chandra 
and colleagues (2013) reported that infertility rates have actually decreased 
among U.S. women of childbearing age from 8.5 to 6.0%. One explanation of this 
common contradiction may arise from data that showed an increase in actual 
fertility treatments. It is quite possible that although fertility ‘treatments’ have 
increased because many couples are having children later in life, it is debatable 
that infertility ‘rates’ among humans are increasing as well.  
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Presently, the most common difference in fertility being observed among 
couples is age. Research shows that individuals need more help in their 40’s to 
obtain pregnancy than in their 20’s. The reasons behind this increased uptake in 
ART treatments are complex. Aitken (2014) proposed that this was a 
consequence of the high incidence of spontaneous male infertility and the 
advanced age at which couples are now attempting to start their families. His 
2014 research demonstrated that age has a dramatic effect on the human 
capacity to reproduce (Aitken, 2014).  
A growing body of literature has been compiled on the influence of 
maternal age on adverse fetal birth outcomes (Abel et al., 2002; Astolfi and 
Zonta, 1999; Croen et al., 2007; de la Rochenbrochard and Thonneau, 2002; 
Salihu et al., 2003; Salihu et al., 2008). Such studies have produced a wealth of 
evidence of an association between advanced maternal age and increased risks 
of fetal loss, preterm delivery, and small size for gestational age (Astolfi et al., 
2006; Astolfi and Zonta, 1999; Fretts and Usher, 1997; Nahum and Stanislaw, 
2002; Raymond et al., 1994; Salihu et al., 2008). Both in general and in relation 
with specific pathologies, researchers have shown that female age induced an 
overall reduction in the chance of bearing a child, and in particular a healthy child 
(Cnattingius et al., 1992; Fretts et al. 1995; Bianco et al., 1996; Dollberg et al., 
1996; Breart, 1997; Faden et al., 1997; Horta et al., 1997; Tarin et al., 1998; 
Gilbert et al., 1999; Pattenden et al., 1999; Astolfi and Zonta, 2002).  
The pressure of the modern career-minded women to meet their twin 
goals of having a family and achieving their professional aspirations makes 
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delaying child bearing inevitable (Aitkin, 2014). This trend is observed in the 
number of first births to US women aged 35 to 39 years that increased by 36.0% 
between 1991 and 2001 and the rate among women aged 40 to 41 increased by 
a staggering 70.0% (Heffner, 2004).  
Lansac (1995) demonstrated that female fecundity declines precipitously 
by the fourth decade of life due to oocyte loss, increased risks of miscarriage, 
trisomies, and/or chromosomal defective offspring. A decade later, Aitken (2014) 
likewise supported the idea that female fertility declines precipitously between the 
ages of 35 and 42 years. Although, coming from both historical records and data 
generated by assisted conception clinics, the Human Fertilization and 
Embryology Authority (2010) claimed the decline can be seen as controversial.  
Studies that have examined paternal age as a risk factor for adverse birth 
outcomes have yielded mixed results as well. Although some studies found an 
association between advanced paternal age and increased risk of spontaneous 
abortion (de la Rochenbrochard and Thonneau, 2002; Kleinhaus et al., 2006; 
Slama et al., 2005), preeclampsia (Harlap et al., 2002), stillbirth (Nyboe 
Anderson et al., 2004; de la Rochenbrochard and Thonneau, 2002), 
schizophrenia (Kϋhnert and Nieschlag, 2004; Malaspina et al., 2001), autism 
(Reichenberg et al., 2006), low birth weight (Tough et al., 2003), and other birth 
defects (Kϋhnert and Nieschlag, 2004; Savitz et al., 1991; Yang et al., 2007), 
other studies found no evidence of a relationship between advanced paternal 
age and adverse fetal birth outcomes (Abel et al., 2002; Chen et al., 2008; 
Nahum and Stanislaw, 2003; Parker and Schoendorf, 1992).  
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This midlife decline in human fertility sets our species apart from all other 
primates, where mortality and reproductive lifespan are coincident and very few 
individuals experience reproductive senescence before death (Alberts et al., 
2013). The reason for this is unknown but may simply be that we have, as a 
consequence of improvements in primary health care, managed to push the 
limits of human mortality beyond the lifespan of the primordial follicle population 
(Aiken, 2014) or the age associated ability to produce quality spermatozoa 
(Singh et al., 2003; Schmid et al., 2007; Das et al., 2013). 
In a 2007 study, Yang et al. explained that although the association 
between maternal age and the risks of birth defects has been well studied, the 
role of paternal age has received relatively little attention. As early as 1912, 
Weinberg hypothesized a genetic component in the effect of advanced age 
suggesting that sporadic cases of achondroplasia, a genetic disorder, could be 
associated with paternal ageing. However, it was not until the past decade that 
research has become more heavily focused on male age as a factor in human 
infertility. In 2013, Chandra and Wu acknowledged that among men, some form 
of infertility was reported by 9.4% of those aged 15 to 44 and by 12.0% of those 
aged 25 to 45 from 2006 to 2010. 
The current societal trend for older parents to have children has raised 
public health concern and encouraged more research to be designed on male 
age-associated risks of abnormal pregnancies and birth defects. Although 
spermatogenesis continues well into male senescence and some men of 
advancing age can father children, in two separate studies, Kidd and colleagues 
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(2001) and Slotter and colleagues (2004) both engaged the subject of male 
fecundity declining with age. It is well known that men have been able to father 
children well in to their 90’s, therefore it seems difficult to contrast the loss of 
fertility due to advanced age in men versus women (Kidd et al., 2001; Slotter et 
al., 2004). However, the risks of abnormal pregnancies and heritable effects 
associated with advancing paternal age are poorly understood, thus increasing 
the development of interest in exploring this outcome. 
Research has demonstrated that older men produced more sperm with 
DNA damage as a consequence of age-associated increased oxidative stress in 
their reproductive tracts (Barnes et al., 1998; Barroso et al., 2000). In 1997, 
Kodama and colleagues reported an association between oxidative DNA damage 
in sperm and male infertility. 
Studies that followed showed that as men age the quality of their gametes 
deteriorates (Singh et al., 2003; Schmid et al., 2007; Das et al., 2013). As a 
result, the spermatozoa of ageing males contain much more DNA damage than 
their younger counterparts. Studies on the Brown Norway rat and the 
senescence accelerated mouse (SAM) both suggested that the origin of this age-
dependent increase in DNA damage in the germ line is oxidative, reflecting the 
general relationship between oxidative stress and ageing observed in most 
biological systems (Paul et al., 2011; Smith et al., 2013).  
Alternately, apoptotic functions of spermatogenesis may be less effective 
in older males resulting in the release of more sperm with DNA damage 
(Brinkworth et al., 1997; Print and Loveland, 2000). Brinkworth and Schmid 
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(2003) reported that the testes of older male mice have lower apoptotic 
frequencies than young adults. It was shown that oxidative stress significantly 
increased the frequencies of apoptotic spermatocytes in young male mice while 
reducing testicular apoptosis in older males (Barnes et al., 1998).  
In 2002, Morris and colleagues reported that sperm DNA damage was 
positively correlated with donor age and with impairment of post-fertilization 
embryo cleavage following ICSI, indicating an overall decline in the integrity of 
sperm DNA in older men. Aitken and colleagues (2003) explained that oxidative 
stress can damage sperm DNA, as well as mitochondrial and nuclear 
membranes. Consistent with the hypothesis of the importance of oxidative 
damage to sperm, it was reported that high antioxidant intake was associated 
with better semen quality, especially motility within the same study group 
(Eskenazi et al., 2005).  
In 2007, Schmid and colleagues found associations between male age 
and sperm DNA strand damage in a non-clinical sample of active healthy non-
smoking workers and retirees. Sperm of older men had significantly higher 
frequencies of sperm with DNA damage measured under alkaline conditions, 
which is thought to represent alkali-labile DNA sites and single-strand DNA 
breaks (Schmid et al., 2007). At the conclusion of the study, Schmid and 
colleagues (2007) determined that age-related increases in sperm DNA damage 
predict that men who delay fatherhood may have increased risks of unsuccessful 




Research has also demonstrated that increased sperm DNA damage has 
been associated with chromosomal abnormalities, developmental loss and birth 
defects in mouse model systems (Marchetti et al., 1997; Haines et al., 1998; 
Hughes et al., 1999; Marchetti et al., 2004), and with increases in the percentage 
of human embryos that fail to develop after ICSI (Morris et al., 2002). Previous 
studies have explained that each successive fragmentation introduces a slight 
risk of error in the genetic material of the new sperm, and this is then passed on 
to the child (Wyrobek et al., 2006).  
Previous studies have also demonstrated that as the age of the father 
increased, the risk of miscarriage and, if the pregnancy does carry to term, 
disease in the offspring, increased in parallel (Aitken and Krausz, 2001; Aitken et 
al., 2004; Kleinhaus et al., 2006). There is a sum of epidemiological evidence 
that have suggested the incidence of abnormal reproductive outcomes and 
heritable defects increase with paternal age (Tarin et al., 1998; de la 
Rochebrochard and Thonneau, 2002), including pregnancy loss (Risch et al., 
1987; de la Rochebrochard and Thonneau, 2002), developmental and 
morphological birth defects (Lian et al., 1986), gene mutations (Crow, 2000; 
Tiemann-Boege et al., 2002), various aneuploidy and chromosomal syndromes 
(Slotter et al., 2004), and diseases of complex aetiology, such as prostate cancer 
(Zhang et al., 1999).  
Research published from the Columbia University School of Public Health 
in 2006 suggested that women who become pregnant by older men are at far 
greater risk of having a miscarriage (Kleinhaus et al., 2006). The researchers 
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noted that the risk of miscarriage appeared to rise along with the father's age, 
regardless of the mother’s age. Even after a range of other risk factors which 
contribute to miscarriage were taken into account, such as smoking during 
pregnancy and maternal diabetes, the risk was still higher (Kleinhaus et al., 
2006).  
This study analyzed data from a survey of nearly 14,000 pregnant women 
undertaken in Jerusalem between 1964 and 1976 (Kleinhaus et al., 2006). The 
group also demonstrated that the risk of losing the pregnancy was 60.0% higher 
when the father was 40 or older, compared to when he was 25 to 29 years old. 
The risk of losing the pregnancy was approximately three times greater when the 
man was between 35 and 39 years of age, than if he were younger than 25 
(Kleinhaus et al., 2006).  
Advanced age has been a significantly studied factor in the fertility of 
human females, and more recently additional attention has been focused males. 
Evidence has suggested that men may in fact have a biological time clock slightly 
similar to that of women. However, men seem to have a gradual rather than 
abrupt change in fertility and the potential ability to produce viable offspring.  
Aside from age, there are a number of other possible factor(s) in humans 
that play a role in the infertility of a couple. However, it is extremely important to 
note, that research has proven about 40.0% of the issues involved with infertility 
are due to the man, another 40.0% are due to the woman, and 20.0% result from 




Environmental Lifestyle Factors and Male Infertility 
In a 2014 research article that evaluated lifestyle and male fertility, 
Jurewicz and colleagues explained that semen quality in the adult male can be 
affected by a number of environmental and lifestyle factors. The group explained 
that the increasing trend in male infertility observed in recent years may be 
associated at least in part with these factors, which are compounded by a 
change in lifestyle. Lifestyle associated exposures including cigarette smoke, 
alcohol, caffeine, use of mobile phones, and body mass index (BMI) have been 
studied in relation to male semen quality (Fejes et al., 2005; Jensen et al., 2010; 
Magnusdottir et al., 2005; Ramlau-Hansen et al., 2007; Li et al., 2009).  
Additional research demonstrated that between 10.0% and 15.0% of all 
couples experience fertility problems due to a variety of causes (Schmidt et al., 
1995; Eugster and Vingerhoets, 1999; Juul et al., 1999), and infertility is 
increasing in the industrialized countries, possibly due to social and behavioral 
factors along with environmental exposures (Skakkebaek et al., 2006). Present 
research has shown that external factors linked to lifestyle negatively affect 
spermatogenesis, both at the central and gonadal levels (Rato et al., 2014).  
It has been shown that epidemiological and controlled animal studies in 
the lab suggested that paternal nutritional and toxicological exposures, as well as 
age, impact the health of the male and the health of his children. These studies 




Male exposures, in isolation from female exposures, have been shown in 
experimental studies to be capable of affecting the entire spectrum of the 
reproductive health endpoint (Olshan and Faustman, 1993) through mechanisms 
involving sperm. Such effects most likely occurred from male exposures in the 
three months prior to conception (Schrader and Kesner, 1993). This suggestion 
parallels the human spermatogenesis timeframe, approximately 72 to 74 days, 
including the transport of sperm through the ductal system. 
 An important lifestyle-dependent factor that adversely affects 
spermatogenesis is obesity (Jurewicz et al., 2014). Several studies have shown 
up to a threefold higher incidence of obesity in infertile men than in those with 
normal semen quality (Hammoud et al., 2008a; Magnusdottir et al., 2005). 
 Also, studies on caffeine intake and semen quality have shown 
contradictory results. Some researchers suggested no associations (Oldereid et 
al., 1992; Ramlau-Hansen, 2008), whereas others found reduced sperm 
concentration as well as reduced total sperm count and motility (Jensen et al., 
2010; Sobreiro et al., 2005). Several studies also examined the effect of smoking 
and alcohol drinking on sperm parameters, but their results were inconsistent 
(Jurewicz et al., 2014). Additional studies (Marinelli et al., 2004; Povey et al., 
2012) but not all (Li et al., 2011; Ramlau-Hansen et al., 2007; Vine, 1996) 
suggested that smoking and alcohol had a limited effect on semen quality. Other 
studies have shown factors such as smoking, alcohol and caffeine consumption 
to be associated with increased genetic damage in blood cells (Park and Kang, 
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2004; Glei et al., 2005, Wyrobek et al., 2005a), but little is known about their 
effects on genetic damage in sperm (Wyrobek et al., 2005b). 
 Nevertheless, growing reviews of male subfertility have highlighted how 
aspects of male lifestyle may significantly increase the risk of subfertility (Li et al., 
2011; Sadeu et al., 2010). These reviews further suggested that higher age, 
smoking, alcohol consumption, and psychological stress were risk factors for 
poor semen quality (Li et al., 2011; Sadeu et al., 2010).  
BMI and Male Infertility 
 The World Health Organization (2014) defines obesity as a BMI ≥ 30 
kg/m2. The Journal of the American Medical Association reported that obesity is a 
public health disorder that affects more than 34.9%, 78.6 million, of U.S. adults 
(Ogden et al., 2014). In addition, infertility is a public health disorder that affects 
10.0% of the worldwide population (Monmandi et al., 2013). Despite one third of 
infertility cases being attributed to male factors, studies on the impact of BMI on 
male fertility are still very limited and controversial as compared to the multiple 
studies evaluating the impact of overweight in women’s fertility (Monmandi et al., 
2013).  
 Research has demonstrated increased evidence that female obesity has a 
negative effect on assisted reproductive technology outcomes (Bellver et al., 
2010; Luke et al., 2011; Pasquali et al., 2003). Excessive weight in women 
undergoing ART treatments has been associated with lower pregnancy rates, 
lower live birth rates, fewer normally fertilized oocytes and the need for higher 
doses of gonadotropins (Bellver et al., 2010; Luke et al., 2011; Maheshwari et al., 
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2007; Shah et al., 2011). Notably, recent studies have demonstrated the effects 
of overweight and obesity on reproductive health in which both members, male 
and female, are at an increased risk of subfertility (Ramlau-Hansen et al., 2007).  
As obesity has become a more serious health problem in the western 
world, researchers speculated that it is partly to blame for the decline in male 
fertility. The average U.S. male has a BMI of 29, which is highly overweight 
(Centers for Disease Control and Prevention, 2012). Some investigators agreed 
that high BMI levels may reduce male fertility and associated it with reduced 
semen quality and hormone alterations (Jensen et al., 2004; Kort et al., 2006; 
Fejes et al., 2005; Fejes et al., 2006). In addition, overweight men may be at 
greater risk of erectile dysfunction (Fung et al., 2004), which could lead to 
reduced fertility.   
In 2008, researchers found a higher incidence of oligozoospermiea and a 
greater prevalence of low progressive sperm count in male patients with 
increased BMI levels (Hammoud et al., 2008b). Additional research 
demonstrated that overweight and obesity in males have been associated with 
poorer semen quality (Sermondade et al., 2012), higher sperm DNA damage 
(Chavarro et al., 2010; Kort et al., 2006; Tanrikut et al., 2010), and infertility 
(Sallmén et al., 2006). In 2011, from a sample of 2,035 male patients, Shayeb 
and colleagues reported that obese men were more likely to have lower semen 




Determined through data obtained from a large patient sample size, Belloc 
and colleagues (2014) reported that semen volume decreased from 3.3±1.6 to 
2.7±1.6 mL when BMI increased from normal, 20 to 25 kg/m2, to extreme male 
obesity, >40 kg/m2, respectively. In addition, the group reported decreased 
semen concentration from 56.4±54.9 to 39.4±51.0 million/mL, total sperm count 
from 171±170 to 92±95 million, and progressive motility from 36.9±16.8 to 
34.7±17.1% when male BMI increased from normal to extreme obesity (Belloc et 
al., 2014). The percentage of cases with azoospermia and cryptospermia also 
significantly increased in connection to higher BMI levels (Belloc et al., 2014). 
However, morphology was not affected as reported by the group.  
 As BMI becomes an increasingly debated topic among male fertility, more 
than one cause of its relationship with couples’ reproductive success is being 
investigated. Some research has shown that obesity has been associated with 
significant disturbance in the hormonal environment that can affect the 
reproductive system. 
In 2007, Nguyen and collaborators demonstrated that excess weight may 
be linked with altered testosterone, estradiol levels, poor semen quality, and 
infertility (Nguyen et al., 2007). When research participants were divided into 
eight categories of male BMI patients, a trend of increased male infertility and 
increased male BMI was observed (Nguyen et al., 2007). Nguyen and colleagues 
(2007) explained that more research is needed to see if weight loss improves 
fertility for men with high BMI levels. 
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Additional research indicated that male BMI is inversely related to 
androgens levels and positively related to estrogens (E2) levels resulting in a 
hormonal profile consistent with hypogondotropic hyperestrogenic 
hypoandrogenemia (Hammoud et al., 2008a; Giagulli et al., 1994; Chavarro et 
al., 2010). The higher E2 levels are reported to have a deleterious effect on 
endogenous gonadotropin secretion as they interfere with GnRH pulsatility 
(Hammoud et al., 2008a; Akingbemi, 2005).  
The specific relationship between male BMI and ART outcomes have 
been examined even less extensively. Due to the scarce and controversial 
literature (Keltz et al., 2010; Colaci et al., 2012) available on this topic, it is 
difficult to correctly assess the origins of differences between these research 
studies. These discrepancies continue to support the importance of further 
evaluating the relationship between male obesity and ART outcomes.  
In 2010, Keltz and colleagues conducted a retrospective analysis that 
showed that couples with an overweight or obese male partner, BMI >= 25 
kg/m2, undergoing traditional IVF had lower clinical pregnancy rates than couples 
with a lean male. However, they did not find this same association in ICSI cycles 
(Keltz et al., 2010). 
In 2012, Colaci and co-workers claimed to initiate the first prospective 
study that addressed the relationship between male BMI and ART outcomes in 
which these associations were adjusted for the most important female 
characteristics that are known to have a critical effect on the overall outcome 
(Weghofer et al., 2005; Chung et al., 2003; Omland et al., 2005; Dunson et al., 
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2004). The group actually reported higher fertilization rates among obese men 
than among normal weight men in conventional IVF cycles and found no 
significant associations between male BMI and the proportion of poor quality day-
3 embryos, slow embryo cleavage rate, or accelerated embryo cleavage rate 
(Colaci et al., 2012).  
The findings of Colaci and colleagues (2012) were in agreement with 
Bakos and colleagues (2011) who reported no association of male BMI with 
overall fertilization rate or day-3 in vitro embryo quality. However, in their 2011 
study, Bakos et al. found a significant reduction of blastocyst development and 
lower pregnancy rate associated with increasing male BMI. In support of those 
results, a recent animal study concluded that male obesity was related to 
reduced embryo cleavage, decreased development to the stage of blastocyst, 
lower implantation rate, and lower fetal development (Mitchell et al., 2011).   
Samavant and colleagues performed a preliminary study in 2014 and 
demonstrated that the acrosome reaction in sperm is impaired in obese men. 
The study showed a reduced response to progesterone and an elevated 
spontaneous acrosome reaction (Sp-AR), associated with altered circulating 
levels of E2 and sperm cholesterol content in males with higher BMI levels 
(Samavant et al., 2014).  
In addition, practitioners have contested that as BMI increased the DNA 
fragmentation rate of sperm increased as well, creating a dramatic reduction of 
sperm quality (Kort et al., 2006; Chavarro et al., 2010; Fariello et al., 2012; La 
Vignera et al., 2012). As previously mentioned the more sperm with fragmented 
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DNA, the higher the chances of miscarriage and lower the chances of conception 
(Sakkas and Alvarez, 2010).  
Adding to the controversy, in 2015 Schliep and colleagues reported that 
weight status did not influence fecundity among couples undergoing infertility 
treatment. However, the group stressed that given the limited and conflicting 
research on BMI and pregnancy success among IVF couples, further research 
designed to include other adiposity measures is needed (Schliep et al., 2015). 
Although the influence of male BMI on fertility remains controversial and 
understudied, there does seem to be some multifactorial relationship, therefore, 
additional studies are needed to determine the association.  
Male Environmental Exposures 
Caffeine   
Studies on caffeine intake and semen quality have shown contradictory 
results as well; some suggested no associations (Oldereid et al., 1992; Ramlau-
Hansen, 2008). Others found caffeine exposure reduced sperm concentration, 
total sperm count, and sperm motility (Jensen et al., 2010; Sobreiro et al., 2005; 
Vine, 1996). In their 1999 study, Sarkaria and colleagues demonstrated that 
caffeine is an efficient inhibitor of DNA double-strand repair, which may explain 
the increased double-strand DNA damage in sperm after high-dose caffeine 
consumption. 
In 2007, Schmid and colleagues found that men with caffeine consumption 
of about three cups per day had significantly higher frequencies of sperm with 
DNA damage as measured under neutral, but not alkaline conditions compared 
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to men with less caffeine consumption. Whereas, in 2014 Jurewicz et al. reported 
that drinking coffee one to six times per week was related to an increase in the 
percentage of motile sperm but also in sperm head abnormalities. The group 
additionally associated drinking coffee every day with an increase in sperm neck 
abnormalities (Jurewicz et al., 2014). However, it was noted that the estimation of 
caffeine intake based on self-report can be a problem because cups of coffee 
vary in strength related to brewing and brand and caffeine is present in many 
products that would not necessarily be recognized and reported during the 
interview (Jurewicz et al., 2014).  
Chemical Exposure 
As early as 1972, it was shown that paternal exposure to mutagenic 
compounds increased the rate of spontaneous abortions in animals (Epstein et 
al., 1972). However, in humans this relationship remains relatively unclear. For 
vinyl chloride (Infante et al., 1976), anesthetic gases (Tomlin, 1979), 
dibromochloropropane (Kharrazi et al., 1980), chloroprene (Sanotsky, 1976), 
smelter work (Beckman and Nordström, 1982), waste water exposures (Morgan 
et al., 1984), and organic solvents (Taskinen et al., 1989), effects on human 
fertility have been suggested, but the data either have been contradictory or 
remain unconfirmed. 
In 1983, Donner et al. reported that rubber chemicals contained several 
microbial mutagens and Lindbohm and colleagues (1983) reported an increased 
risk of abortion observed among women exposed to rubber chemicals. An 
excessive rate of spontaneous abortion was also found among the wives of 
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workers in a waste water treatment plant of a petroleum refinery (Morgan et al., 
1984) and among the wives of workers exposed to organic solvents (Taskinen et 
al., 1989).   
Researchers also found an association with male infertility among some 
paternal occupations: metal-plate and constructional steel workers, crushers and 
grinders, sewage, workers caring for fur-bearing animals (Lindbohm et al., 1984), 
and mechanics and repairers of motor vehicles (McDonald et al., 1989). In a 
1991 study, Lindbohm and colleagues evaluated 25 specific mutagens or groups 
of mutagens. Paternal exposure to ethylene oxide, rubber chemicals, solvents 
used in petroleum refineries, and solvents used in manufacture of rubber 
products were the only four chemicals that the group found to be associated with 
an increased risk of spontaneous abortion. However, Lindbohm and colleagues 
(1991) were unable to separate the routes of exposure; harmful substances 
transmitted to the pregnant woman by contact with clothes or by semen leading 
to secondary maternal exposure. 
Among the chemicals, Lindbohm and colleagues (1991) acknowledged 
that ethylene oxide had been identified as a mutagen by almost all mutation 
assays, including the dominant lethal assay (International Agency for Research 
on Cancer, 1988). Exposure to this chemical has also been associated with 
spontaneous abortion in women who use ethylene oxide to sterilize hospital 
instruments (Hemminki et al., 1982).  
Several studies have addressed the pesticide dibromochloropropane as a 
proven cause of male infertility. A report by Kharrazi et al. (1980) suggested a 
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threefold increased risk of miscarriage in the offspring of exposed males. 
Additional studies indicated a decrease in the proportion of male offspring after 
paternal exposure (Goldsmith et al., 1984; Potashnik et al., 1984). 
Dibromochloropropane exerts its effects through direct testicular toxicity, which is 
not known to occur from other more commonly used pesticides (Kharrazi et al., 
1980).    
In 1993, Moses described studies of both maternal and paternal pesticide 
exposure in relation to such endpoints as infertility, miscarriage, stillbirth, preterm 
delivery, low birth weight, and birth defects. For miscarriage, Olshan and 
Faustman (1993) published clear experimental evidence of a paternal effect. In 
addition, epidemiologic literature offered at least some replicated indications of 
an environmental contribution to human infertility (Savitz et al., 1994).  
A 1996 report from the National Institute for Occupational Safety and 
Health (NIOSH) identified a number of workplace substances such as, lead and 
radiation as reproductive hazards for men. The study explained that the harmful 
substances can enter the body by inhalation, contact with the skin, or ingestion, if 
workers do not properly wash their hands before eating, drinking or smoking.   
  In 1997, Savitz et al. claimed that despite the generally favorable health 
experience of farmers, potential adverse reproductive health effects associated 
with pesticides were of concern. The group identified five activities that were 
presumed to involve direct pesticide exposure:  mixing or applying crop 
herbicides, crop insecticides and fungicides, livestock chemicals, yard herbicides, 
and building pesticides (Savitz et al., 1997). The results of the study provided 
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some indication that male farm activities may influence the risk of preterm 
delivery, particularly when occurring in combination with reported applications of 
specific chemicals on the farm (Savitz et al., 1997).  
 The overall implication of the study results of Savitz and colleagues (1997) 
added to the interest in a possible role of male pesticide exposure in adverse 
pregnancy outcome and directed attention to both preterm delivery and 
miscarriage. With their refined measures of exposure and outcome, the 
researchers pointed out that detailed consideration of male pesticide exposure in 
relation to sperm function and genetic alterations would help to bridge 
experimental and epidemiologic studies (Savitz et al., 1997).   
The blood-testis barrier is a defense mechanism that has been shown to 
protect testicular cells from direct exposures to high levels of hazardous 
chemicals in the blood (Cheng and Mruk, 2012). Vigeh et al. (2011) supported 
this theory with their review of lead toxicity on reproductive hormones. The group 
suggested that lead’s main influence on male reproduction probably occurred by 
altering the reproductive hormonal axis and the hormonal control on 
spermatogenesis, rather than by a direct toxic effect on the seminiferous tubules 
of the testes. In a previous study, Wong and collaborators (2004) discovered that 
cadmium, as well, caused changes on the blood-testis barrier before inducing 
vascular changes.  
Effects of cadmium on the blood-testis barrier are well document in the 
literature (Hew et al., 1993; Chung and Cheng, 2001, Cheng and Mruk, 2002). In 
1993, researchers proposed that cadmium may promote disruption of Sertoli cell 
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tight junctions (Hew et al., 1993). Chung and Cheng (2001) proposed that 
cadmium reduced tight junction proteins responsible for cell adhesion that 
participate in intercellular sealing (Cheng and Mruk, 2002) expression in Sertoli 
cells.  
Cigarette Smoke  
Reviewing another common environmental exposure, Vršanská and 
colleagues (2003) explained that in addition to being widely recognized as a 
health exposure hazard, smoking cigarettes also affected reproductive health.  
The link between smoking and female fertility disorders, including poor embryo 
development following in vitro fertilization treatment and even infertile offspring 
has been well established (Zenzes, 2000). Smoking has also been associated 
with delayed conception, in human females, (Baird and Wilcox, 1985) and a 
reduced number of retrieved oocytes leading to premature menopause (Bolumar 
et al., 1996).  
 Supporting the notion that smoking has contributed to the worldwide 
decline in semen quality; male studies that examined environmental factors and 
paternal fertility have demonstrated an association between cigarette smoke and 
sperm concentration. In 1992, Carlsen and collaborators systematically reviewed 
61 studies of semen quality conducted over 50 years and found that mean sperm 
concentration worldwide fell by half from 113x106/ml in 1940 to 66x106/ml in 
1990. In 1993, Giwercman et al. concluded that such a fast decline in semen 
quality was probably due to environmental, rather than genetic factors. The group 
suggested that in utero exposure to environmental oestrogens, pollution and 
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lifestyle exposures, including cigarette smoking were possible causes of this 
decline in quality (Giwercman et al., 1993).  
In a 1996 paper, through meta-analysis of studies previously between 
1981 and 1982, Vine showed that smokers’ sperm concentration was on average 
about 15.0% lower than that of non-smokers. Two decades later, Lotti and 
colleagues (2015) confirmed that male smokers showed lower ejaculate and 
lower ultrasound-derived seminal vesicles volume, despite higher testosterone 
levels, when compared with non-current smokers.   
Cadmium, a heavy metal previously discussed as an environmental 
exposure, is present in tobacco as well. Stassen et al. (1990) demonstrated that 
smoking cigarettes, and most likely second hand smoke inhalation, represented 
a primary source of inhaled cadmium. Investigators have hypothesized that 
second hand smoke has caused a significant decline in the fertility ability of men 
(Cheng and Mruk, 2012). Researchers explained that cadmium is a known 
teratogen and carcinogen that accumulates over a period of years and is easily 
incorporated in the reproductive tissues such as gonads and uterus (Pařízek et 
al., 1969; Hamada et al., 1998). 
In a 2009 murine study, Oliveira and colleagues, reported that short term 
effects of cadmium resulted in an increased fraction of sperm with abnormal 
morphology, premature acrosome reaction, and reduced motility. Late term 
effects included a drastic reduction of sperm cell numbers and sperm motility, as 
well as, an increased detection of DNA fragmentation (Oliveira et al., 2009).  
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Previously, in a 2000 study, Telisman et al. reported decreased male 
fertility related with occupational exposure to cadmium. In addition, an 
association was observed, by Xu and colleagues (2003), between the presence 
of cadmium in seminal plasma and decreased sperm quality and increased 
sperm oxidative damage. In 2007, Ozmen and colleagues detected a cadmium 
based correlation between progressive motility and human sperm cells. In the 
same study, the group observed a relationship between DNA fragmentation and 
acrosome integrity in sperm cells exposed to cadmium (Ozmen et al., 2007).   
The Centers for Disease Control and Prevention (2006) suggested that 
cigarette smoke leads to infertility through a combined effect of decreased sperm 
motility with active paternal smoking, decreased tubal patency with active 
maternal smoking, and/or second hand smoke exposure. The observed 
relationship between lifestyle exposures and the adverse effects on male 
reproductive health has increased the need for further smoking related studies.   
Heat Exposure 
Research has demonstrated that an increase in testicular temperature is 
considered another environmental exposure that has a negative effect on male 
fertility. In 2007, Shefi and investigators described that increased testicular heat, 
such as in saunas or hot tubs, elevated the testicular temperature and impaired 
sperm production. In 2014, Rato and colleagues further described such 
sensitivity to increased testicular heat, that even a sedentary lifestyle should be 
considered a potential confounder for reduced sperm count because of the 
increase scrotal heat.  
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Senger (1999) explained that researchers found that exposure of the 
scrotum to hot temperatures for periods of 16 hours a day did not influence the 
spermatozoal numbers. However, a reduction in motility and percentage of live 
spermatozoa occurred when the testes were heated for only eight hours per day. 
Additionally, the group observed that when 16 hours per day of heat was applied 
to the scrotum the survival of embryos produced by normal females was reduced 
(Senger, 1999). 
Male Infertility Length with Current Partner 
In a 2005 publication, Wright and colleagues were in agreement that the 
rising number of children born after assisted reproductive technology is a 
reflection of the increasing number of couples seeking treatment for infertility. 
Recent studies have emerged stating that underlying infertility and time to 
pregnancy is a proposed risk factor for adverse pregnancy outcomes, 
independent of maternal age (Zhu et al., 2006).  
About 10.0 to 20.0% of couples who are trying to become pregnant 
experience a waiting period to pregnancy longer than 12 months, which is the 
clinical definition of infertility in most industrialized countries (Juul et al., 1999). A 
2000 study suggested that the older a man was the higher his infertility length 
with current partner (ILCP) or the longer it may take his partner to conceive, 
regardless of her age (Ford et al., 2000). The authors’ claimed that women with 
partners five or more years older have less chance of conceiving within a year of 




The investigation, through a large population study, was conducted by 
Ford and colleagues in 2000 to evaluate the effect of paternal age on time to 
conception. The group reported that older men were significantly less likely than 
younger men to impregnate their partners in ≤6 or in ≤12 months. Interestingly, 
the average male age in which fertility expressed a significant decline was similar 
to that of previous research studies on women.  
The independent effects of female ageing on fertility among the general 
population have been clearly demonstrated using donor insemination as a model 
(Federation CECOS et al., 1982). After age 30 years, a slow decline has been 
observed in females and it rapidly increased after 40 years; now the main limiting 
factor in the treatment of infertility (Hull et al., 1996; Templeton et al., 1996; 
Spandorfer et al., 1998). However, a decline in male fertility with age has never 
been confirmed or quantified by studies in the general population. Male fertility 
remains difficult to measure directly except in small and atypical populations such 
as couples attending fertility clinics. In addition, quantification of the effect of 
advanced male age is confounded by many other factors. Weinstein and Stark 
(1994) acknowledged that studies on the ageing of a male can be compromised 
by the ageing of his partner and/or the decline in coital frequency associated with 
prolonged co-habitation. 
Ford and colleagues (2000) took those effects into consideration and after 
adjustment the results of their study demonstrated a statistically significant 
increase with advancing male age in the proportion of couples who took longer 
than 6 or 12 months to conceive. The average age of the men who took >6 
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months to impregnate their wives was 31.8±5.75 years compared with 30.8±5.27 
years in men who took ≤6 months (Ford et al., 2000). In addition, the group 
discovered that men who took >12 months were also significantly older, 
32.6±5.91 years, than men who took ≤12 months, 30.9±5.32 years (Ford et al., 
2000). 
From their 2000 study, Ford et al. reported that the odds of conceiving 
within six months of trying decreased by 2.0% for every year that the man is 
older than 24 years, and for conception within a year decreased by 3.0% for each 
year. The group came to the conclusion that the probability of an ultimately fertile 
couple taking >12 months to conceive nearly doubles from approximately 8.0% 
when the man is <25 years to approximately 15.0% when he is >35 years. The 
authors proposed that these results suggested a larger decline in male fecundity 
with advancing age than reported in earlier population studies. 
There are a number of researchers that believe time to conception can be 
a useful epidemiological marker of fertility. Even so, it has to be used with caution 
because it ignores couples who fail to conceive and is subject to a number of 
sources of bias (Baird et al., 1986; Joffe and Li, 1994; Olsen et al., 1998; Spira, 
1998; Tuntiseranee et al., 1998).  
Significance of Male Infertility Research  
It is important to note that 10.0% of couples attempting to have children 
suffer from infertility. According to a 2001 report from Guzick and colleagues, 
each year 1.2 million men seek help for infertility and 15.0% are accurately 
diagnosed with male factor infertility using a semen analysis. Seventy percent of 
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IVF cycles fail for reasons unknown. However, sperm is suspected to contribute 
significantly to this failure rate.  
Heightened by current societal trends to delay parenthood, understanding 
the effects of male age on semen quality is especially relevant for men attending 
reproductive clinics. The reliance on modern technologies, especially among 
marginally fertile older men is steadily increasing (Schmid et al., 2007). Although, 
ICSI and IVF have enhanced the probability of achieving fatherhood, they also 
circumvent the natural barriers against fertilization by damaged sperm (Maher et 
al., 2003; Singh et al., 2003). Further research needs to be done to better 
understand the mechanisms that are involved in the decline of sperm quality and 
fertilization capabilities, with regards to advanced male age and environmental 
lifestyle exposures. 
Reproductive Clinician Perspective 
 Due to the increased proportion of infertile couples adopting to conceive 
by in vitro fertilization, predicting outcomes is of ever increasing importance in the 
human fertility industry (Brincat et al., 2014). Clinicians agree, since pregnancy 
rates following IVF are still quite low, prognostic information is very helpful in 
clinical decisions. Brincat and colleagues (2014) explained that although 
significant research is available on the maternal influence, updated male factor 
infertility research is still relatively unavailable for clinician application.  
 A new concern addressing the human fertility industry is the lack of 
adequate information clinicians are giving to patients on male infertility factors. 
Investigators from various industries have conveyed a number of sources that 
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have led to this phenomenon in male fertility treatment. However, most clinicians 
agree on two major issues that hinder sufficient male participation and treatment; 
a lack of consistent and current male infertility data and the deficiency in personal 
medical information provided by male patients. Both of these concerns are 
significant contributors to less efficient clinical treatment of male infertility factors. 
Additionally, this supports the current discrepancy in the treatment process 
experienced individually by the male and the female within the infertility couple.  
Researchers have explained that male patients appeared to be more likely 
to confide in and desire information and emotional support from infertility 
clinicians rather than from friends or mental health professionals (Glover et al., 
1994; Hammarberg et al., 2010; Brucker and McKenry, 2004). Therefore, if 
patients are not getting adequate information on male infertility factors from their 
doctor visits they are highly unlikely to learn about fertility issues and lifestyle 
exposure factors through additional resources.   
In a 2010 review of research, Dancet and colleagues discovered that in 
only 5.0% of studies concerning patients’ perspectives on fertility care focused 
specifically on the male perspective. Throsby and Gill previously broached this 
subject in a 2004 study of the male experience and ART. The pair reported that 
the normative assumption about the importance of child bearing and rearing 
coupled with the focus of ART treatment on the woman’s body have reduced the 




Coupled with the abundant research on the natural behavioral differences 
observed between males and females, male reproductive studies have reinforced 
that men are more likely to avoid issues concerning their personal infertility. 
Hjelmstedt et al. (1999) found that significantly more men, approximately 50.0%, 
than women had not shared their infertility issues with another person. The group 
interpreted the study results as a reflection of the inherent male frustrations of 
being in a situation that is poorly understood and in which assured treatments are 
availably researched or described to the patient. 
Greil and colleagues (2010) explained that men can be affected by 
infertility in several ways: through receiving a diagnosis of their own infertility, 
through being the partner of a woman who is infertile, or through being part of a 
couple with unexplained infertility. Although the psychological and social aspects 
of infertility, fertility treatment with ART, and infertility-related childlessness have 
been investigated comprehensively in women, the psychosocial consequences of 
infertility for men are less well understood (Greil et al., 2010). Therefore, with 
continued research, clinicians would have the ability to provide male patients with 
answers to the unknown factors and encourage improvements in their 
environmental lifestyles to enhance their personal reproductive success.  
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CHAPTER III:  RETROSPECTIVE STUDY 
EXAMING MALE INFERTILITY; THE ASSOCIATION BETWEEN 
AGE, ENVIRONMENT, AND REPRODUCTIVE SUCCESS IN MALE 




In high-income countries, approximately 15.0% of heterosexual couples 
experience difficulties conceiving when pregnancy is desired, and in up to half of 
these couples, infertility is attributable to the male partner (Skakkebaek et al., 
1994). Inhorn (2009) explained that in the world’s resource constrained low and 
lower-middle income countries, the prevalence of infertility in couples is thought 
to be higher because of undetected and untreated reproductive-tract infections. 
Research has proposed several theories on the exact mechanisms that 
are responsible for the age-related decline in male fertility. Yet, scientists are still 
unable to determine exact mechanisms that are to be blamed (Belloc et al., 
2014). One obstacle to overcome is the natural heterogeneous nature of human 
sperm. Semen samples in humans are so variable that it has been difficult for 
investigators to define the exact mechanisms. 
In addition to age, there are a growing number of male infertility factors 
that are receiving new interest from reproductive scientists. Recent research has 
reported controversial results on a number of possible male infertility factors such 
as; lifestyle exposures, BMI, and ILCP. However, the fact that the exact 
associations have not been found has done nothing to deter the ever rising 
popularity of assisted reproductive physiology treatments. 
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In 2011, a total of 151,923 ART procedures performed in the U.S. were 
reported to the Centers for Disease Control and Prevention (2012). These 
procedures resulted in the birth of 61,610 infants. In line with the rising ART 
procedures is the rising age of couples receiving infertility treatment. 
A number of studies demonstrated that as female age increased, fertility 
rates decreased. Yet, little research attention has been focused on male related 
infertility factors. The few studies performed; claim that 40.0 to 50.0% of infertility 
problems experienced by couples originate from paternal factors. Considering 
that statement, male age and lifestyle need to be equally factored into the 
equation. 
To date, research has identified these potential predictors: fertilization, 
age, reactive oxygen species, sperm quality parameters, and DNA fragmentation 
(Brincat et al., 2014). Predictors under investigation which have shown promising 
signs in data include: folate and homocysteine, anti-mullerian hormone 
measurement, environmental factors, body mass indexes, smoking, male age, 
stress, some subsets of antisperm antibodies, and epigenetic features (Brincat et 
al., 2014). However, no definitive predictive value of these and more male 
infertility factors have been isolated to accurately gauge reproductive success. 
In a 1998 review, Tarin and colleagues explained that late spermatids and 
immature and mature spermatozoa do not have a DNA repair system. Moreover, 
the activities of antioxidant enzymes within the seminal plasma and spermatozoa 
from older men may be reduced, thus, contributing to the reason that 
spermatozoa of older men are more vulnerable to mutational changes.  
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These detrimental effects can lower the overall sperm count by stopping 
or slowing the actual production of sperm. The fewer the normal sperm that are 
present the less likely it is that the oocyte will be successfully fertilized. In 
addition, these adverse factors can cause decreased mobility, abnormal 
morphology, and/or other DNA damage. Many defects can contribute to impaired 
fertilization so ideally, the fewer sperm with problems, the more likely that the 
sample has good fertilizing potential (Menkveld and Kruger, 1995).  
Male and female gametes each contribute 23 DNA storing chromosomes 
at fertilization. Therefore, any damage, breaks, or changes in DNA can result in 
the inability of the sperm to fertilize the oocyte. If the altered sperm cell does in 
fact fertilize the oocyte, then development of the embryo and fetus may be 
affected, causing miscarriage or possible health problems for the offspring 
(National Institute for Occupational Safety and Health, 1996).    
 Investigators perform semen analysis testing to diagnose and manage 
male infertility. However, the limitations of conventional testing methods have 
been well documented. The most commonly evaluated parameters are sperm 
volume, sperm morphology and sperm motility. Recently, a number of more 
sophisticated assays including; measurements of sperm DNA fragmentation 
rates, seminal oxidative stress, and antioxidant capacity have been identified 
(Barazani et al., 2014). However, they are not a standard in the evaluation of 
male infertility and many clinics do not test for such additional parameters. 
Previous research has led to the need of implying a female cutoff age. As 
researchers are discovering semen quality is a large contributor to reproductive 
70 
 
success, further research will help to determine if cutoff ages need to be applied 
for males as well. Theoretically, if cutoff age limits were currently mandated 
under federal law, having age limits for females and not males would be 
considered sex discrimination. We can only assume that these issues and more 
will arise in the next decade. 
Purpose and Objectives of the Study 
 
This study was designed to investigate the effect of male age and 
environmental lifestyle factors on the reproductive outcome of patients who had 
previously participated in clinical fertility treatments. Prior research has 
demonstrated that advanced female age, among other female factors, is directly 
related to reproductive success. However, there has been a limited amount of 
research performed on the effects of advanced paternal age and male lifestyle 
factors on reproductive success. This study was designed as part of a two 
component project to address these influences. 
Reproductive clinicians are being confronted with elevated pressure to 
produce successful fertility treatments for an increasing number of couples. As 
older age and environmental factors are being shown to reduce reproductive 
success rates, more information regarding this problem is necessary to 
implement more efficient practices of infertility treatment programs.  
In the first study, reproductive success will be determined through a 
combination of outcome variables; semen analysis, including sperm volume, 
concentration, morphology, motility, and percent normal, and biochemical 
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pregnancy rates. The type of reproductive treatment administered will be 
recorded as IVF or ICSI. 
The original purpose of this study was to evaluate possible correlations 
between male age and environmental lifestyle factors that posed a threat to male 
fertility. Originally, data on approximately 50 variables were attempted for 
collection from male electronic medical records; they were subsequently 
narrowed down based on various factors. The selected variables were isolated 
for two specific reasons; they were listed in the review of literature and they 
provided the most consistent data available in the male medical charts. The 
following list of specific objectives was designed by the researcher to evaluate 
any possible correlations:  
1. To describe clinical and study sample data on infertility patients who 
have participated in retrospective ART treatments from 2011 to 2014 at a 
private human fertility clinic in the southwestern region of the United 
States on the following selected characteristics. 
2. To determine if there is a relationship between the age and reproductive 
success rate of male infertility patients who have participated in ART 
treatments at a private human fertility clinic in the southwestern region of 
the United States as measured by a randomized retrospective evaluation 
of patient charts from 2011 to 2014.   
3. To determine if there is a relationship between environmental lifestyle 
factors such as; male occupation, cigarette smoking, alcohol use, caffeine 
use, recreational drug use, hot/bath tub use, steroid use, high fever, 
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and/or chemical exposure, and reproductive success rate of male infertility 
patients who have participated in ART treatments at a private fertility clinic 
in the southwestern region of the United States as measured by a 
randomized retrospective evaluation of patient charts from 2011 to 2014.  
4. To determine if there is a relationship between male body mass index 
(BMI) and reproductive success of male infertility patients who have 
participated in ART treatments at a private fertility clinic in the 
southwestern region of the United States as measured by a randomized 
retrospective evaluation of patient charts from 2011 to 2014. 
5. To determine if there is a relationship between infertility length with 
current partner and reproductive success in male infertility patients who 
have participated in ART treatments at a private fertility clinic in the 
southwestern region of the United States as measured by a randomized 
retrospective evaluation of patient charts from 2011 to 2014. 
Materials and Methods 
Research Design 
The primary purpose of this retrospective study was to determine if a 
relationship existed between advanced male age infertility factors and human 
reproductive success. After a review of the literature, the researcher chose to 
investigate three additional variables of controversy; male environmental lifestyle 
exposures, male BMI, and infertility length with current partner. 
A retrospective study was conducted using anonymous data from patients 
who had previously participated in ART cycles. The samples included patients 
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treated from 2011 to 2014 at a private human fertility clinic in the southwestern 
region of the United States. Reproductive success was determined by assessing 
biochemical pregnancy rates and semen analysis. 
The study was designed to address research findings from the review of 
literature and available patient data observed retrospectively. The following 
objectives were written in the form of research hypotheses to be tested: 
1. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates as male age increased in these patients. 
2. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates based on cigarette smoking. 
3. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates based on alcohol usage. 
4. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates based on caffeine usage. 
5. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates as BMI levels increased in these patients. 
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6. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates as ILCP increased in these patients. 
The dependent variables for this study were biochemical pregnancy rates 
and semen quality. Commonly evaluated semen parameters used to determine 
quality were; volume, concentration, motility, progressive motility, percent normal, 
and total motile sperm per specimen. Independent variables were male age and 
male environmental lifestyle factors such as; urological history, chemical 
exposure, male BMI, and infertility length with current partner. 
Approval to conduct this study was obtained from the Louisiana State 
University Institutional Review Board, IRB# E8892 (Appendix A). Exemption was 
granted under the compliance of the guidelines for human retrospective studies. 
In addition, a request to waive patient consent forms was approved by the IRB 
for reasons that; the type of research presented no risk of harm to the subjects 
and there would be no way to trace the study data back to the individual 
participant(s) (Appendix B). In addition, there was a high possibility that some 
participants may not be accessible to sign the consent waiver as they were no 
longer patients of the clinic. 
In August of 2014, a study collaboration agreement was discussed 
amongst the primary researcher and the laboratory director of a private human 
fertility clinic located in a largely populated area of the southwestern region of the 
United States. The specific clinic was selected for a number of reasons; the 
utilization of advanced electronic patient records, proven clinical success rates, a 
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high volume of diversified patients among a large area, and the consistency of 
the same technician performing semen evaluations and assisted fertility 
procedures. 
In a positive association, The Society for Assisted Reproductive 
Technologies (SART) has reported more than once that the current study clinic 
consistently outperformed the national average. According to the recently 
released SART report on 2013 IVF cycles, or procedures involving IVF, the study 
clinic once again achieved one of the highest IVF success rates in the nation. In 
2013, SART reported that the national average pregnancy of women under the 
age of 35 was 47.7% (Society for Assisted Reproductive Technology, 2013); the 
collaborating clinic reported an average of 58.3% (Society for Assisted 
Reproductive Technology, 2013). The clinic also reported success rates for 
women ages 35 to 37 at 43.2% and women between the ages of 38 to 40 at 
59.5%, significantly higher than respective national figures, 39.2% and 28.5% 
(Society for Assisted Reproductive Technology, 2013). 
With IRB and private clinic approval, the retrospective study was designed 
around initial clinical patient consultations. Each patient and their partner were 
asked to complete an electronic questionnaire. Both males and females were 
requested to examine approximately 50 questions on lifestyle factors; such as 
physical characteristics, medical history, fertility history, urological factors, 
infertility length with current partner, gender specific questions, and a history of 
various exposures. The descriptive information collected from these 
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questionnaires was incorporated into each new patient’s secured electronic 
medical records. 
Population and Sample 
The population of the study was defined as male infertility patients and 
their partners who have previously participated in fertility treatment(s). The 
patients specifically went through ART treatment cycles from 2011 to 2014, at a 
private human fertility clinic in the southwestern region of the United States. In a 
retrospective analysis of the total population, the average female age was 35 
years old and a pregnancy rate of 55.0% was observed by the researcher. 
A sample of 132 randomly selected female patients was obtained from the 
original population of ART participants. Matching male partner data was 
subsequently collected from patient electronic medical records. The random 
sample of females was each assigned an identification number. Then male 
partner information was collected and assigned a corresponding identification 
number.  
Instrumentation and Data Collection 
In September of 2014, e-mail correspondence between the Researcher, 
the Reproductive Laboratory Director, and the Medical Director was exchanged 
regarding the study proposal and IRB approval. On December 16, 2014 the 
researcher e-mailed the fertility clinic a signed copy of a confidentiality and 
nondisclosure agreement designed specifically for this study (Appendix C). In 
addition, a copy of the IRB approval form and project summary were forwarded 
to the clinic. On January 20, 2015, at the invitation of the lab director, the 
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researcher visited the human fertility clinic to further present the purpose and 
rationale of the retrospective study and to discuss lab protocol. In agreement, the 
group decided that the most useful and accurate patient information would be 
obtained from cycles performed from June 2011 to December 2014. This time 
period would provide the most complete electronic medical records. At the 
conclusion of this meeting, the confidentiality and nondisclosure agreement was 
verified and additionally signed by the Medical Director. 
The initial study proposal was to include a multi-center population of male 
patients; however, the group decided that the diversity of the population in this 
particular clinic, the normal to above normal average success rates, and the 
consistency of using the same evaluator would produce generalizable results. 
Additionally, in the review of literature, the researcher examined a large 
population of studies that came from individual clinics. 
Over the next two months, the researcher traveled to the fertility clinic for 
three to four days at a time to securely collect patient data. This was done to 
ensure that the sample patient identification was kept anonymous. The laboratory 
directory generated a discrete list of all female patients who had partaken in a 
treatment cycle or multiple cycles in the previous six years, listing only patient 
identification number, retrieval date, female age, peak E2 at hCG, βhCG levels 
on day 14, and the observation of a gestational sac(s).  
Variables associated with male infertility factors were initially collected 
following a review of related literature and analysis of the specific clinic survey 
questionnaire. Original variables collected were; male and female age and 
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biochemical pregnancy status. From the female patient medical charts fertility 
partners were identified as male, female, or donor. The date and type of the ART 
treatment was collected in addition to the date of semen collection and 
characteristics analyzed. Descriptive male factors such as; height, weight, male 
BMI, infertility length with current partner, pregnancy history, medication history, 
and longtime illness history, were also collected. Urological and environmental 
lifestyle variables collected included; male occupation, patient and partner 
smoking history, male caffeine and alcohol consumption, history of vasectomy, 
hormone treatment, impotence, testicular abnormalities, white blood cell count in 
semen, male recent high fever, male hot/bath tub use, steroid use, recreational 
drug use, and male chemical exposure. 
Through an extensive review of the female electronic patient records of 
the randomly selected sample, available data was collected and couples were 
recorded by their corresponding sample numbers. Patient numbers were 
recorded into an excel spread sheet with female age and the presence of a 
biochemical pregnancy. Male information was added to the document and 
identification numbers were recorded as one complete sample. For example, a 
female sample number 111 was correlated to male partner number 111.111 and 
their data were recorded jointly as a sample couple. 
Data Collection 
Pregnancy status based on gestational sac(s) presence, were observed 
by an ultrasound technician at an eight week gestational sonogram of the female 
patient. The presence of one or more gestational sacs confirmed a biochemical 
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pregnancy. For this study one or more gestational sacs were recorded as a 
positive biochemical pregnancy and zero sacs observed were recorded as non-
pregnant. 
Date of semen collection and cycle treatment was recorded as month, 
day, and year. This allowed the researcher to calculate the correct male age at 
the time of semen collection. Abstinence time period before collection was 
recorded in number of days. Semen parameters were recorded from male 
electronic patient records. Semen evaluation scores were previously recorded by 
the clinical andrologist, using the WHO reference values of human semen 
characteristics 5th edition in combination with the Kruger Strict Criteria for; 
volume, concentration, motility, progressive motility, Strict morphology percent 
normal, number of round cells, pH, and total motile sperm per specimen sample 
(Table 3.1). 
Height and weight were recorded as self-reported by the patient. Male BMI 
levels were automatically calculated by the clinic evaluation form or by the 
researcher from supplemental male patient data. BMI levels were recorded as 
underweight, normal weight, overweight, or obese. According to the CDC 
(Centers for Disease Control and Prevention, 2015), overweight refers to an 
excess amount of body weight that may come from muscles, bone, fat, and 






Table 3.1.  Semen was analyzed using the following parameters and range of  
                  references (Cooper et al., 2010). 
 
  Semen Parameters                                    Normal Range of Reference 
    Volume (ml) 1.5 to 5.0 ml 
    Concentration (million/ml) >=15 million/ml 
    Motility (%) >=40.0% 
    Progressive Motility >=3 on 0 to 4 scale 
    Strict Morphology Percent Normal >=4.0% 
    Round Cells <1 million 
    Ph 7.2 to 8.5 
    Motile Sperm/Specimen >=16 million 
  
 
Length of infertility with their current partner was determined by the 
number of months without conception and/or live birth. When evaluating male 
BMI levels and ILCP, donor samples were automatically removed because no 
data was obtained for those patients. Additional samples were removed for ILCP 
in same sex partners. 
Environmental lifestyle exposures were recorded to analyze data on 
occupation, male smokers, male alcohol use, male caffeine use, male 
recreational drug use, history of male hot/bath tub use, male steroid use, history 
of recent high fever, and male chemical exposure. In addition, male chart 
completion rate was recorded for the samples that were analyzed for the clinic 
evaluation. This data collection addressed two purposes of the study; one was to 
investigate the presence of a relationship between these variables and male 
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reproductive success and the second was to evaluate the amount of missing 
male data. 
Occupation was originally recorded as specific job type and then grouped 
into categories of job exposure to possible harmful variables. This data was 
collected for two purposes as well. The first was an attempt to obtain a large 
enough sample size to evaluate a relationship between occupation and male 
reproductive success. The second was to again, identify the number of missing 
male sample data. 
Cigarette smoking was recorded as smoker or non-smoker for the male 
patient and their partner. Alcoholic beverages were recorded as the number of 
drinks the male patient consumed daily, weekly, or socially. The number of 
caffeinated beverages was recorded as the amount consumed by the male 
patient per day, per week, or per month. Data was also recorded for male usage 
of recreational drugs, hot/bath tub use per week, recent high fever, steroids for 
body building, and chemical exposure. 
History of sexually transmitted disease and treatment were recorded as 
the type of disease(s) and current status. Impotence, history of hormone 
treatment, history of vasectomy, and surgical history were recorded. In addition, 
undescended testicles, trauma to the testicles, painful swelling or torsion of the 
testicles were recoded. History of white blood cells in the semen and history of 
prostate infection were recorded for male patients with available data. Herbal 
remedies or vitamins, medications, and long standing medical illness(s), as well 
as, special diet were recorded for male patients when data was available. 
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The researcher then reviewed the expansive data set for inadequate study 
samples. Samples were removed if they fell into one or more of the following 
categories; canceled cycle, no partner identified, and/or the patient quit. Due to 
the nature of the fertility industry, incomplete patient data is commonly seen, 
especially in males. Based on the specific data available for study participants, 
the researcher elected to create two sub-samples containing separate variables. 
Although, a large number of participants were in both sub-samples, a few 
additional samples were included or excluded based on their available data. To 
increase clarity for the reader, the sub-samples will be identified as biochemical 
pregnancy sample and semen sample from this point forward. 
The biochemical pregnancy sample consisted of 102 sample couples. 
Twenty samples were excluded from the original sample for the following 
reasons; the sample consisted of couples with missing biochemical pregnancy 
data, the use of biopsy ICSI for patient ART procedure, missing male age data, 
and some samples of donor sperm. In the cases of donor sperm, same sex 
female couples were removed; however, same sex male couples were retained if 
one of the partners semen sample was used for treatment. The average female 
age in the biochemical pregnancy sample was 35 years old, the average male 
age was 38 years old, and biochemical pregnancy was recorded at 44.0%. Males 
ranged in age from 26 years old to 52 years old and females ranged in age from 
24 years old to 44 years old. 
In the semen sample, 104 patients were included based on their available 
data of semen analysis parameters. Since the current study defined reproductive 
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success in two ways; biochemical pregnancy observation and semen analysis, 
21 male patients who lacked pregnancy data but contained complete semen 
sample data, where included in this population. The sample variables included; 
semen characteristics, male age, lifestyle exposures, urological history, BMI, and 
ILCP. Average male age and range did not change among samples. 
A normal characteristic of the human fertility industry is the lack of 
complete data for collection and/or analysis of patient samples. The semen 
sample contained more missing variable data than the biochemical pregnancy 
sample. However, that was to be expected due to the fact that not all sperm 
donors reported abstinence length and certain semen evaluation parameters are 
not available once the sperm has been frozen and thawed. 
Data Analysis 
The unit of observation, for evaluating male infertility factors, was 
reproductive success, defined by two dependent variables; biochemical 
pregnancy and semen analysis. As previously mentioned, patients were divided 
into two sub-samples, n = 102 and n = 104, based on the availability of patient 
data. Both samples were used to evaluate the relationships of each objectives 
listed below. Due to lack of response data, sample size ranged in some of the 
variables. 
Since, the availability of male data unreported was a variable of interest; 
the researcher identified the samples that had missing data due to collection 
constraints, not because of the lack of patient response. Those cases were not 
included in specific variable evaluations. In contrast, data that were obviously 
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missing because of a lack of patient response were retained to evaluate the 
response rate of male data collection. 
The researcher developed the following objectives to accomplish this 
portion of the study: 
1. To describe clinical and study sample data on infertility patients who 
have participated in retrospective ART treatments from 2011 to 2014 at a 
private human fertility clinic in the southwestern region of the United 
States on the following selected characteristics: 
 Male and Female Age 
 Biochemical Pregnancy Rates 
 ART Procedure Implemented 
 Semen Analysis 
 Male BMI Rates 
 Male Occupation 
 Patient and Partner Smoking History 
 Male Alcohol Usage 
 Male Caffeine Consumption 
 Male Hot/Bath Tub Exposure 
 Male Chemical Exposure 
 Male Medication Usage 
 Male Infertility Length with Current Partner 
IBM SPSS was used to run descriptive statistics for Objective 1. Data was 
collected upon initial random sampling from the study clinic female patient list; 
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subsequently, male data was collected after being matched with the correct 
female identification number. Mean, sample size, standard deviation, frequency, 
and normal distribution were used to characterize the study samples. 
Descriptive statistics were also utilized to identify data with relevant 
sample sizes for further analysis, additionally bringing to light the number of 
incomplete male patient records. The mean male age at collection was 38 years 
old and using IBM SPSS was found to be normally distributed (Appendix F.1).  
Biochemical Pregnancy Sample 
Biochemical pregnancy rate for the sample of 102 patients was 44.0%, 
regardless of female age or art procedure. A one-sample t-test (Appendix F.2) 
showed no significant difference between the average pregnancy rate of the 
study sample, 44.0%, and the average ART pregnancy rate of the national 
population, 39.0% (Society for Assisted Reproductive Technology, 2013). The 
average female age of the 102 study sample patients was 34.5 years old. 
Females ranged in age from 24 to 44 years old with a standard deviation of 4.6 
years.  
Of the 102 samples, 72 contained data for the type of ART treatment 
performed, IVF or ICSI. This difference in sample size is from research collection 
constraints not missing data. ART procedures were evaluated for frequency and 
were found randomly equivalent; 36 IVF cycles and 36 ICSI cycles. The mean for 
the 72 samples was .50 and the standard deviation was .50. For IVF, 15 patients 
were recorded as not pregnant and 21 patients were recorded as biochemically 
pregnant. For ICSI, 14 patients were recorded as not pregnant and 22 patients 
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were recorded as biochemically pregnant. The type of treatment cycle was held 
constant for Objective 2, after the researcher observed a common trend in 
positive pregnancy data in older males and ICSI rates. 
Semen Sample 
When descriptive statistics were obtained for the 104 samples of semen 
analysis data, the average male age at collection was 38 years, ranging from 26 
to 52 years old with a standard deviation of 6.14 years. The semen descriptions 
that follow will identify the sample size for each variable, as well. Once semen is 
frozen and then thawed out, certain characteristics cannot be obtained or no 
longer provide relevant results. Different sample sizes were seen for abstinence, 
progressive motility, percent normal, and pH, due to donor records and frozen/ 
thawed semen records. 
Abstinence contained 93 samples that reported an average time period of 
three days. Patients reported a range in abstinence from 1 to 21 days and a 
standard deviation of 2.58 days. Out of all of the 104 samples reported, average 
semen volume was 2.6 ml. Semen volume ranged from .2 to 8.5 ml with a 
standard deviation of 1.62 ml. Semen concentration was also available for 104 
samples and demonstrated an average of 39.14 ml/million, with a notable 
standard deviation of 32.20 ml/million and a reported range of 0 to 
144.00.ml/million. Average motility, also with104 samples recorded, was 47.1%. 
Range in motility varied from 0 to 84.0% with a standard deviation of 18.44. Out 
of 100 samples, progressive motility showed a 2.7 average measured on a scale 
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of 0 to 4. The progressive motility range reported included the entire scale from 0 
to 4 with a standard deviation of .85.  
For percent normal, 90 samples were available with a reported average of 
5.8%, a reported range of 0 to 15%, and a calculated standard deviation of 3.64. 
With 90 samples, pH average was recorded at 7.6. The minimum pH level 
recorded was 7.2 and the maximum pH level recorded was 7.8 with a standard 
deviation of .16. Out of 104 samples, total sperm per specimen showed an 
average of 52.8 million, with a range of 0 to 403.2 million, and a standard 
deviation of 61.8. Out of the 72 samples that contained biochemical pregnancy 
rates in combination with semen factors, a 60.0% average was recorded, which 
is abnormally high compared to the national average but not compared to the 
clinic average. 
Male BMI data was available for 70 respondents with the average level 
being 29, an identical reflection of the national average of male BMI rates which 
are currently reported at 29 (Flegal et al., 2012; Ogden et al., 2012), confirmed 
by a one-sample t-test (Appendix F.3). The range in BMI level recorded was 
19.93 to 45.23 with a standard deviation of 5.9. The researcher converted BMI to 
categorical data for better analysis of the results. BMI levels were distributed 
throughout four commonly observed groups as seen in Table 3.2. The four levels 
of 70 samples were coded and first evaluated for frequency and then for bivariate 
correlating relationships using SPSS.  
Sixty participants contained data recorded on ILCP, averaging 38 months. 
With a reported maximum ILCP at 210 months and a minimum at 0 months the 
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standard deviation was calculated at 39.8 months. When the researcher 
evaluated the large range in data, outliers and unqualified data samples were 
removed. Still, the remaining data left to be evaluated contained 49 samples with 
an average ILCP of 42 months, a range of 12 months to 150 months and a 
standard deviation of 32.7. The researcher chose to categorize the data into 
groups to try and obtain a better correlation analysis. In addition, let it be noted 
that a high lack of male patient response to this variable led to approximately 
50.0% of the data being obtained from female partner electronic medical records. 
 
Table 3.2.  Male BMI Level Classification (Centers for Disease Control and  
                  Prevention, 2015). 
 
  BMI Classification 
 
        Below 18.5 
 
Underweight  
        18.5 to 24.9        Normal Weight 
        25.0 to 29.9              Overweight 
        30.0 or Greater         Obesity 
  
 
Occupation was first evaluated for frequency; and, of the 37 samples 
recorded out of a sample size of 83, only three occupations listed more than one 
frequency. Seven of the male participants filled out evaluations but were 
identified for specifically skipping that question. The reason the researcher 
recorded it as a skipped question instead of missing data was to further identify 




For that reason, occupation data was combined into five very subjective 
categories of possible work hazards or work exposure. To be clear, this was just 
an estimated distribution into categories created by the researcher’s review of 
related literature and the researcher’s evaluation of the occupation job 
description. There were no distinguishing differences among the samples when 
occupations were placed into the categories; inside versus outside work, positive 
or negative chemical exposure, sedentary or active occupation, and high stress 
as opposed to low stress occupations. Therefore, occupation was not further 
analyzed. 
With a sample size of 83, frequency of partner smoking did not contain 
enough variance to analyze. Only two cases of partner smoking were observed 
and 23 samples were missing. The frequency of male patients who smoked was 
51 non-smokers, four smokers, 5 to 10 cigarettes per day, and 28 missing 
samples. 
Out of 83 samples observed for male alcohol use, 48 samples responded. 
The highest frequency was from 18 patients who recorded 0 drinks per day. The 
second highest frequency, with 10 samples, was one drink socially. Responses 
ranged from 0 drinks to 14 drinks socially. The researcher removed extreme 
outliers and coded alcohol usage as yes or no. Alcohol use was defined as 1 to 5 
drinks socially. Caffeine use contained 49 responses and 29 of the samples 
recorded daily use. These variables were correlated to determine if a relationship 
existed between male consumption and reproductive success.   
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With 50 valid responses out of 83 samples, there were only seven reports 
of bath/hot tub use. Frequency of chemical exposure had little information. Three 
samples out of 83 reported chemical exposure to toluene, refrigerant, and 
pesticides/herbicides. There was not enough information to be analyzed for 
either variable.  
2. To determine if there is a statistically significant relationship between 
male age and reproductive success rate of male infertility patients who 
have participated in ART treatments at a private human fertility clinic in the 
southwestern region of the United States as measured by a randomized 
retrospective evaluation of patient charts from 2011 to 2014. 
The researcher used a point-biserial correlation coefficient to evaluate 
biochemical pregnancy rate, a dichotomous variable, in relation to age and 
semen characteristics. In addition, the type of ART treatment was analyzed for 
correlation among pregnancy rate and male age using a point-biserial correlation 
coefficient. Pearson’s product moment correlation coefficient was used to 
analyze possible relationships between semen characteristics and male age. 
3. To determine if there is a statistically significant relationship between 
environmental lifestyle factors such as; male occupation, smoking, alcohol 
use, caffeine use, recreational drug use, hot/bath tub use, steroid use, 
high fever, and/or chemical exposure and reproductive success rate in 
male infertility patients who have participated in ART treatments at a 
private fertility clinic in the southwestern region of the United States as 
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measured by a randomized retrospective evaluation of patient charts from 
2011 to 2014. 
A frequency analysis was performed using data from the semen sample 
group. This section contained the majority of the variables from the patient 
questionnaire and the response rates were not consistent. If there was not a 
substantial amount of relevant data, the variable was not further analyzed. 
Initial analysis of male patient data revealed a 62.3% response rate of the 
male patients’ history of smoking. Five percent of male patients reported smoking 
5 to 10 cigarettes per day and 61.4% reported not smoking. 
Alcohol usage and amount displayed and 69.0% response rate. Caffeine 
usage and amount showed a 64.0% response rate. The response rate for 
recreational drug use was 64.0%, 1.0% of the sample reported cannabis use and 
all other respondents reported no drug usage. 
With a 63.0% response rate, medication initially looked to have valid data. 
From the response group, the percent of samples that reported no medication 
usage was 65.0%. Samples in the response group reported usage of 4.0% for 
each of the following; Adderall, antidepressant, hormone related medication, and 
asthma medication. The use of blood pressure medication was reported by 
14.0% of the response sample. In addition, the use of herbs or vitamins was 
reported by 31.0% of the response group. 
Urological variables presented similar response rates, and due to lack of 
variance in the data, a number of variables were not further analyzed. White 
blood cells in the semen had a response rate of 64.0%, of which 98.0% reported 
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having no history and 2.0% reported yes to having had white bloods cells in 
semen. The response rate for prostate infection data was 65.0%, no history of 
infection was reported by 96.0% and 4.0% reported having had a prostate 
infection. In the data on recent high fever, 49.0% samples reported no and 51.0% 
had no response. STD data displayed a 58.0% response rate, of that 81.0% 
responded with no history, 14.0% reported having been treated for an STD, and 
5.0% skipped the question. Difficulty with erection had a response rate of 62.0%; 
of the samples, 90.0% said no, 8.0% said yes, and 1.0% skipped the question. 
Difficulty with ejaculation had a response rate of 62.0%; of the samples, 70.0% 
said no, 8.0% responded yes, and 22.0% skipped the question. 
The remaining urological variables did not have enough variance in the 
data to further explore; hormone treatment, vasectomy, surgery to the testicles, 
undescended testicles, trauma to the testicles, and painful swelling of the 
testicles. Overall these variables had an average of 60.0% for their response 
rates. However, the majority of the responses stated no issue, and the average 
answer of yes was approximately 2.0%. 
The following variables were removed based on low frequency rate of 
response and/or invalid data. Male diet was removed because out of a 50.0% 
response rate, one sample recorded a special gluten free diet and the remaining 
samples reported no special diet. Steroid usage was removed because the entire 
52.0% response rate samples reported no use. With a 56.0% response rate for 
hot/bath tub use, 78.0% responded no usage.  
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4. To determine if there is a statistically significant relationship between 
BMI and reproductive success rate in male infertility patients who have 
participated in ART treatments at a private fertility clinic in the 
southwestern region of the United States as measured by a randomized 
retrospective evaluation of patient charts from 2011 to 2014. 
When categorical BMI data was analyzed the sample of 70 consisted of; 
0% underweight males, 13.5% normal weight males, 34.6% overweight males, 
and 19.2% of males were classified as obese. BMI classification levels of male 
patients were correlated with biochemical pregnancy, male age, ILCP, and 
semen samples to meet this objective. 
5. To determine if there is a statistically significant relationship between 
infertility length with current partner and reproductive success rate in male 
infertility patients who have participated in ART treatments at a private 
fertility clinic in the southwestern region of the United States as measured 
by a randomized retrospective evaluation of patient charts from 2011 to 
2014. 
Upon initial analysis, the researcher used a normal distribution analysis 
and observed a maximum outlier of 210 months and a minimum outlier of 8 
months, both were removed from the sample group. Additionally, as human 
fertility treatment procedures increase in popularity, we must consider that not all 
patients participate in treatment cycles due to infertility issues. Therefore, the 
samples that recorded less than 12 month and were seeking treatment for things 
such as gender selection of the offspring were removed as well. Two samples 
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were removed with an answer of zero, stating that the couple was preparing for 
male infertility, and one sample with an un-reversed vasectomy was removed. 
A Pearson’s correlation coefficient in SPSS was used to evaluate for a 
relationship between ILCP and male reproductive success. A point-biseral 
correlation coefficient was used to analyze for a biochemical pregnancy 
relationship and ILCP. No significant correlation was observed among any of the 
variables. Further analysis could either stop here or ILCP could be converted to 
categorical data. The researcher decided to further analyze ILCP by forming 
three categories; ILCP 12 to 24 months, ILCP 25 to 48 months, and ILCP ≥49 
months. 
Statistical Analysis and Findings 
 
In this section, results of correlational analyses are reported for the 
dependent and independent variables. The research hypotheses are listed at the 
beginning of each respective subsection, and are followed by an explanation of 
the statistical analyses. The final section will contain an overview of the results in 
a discussion. 
1. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
as male age increases in these patients. 
The researcher ran a point-biseral correlation coefficient to evaluate if a  
significant relationship existed between biochemical pregnancy status and male 
age at collection. At a value of r = -.196, a statistically significantly negative 
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correlation was exhibited between biochemical pregnancy and advanced male 
age at a confidence level of .05 (Table 3.3). 
 
Table 3.3.  Pearson product point-biseral correlation coefficient table exhibits a  
                  statistically significant negative relationship between biochemical  
                  pregnancy and age of male infertility patients who have participated in  
       ART treatments at a private human fertility clinic from 2011 to 2014   
       (Appendix F.4). 
 
  Point-Biseral Correlation Coefficient 
 




 Male Age at Collection 
Pearson Correlation 1 -.196* 
Sig. (2-tailed)  .049 
N 102 102 
 Biochemical Pregnancy 
Pearson Correlation -.196* 1 
Sig. (2-tailed) .049  
N 102 102 
* Correlation is significant at the 0.05 level (2-tailed). 
 
As the researcher expected to find, female age demonstrated a negative 
correlation with biochemical pregnancy rate and a positive correlation with male 
age at time of collection. When comparing female age and biochemical 
pregnancy rate the researcher performed a point-biseral correlation coefficient 
generating a Pearson’s r value of r = -.209 at a confidence interval of .05. The 
relationship between female age and male age at the time of collection was 
analyzed using a Pearson’s correlation coefficient. With a value of r = .549 at a 
confidence interval of .01, the two variables exhibit an obvious significant 
relationship (Table 3.4). 
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Table 3.4.  Pearson product correlation coefficient exhibits a statistically  
                  significant relationship between biochemical pregnancy rate, female  
                  age, and male age of infertility patients who have participated in ART  
                  treatments at a private human fertility clinic from 2011 to 2014. 
 






Male Age  
at Collection 
 Female Age 
Pearson Correlation 1 -.209* .549** 
 Sig. (2-tailed)  .035 .000 
N 102 102 102 
 Biochemical     
 Pregnancy 
Pearson Correlation -.209* 1 -.196* 
Sig. (2-tailed) .035  .049 
N 102 102 102 
 Male Age at   
 Collection 
Pearson Correlation .549** -.196* 1 
Sig. (2-tailed) .000 .049  
N 102 102 102 
     
 * Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). 
 
Figure 3.1 demonstrates the decreasing percentage rates of biochemical 
pregnancy success as male patient age increases. Results identified a 62.0% 
biochemical pregnancy rate for male patients’ age 26 to 30 years old. Male 
patients’ age 31 to 35 years old revealed a 59.0% rate, 36 to 40 years old a 








Figure 3.1.  Biochemical pregnancy percentage rates of male infertility patients 
































Male Age (Years) 
n = 102 
 26-30 Yrs        31-35 Yrs         36-40 Yrs        41-45 Yrs        46-56 Yrs 
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Previous observations led the researcher to further evaluate the 
relationship between male age and the type of treatment used for assisted 
reproduction. Table 3.5 displays the frequency distribution of ART procedures 
performed and recorded from the retrospective study sample. The researcher ran 
bivariate correlations for each of the two ART treatments in relation to 
biochemical pregnancy. Holding the ART treatment group constant for IVF  
(n = 36), a point-biserial correlation was performed to determine if a significant 
relationship between IVF biochemical pregnancy rates and advanced male age 
existed. Reporting a value of r = -.491, IVF biochemical pregnancy rates and 
advanced male age demonstrated a statistically significant negative correlation at 
a highly significance level of .01 (Table 3.6). 
 
Table 3.5.  Frequency distribution of retrospective study sample ART procedures  
                  performed at a private infertility clinic from 2011 to 2014. 
 





IVF 36 35.3 50.0 50.0 
 ICSI 36 35.3 50.0 100.0 








Table 3.6.  Pearson’s point-biseral correlation coefficient table exhibits a  
                  statistically significant negative relationship between IVF biochemical  
                  pregnancy and age of male infertility patients who have participated in    
                  ART treatments at a private human fertility clinic 2011 to 2014  
       (Appendix F.5). 
 




Male Age at 
Collection 
  IVF Biochemical    
  Pregnancy 
Pearson Correlation 1 -.491** 
Sig. (2-tailed)  .002 
N 36 36 
  Male Age at  
  Collection 
Pearson Correlation -.491** 1 
Sig. (2-tailed) .002  
N 
36 36 
** Correlation is significant at the 0.01 level (2-tailed). 
 
The researcher went on to run an additional point-biserial correlation to 
investigate if a significant correlation existed between ICSI biochemical 
pregnancy rates and advanced male age. This time holding ART treatment 
constant for ICSI, the results recognized an insignificant p value of r = .153.  
Table 3.7 demonstrates the results of descriptive statistics used to analyze 
semen characteristics from male patients included in the retrospective study 
sample. Using a point-biserial correlation coefficient to evaluate for relationships 
among biochemical pregnancy and each semen parameter, no significant 
correlations were found. However, a Pearson’s coefficient demonstrated a 
statistically significant negative correlation between male age and volume,  
100 
 
r = -.338 at a confidence level of .01. Pearson’s correlation coefficient also 
exhibited a statically significantly negative correlation among male age and 
progressive motility at r = -.202 with a confidence level of .05. Table 3.8 displays 
a complete list of the significant relationships found among male patient semen 
characteristics.  
 
Table 3.7.  Descriptive statistics of semen characteristics collected    
                  retrospectively from study sample male patients that participated in  
                  private clinical infertility treatment cycles from 2011 to 2014.  
 
  Characteristics Mean Std. Deviation N 
    Male Age (years) 37.7 6.1 104 
    Abstinence (days) 3.0 2.6 93 
    Volume (ml) 2.7 1.6 104 
    Concentration (million/ml) 39.1 32.2 104 
    Motility (%) 47.0 18.4 104 
    Progressive Motility 2.7 0.9 100 
    Percent Normal (%)  5.8 3.6 89 
    Total Motile Sperm            
    (specimen/million) 
52.8 61.8 104 






Table 3.8.  Statistically significant bivariate correlations among semen  
                  parameters collected retrospectively from study sample male patients  
                  that participated in private clinical infertility treatment cycles from  







  Male Age/ Volume -.338** .001 104 
  Volume/Total Motile Sperm .399** .001 104 
  Male Age/Progressive Motility -.202* .043 100 
  Progressive Motility/Motility .769** .001 89 
  Progressive Motility/Concentration .500** .001 100 
  Progressive Motility/Percent Normal .288** .007 89 
  Progressive Motility/Total Motile Sperm .379** .001 100 
  Progressive Motility/Abstinence -.219* .035 93 
  Motility/Abstinence -.340** .001 93 
  Motility/Concentration .436** .001 104 
  Motility/Percent Normal .416** .001 89 
  Motility/Total Motile Sperm .476** .001 104 
  Concentration/Total Motile Sperm .704** .001 104 
  Concentration/Percent Normal  .269* .011 89 
  Percent Normal/Total Motile Sperm .321** .002 89 
 * Correlation is significant at the 0.05 level (2-tailed). 




2. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates based on cigarette smoking. 
Using a point-biserial correlation coefficient a statistically significant 
positive relationship was observed between male smokers and sperm 
concentration at a p value of r = .313 with a confidence level of .05. In addition, 
using the same correlation coefficient, a statistically significant correlation 
between smoking and progressive motility was exhibited at r = .294 with a 
confidence level of .05 (Table 3.9). Using a cross tabulation table (Table 3.10) 
with Cramer’s V coefficient exposed a statistically significant correlation between 
male smokers and difficulty with ejaculation at a value of r = .465 with a 
confidence level of .01 (Table 3.11). 
3. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates based on alcohol usage. 
Social alcohol usage was defined once the results were analyzed. Male 
patient social alcohol usage was considered an average consumption of 1 to 5 
drinks socially (Appendix F.6). No significant correlation was found in male 
patients between consumption of alcohol socially and biochemical pregnancy. 
However, when evaluating for male age and semen characteristics related to 
social drinking, several significant correlations were identified. Using a Pearson’s 
coefficient, male social alcohol usage and semen volume displayed a negative 
statistically significant correlation at r = -.304, with a confidence interval of .05.  
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Table 3.9.  Pearson’s point-biseral correlation coefficient table exhibits a  
                  statistically significant relationship between smoker, semen  
                  concentration and semen progressive motility of male infertility  
                  patients who have participated in ART treatments at a private human  
                  fertility clinic 2011to 2014 (Appendix F.7a and F.7b). 
 
 Point-Biseral Correlation Coefficient 




Pearson Correlation 1 .313* .292* 
Sig. (2-tailed)  .020 .036 
N 55 55 52 
 Concentration 
Pearson Correlation .313* 1 .545** 
Sig. (2-tailed) .020  .000 
N 55 83 79 
 Progressive 
  Motility 
Pearson Correlation .292* .545** 1 
Sig. (2-tailed) .036 .000  
N 52 79 79 
 * Correlation is significant at the .05 level (2-tailed). 




Table 3.10.  Frequency distribution of retrospective study sample male patient  
                    smokers and difficulty with ejaculation presented in a Cramer’s V  
                    correlation coefficient contingency table.  
 
 Difficulty with Ejaculation*Smoker Contingency Table 
 
        Smoker 
     Total Non Smoker Smoker 
Difficulty with Ejaculation 
No 34 2 36 
Yes 2 2 4 
Skipped 11 0 11 
Total 47 4 51 
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Table 3.11.  Cramer’s V correlation coefficient exhibits a statistically significant  
                    relationship between male patient smokers and difficulty with  
                    ejaculation.  
 
 Cramer’s V Correlation Coefficient Value Approx. Sig. 
Nominal by Nominal 
Phi .465 .004** 
Cramer's V .465 .004** 





  ** Correlation is significant at the .01 level. 
 
In addition, when using Pearson’s r correlation to compare male social 
alcohol usage and total motile sperm per specimen a statistically significant 
negative relationship was observed at a value of r = -.293, with a confidence 
interval of .05 (Table 3.12). 
4. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates based on caffeine usage. 
No significant correlation was found among the relationship of caffeine 
and biochemical pregnancy. However, a single statistically significant relationship 
was observed correlating BMI and caffeine using a Pearson correlation, with a 







Table 3.12.  Pearson product correlation coefficient exhibits a statistically  
                    significant relationship between biochemical pregnancy rate, female  
                    age, and male age of infertility patients who have participated in  
                    ART treatments at a private human fertility clinic from 2011 to 2014. 
 













N 48 48 48 
Volume 
Pearson 
Correlation -.304* 1 .342** 
Sig. (2-tailed) .035  .002 





Correlation -.293* .342** 1 
Sig. (2-tailed) .043 .002  
N 48 83 83 
 * Correlation is significant at the 0.05 level (2-tailed). 






5. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rates as male BMI levels increased in these patients. 
Using a point-biserial correlation coefficient there was no significant 
correlation observed between the BMI and biochemical pregnancy rate at a p 
value of r = -.018. A Pearson’s correlation coefficient revealed a non-significant 
relationship between BMI and male age (r = .040), semen volume (r = .051), 
semen concentration (r = -.004), sperm motility (r = -.088), progressive motility  
(r = .042), percent normal (r = -.134), and pH (r = .008). 
6. Human males who have previously participated in clinical ART 
treatments from 2011 to 2014 will have decreased reproductive success 
rate as infertility length with current partner increased in these patients. 
Running a point-biseral correlation coefficient the researcher found no 
significant correlation between biochemical pregnancy rate and ILCP (r = .038). 
Via a Pearson’s r correlation coefficient the researcher also discovered a non-
significant relationship between ILCP and male age (r = -.193), semen volume  
(r = -.049), semen concentration (r = -.048), sperm motility (r = .058), progressive 
motility (r = .101), pH (r = .213), and total motile sperm per specimen (r = .021). 
However, a statistically significant correlation was observed between ILCP and 
percent normal semen at a value of r = .304, with a confidence level of .05, using 







Table 3.13.  Pearson product correlation coefficient exhibits a statistically  
                    significant relationship between ILCP and percent normal semen of  
                    male infertility patients who have participated in ART treatments at a  
                    private human fertility clinic from 2011 to 2014. 
 
 The Pearson Product Moment Correlation Coefficient 
 % Normal Semen ILCP 
% Normal Semen 
Pearson Correlation 1 .304* 
Sig. (2-tailed)  .030 
N 70 51 
ILCP 
Pearson Correlation .304* 1 
Sig. (2-tailed) .030 
 
N 51 60 
* Correlation is significant at the 0.05 level (2-tailed). 
Discussion 
 
Assisted reproductive techniques have become increasingly popular with 
the current aging first time parental population. Although, one critical aspect that 
has been overlooked for years is the effect of male age on reproductive success. 
Previous decades of research have focused almost entirely on female infertility 
factors. However, recent studies have started to demonstrate that males may be 
affected in a similar manner. In a 2014 study, Brincat and colleagues claimed 
that abstract paternal influences on reproduction are significant in causing about 
half of infertile couples to turn to ART procedures.  
Data from the current study demonstrated that male age does in fact have 
a significantly inverse relationship with biochemical pregnancy rate. The results 
demonstrated that as male age increased, fertility capabilities were shown to 
decrease. The older the male patient, regardless of their female partner’s age, 
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the less likely they were to get a positive biochemical pregnancy result. This is 
not only important knowledge for clinicians; it is also important information to 
share with the population of couples who plan on starting families later in life. 
Previous research has shown that advanced female age is correlated with 
reduced reproductive success. Therefore, the researcher expected a significant 
relationship to be demonstrated in older female patients and biochemical 
pregnancy rates. However, a noteworthy finding was the similarity of variance in 
the significant relationships discovered between biochemical pregnancy rate for 
female age and biochemical pregnancy rate for male age. In other words, the 
current results revealed a very similar relationship in individual contribution of 
advanced male age and advanced female age to reproductive success. 
Furthermore, when the relationship between female age and male age was 
correlated a highly significant relationship was found and should be further 
analyzed in future studies. 
Females have continually been reminded of the biological time clock 
winding down on their reproductive years. However, current research has not 
only started to focus on age related factors of male infertility, but on the entire 
male lifestyle. Studies are beginning to acknowledge that age may not be the 
only newly recognized factor contributing to male infertility. Although researchers 
have accepted that there are more factors playing a role, determining those 




Therefore, the current study first chose to further examine the question of 
change in male reproductive capabilities as they increase in age. The 
controversy lies in determining if the factor contributing to decreased male 
reproductive success is in fact age. On the other hand, it is hypothesized that as 
males age they actually become more susceptible to environmental lifestyle 
factors that are hazardous to reproductive success. 
Additionally, results from the present study demonstrated that in advanced 
age males, IVF pregnancy success rates significantly decrease. In today’s fertility 
industry, ICSI has become a common procedure used by clinicians to treat older 
males or patients with known male infertility factors. The ICSI data from the 
retrospective study supported the use of that practice. When researching male 
fertility, consistency is extremely important considering there are so many 
variables when working with human semen. Therefore, the researcher felt it was 
beneficial to analyze the biochemical pregnancy rate while holding the ART 
treatment constant due to the increased efficiency of ICSI. 
When evaluating semen results the researcher found a similar decrease in 
reproductive success as male patient age increased. Even with the small sample 
size of the current study, data confirmed that as male patient age increased 
semen volume decreased. The data also revealed an inverse relationship with 
advanced male age and progressive semen motility.  
Once a human female reaches a certain age there is an abrupt decrease 
in reproductive capability. Conversely, newly focused research on the 
reproductive capabilities of the human male proposes a slow senescence of 
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reproductive decline as they age. The decrease in seminal volume observed in 
the current study further supports the indication of a significant decline in 
advanced age reproductive males.  
Due to convenience and efficiency the fertility industry has adopted a 
simple one or two based semen analysis procedure. This leaves clinicians with 
an approximate 50.0% successful evaluation. The current study demonstrated an 
absolute need for more male data, more male awareness, and more male 
evaluation techniques. Changes will not happen overnight but the more 
frequently male fertility factors are researched, the more exposure they will 
receive. 
When considering environmental threats, previous studies on the effects 
of smoking have reported reduced sperm concentration and motility in male 
cigarette smokers (Kunzle et al., 2003; Vine, 1996; Vine et al., 1996). The current 
study results reported a similar observation. Results demonstrated a decrease in 
semen concentration and progressive motility in those male patients who 
reported smoking 5 to 10 cigarettes a day. The results additionally concluded that 
male patients who reported smoking were also associated with ejaculation 
difficulty. 
We must take in to consideration that since this was a retrospective study, 
missing data created a smaller sample size. When researching human semen 
characteristics it is more desirable to have a larger sample size for a more 
normalized average. In the current study, the sample of patients who 
demonstrated adequate data to compare for a relationship between smoking and 
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semen concentrations consisted of 55 males. For the relationship between 
smoking and progressive motility, 52 male patients reported adequate data. A 
future study with a larger sample size would be beneficial in examining the 
increasing age of male smokers in contrast to decreasing semen concentration 
and decreasing progressive motility. 
The results of the current study also indicated that alcohol use in male 
patients was, in fact, correlated to impaired semen quality. Since, the impact of 
alcohol consumption on male fertility potential remains a controversial topic; the 
results of the current study are an important addition to the research. The results 
demonstrated that as male alcohol use increased seminal volume and total 
motile sperm per specimen showed a significant decline. Again the researcher 
observed two common semen variables that are reportedly affected by advanced 
male age as well. Further research is needed to test for repeatable results and 
correlations. Studies should be designed to evaluate the question of reduced 
semen quality from the effects of advanced male age or the susceptibility to 
alcohol consumption at advanced male age.  
In the current research study, male BMI levels did not show a significant 
relationship with biochemical pregnancy rate and semen evaluations. In a 
previous study, Anifandis and colleagues (2013) reported similar results, finding 
no evidence of male BMI correlating with sperm parameters. However, in the 
Anifandis study, BMI did influence the quality of embryos produced in such a way 
that impacted pregnancy rate (Anifandis, 2013). The design of the current study 
would have failed to pick up on impaired embryo quality because retrospective 
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data was only collected on embryos that were fertilized and then transferred. 
Further studies need to be performed to isolate the effect of BMI on embryo 
fertilization and quality prior to transfer.   
This raises the question, if high BMI levels are claimed to influence the 
quality of the embryo, how can researchers assume that BMI is not in some part 
responsible for alterations in semen quality. One consideration, of this 
assumption is that whatever factors are playing this detrimental role in embryo 
production, are not being tested for in a common semen analysis.  
Another consideration is the difference between the effects of being 
overweight versus being obese. In 1998, the National Institutes of Health defined 
overweight as an excess amount of body weight that may come from muscle, 
bone, fat, and water. Obesity was defined as an excess amount of body fat. This 
suggests there may be a difference in semen quality expressed between the two 
BMI classifications. Research has demonstrated that increased lipid amounts 
have been shown to act on the male reproductive axis. It is possible that the key 
factor is the actual amount of fat. 
In 2014, Rato and colleagues published a study that explained lifestyle 
and unhealthy eating can negatively affect spermatogenesis, both at central and 
gonadal levels. The group described that the overconsumption of high-energy 
diets (HED) altered the function of the male reproductive axis and consequently 
affects the testicular physiology, disrupting its metabolism and bioenergetic 
capacity. The group emphasized that disruption of the tightly regulated metabolic 
pathways leads to adverse reproductive outcomes, such as inefficient energy 
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supply to germ cells, sperm defects, or spermatogenesis arrest (Rato et al., 
2014). 
This leads to an interesting observation in the current study results. As 
previously mentioned, the researcher observed an unusual amount of male 
patients that very likely intentionally skipped the questions on difficulty with 
erection and difficulty with ejaculation. Further evaluation of these skipped 
samples, in addition to the samples who reported an erectile problem, revealed 
an average male patient BMI of 31.7, which is considered obese. If, in fact, this 
sensitive question is being skipped due to male discomfiture, we assume that 
there is more than likely some level of an erectile dysfunction problem with the 
male patient. Several investigators have reported that high BMI levels may 
reduce male fertility and have associated it with reduced semen quality and 
hormone alterations (Jensen et al., 2004; Kort et al., 2006; Fejes et al., 2005; 
Fejes et al., 2006). In addition, a 2004 study published by Fung and colleagues 
stated that overweight men may be at greater risk of erectile dysfunction which 
could lead to reduced fertility.   
The final results of the current study found no significant relationship 
between ILCP and biochemical pregnancy rates or male patient age. The one 
significant correlation observed among semen characteristics was the 
relationship between ILCP and the percent normal semen. In 2006, Zhu and 
colleagues reported that underlying infertility and time to pregnancy is a 
proposed risk factor for adverse pregnancy outcomes, independent of maternal 
age. However, Weinstein and Stark (1994) acknowledged that studies on the 
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ageing of a male can be compromised by the ageing of his partner. Additionally, 
the group contributed a decline in coital frequency to be associated with 
prolonged co-habitation, (Weinstein and Stark) which could lead to a negative 
effect on the percent of normal semen. 
There are a number of researchers that believe time to conception can be 
a useful epidemiological marker of fertility. Even so, it has to be used with caution 
because it ignores couples who fail to conceive and is subject to a number of 
sources of bias (Baird et al., 1986; Joffe and Li, 1994; Olsen et al., 1998; Spira, 
1998; Tuntiseranee et al., 1998). Unlike the small sample size of the current 
study, Ford and colleagues (2000) found significant correlation among older men 
and ILCP by performing a large population study.   
Unfortunately, by the time a couple gets to the fertility clinic today, most 
are at the point of wanting a child immediately, not wanting to change a lifestyle. 
As more research is done on male infertility factors, the issue is further 
uncovered. Therefore, this will only increase public exposure to the discussion on 
male infertility factors. Couples should be aware that the male partner is now 
realized to be a large contributor to reproductive success. Additionally, couples 
need to be informed that there are ways to proactively improve their own fertility 
chances, as well as, specific lifestyle changes that will accomplish improved 
reproductive success. 
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CHAPTER IV:  CLINICIAN RESEARCH SURVEY METHOD: 
EXAMINING MALE INFERTILITY; THE ASSOCIATION BETWEEN 
AGE, ENVIRONMENT, AND REPRODUCTIVE SUCCESS IN MALE 
PATIENTS THAT HAVE PARTICIPATED IN ASSISTED 
REPRODUCTIVE THECHNOLOGY 
Introduction 
Male infertility is a term that was rarely discussed just a decade ago. 
Although, it is heard more frequently today, the term still carries considerable 
taboo behind its meaning. Decades of research have highlighted female as the 
focus of human infertility. It has been the female, not the male, who has been 
consistently studied on the successes and failures of reproduction. Early studies 
identified a number of female lifestyle factors that affected reproductive success. 
Subsequent research led to an establishment of assisted reproductive treatment 
methods, for specific infertility issues. 
One form of assisted treatment, in vitro fertilization, is a common medical 
procedure practiced today. Although, not so long ago, it was a mysterious 
procedure that produced what were then only known as ‘test-tube babies.’ The 
same unknown label has been associated with male infertility today. What we 
currently view as foreign concepts may evolve into common practices, just as IVF 
demonstrated in a few short decades. 
Reproductive research has progressed exponentially in the past 50 years 
and even still, we are continuously discovering additional factors. As couples wait 
longer to start families, an increased demand for research in the area of male 
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reproductive fertility is revealed. As our societal trends continue to evolve, 
advanced male age must be considered in the human infertility discussion. 
Previous data has provided limited research on male infertility factors for a 
number of reasons. It is a continuous challenge to find adequate sample 
populations for human male studies in places other than infertility treatment 
centers.   
Purpose and Objectives of the Study 
The researcher selected an alternative approach by investigating the 
relationship of male age and environmental lifestyle factors on assisted 
reproductive technique success rates as observed from an infertility clinician’s 
standpoint. The first objective was to compare the retrospective response rates 
of male patients in the previous study to clinicians’ response ranks of the 
importance of specific male factors.  
Next, was to compare the percent of retrospective male patient data 
available to male patient data observations made by clinicians in their own 
professional experience. The purpose of addressing missing information was to 
expose the amount and the importance of unreported male patient data. Through 
the retrospective study, the researcher wanted to take an inventory on the 
completion level of male patient records. Through the survey study, we wanted to 
gain data on the clinicians’ experiences with incomplete male records. From the 
results, we expected to increase some understanding of the reasons behind 
missing data. Newfound information would help to encourage improved collection 
methods. In addition, the study was designed to help determine if there was a 
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pattern in the missing data, as well as possible ways to identify the purpose. For 
example, a male patient may not answer a sensitive question because he is 
uncomfortable with the topic or because he thinks the question is irrelevant to his 
fertility issues.  
The goal of the survey study was not only to evaluate the actual opinion of 
professional clinicians, but to also compare the differences in opinions among 
clinicians. This will help to exemplify the variation level of existing standards 
among the infertility industry. Professional experience, from someone currently 
working in the industry, should provide a different perspective than the 
retrospective data results. The researcher designed the following objectives to 
describe study sample characteristics and to identify correlation data:  
1. To describe the level of importance of male infertility variables that 
clinicians report as the most commonly observed in their professional 
experiences in comparison to the retrospective male response data 
collected on those same male infertility variables.   
2. To describe the percentage of completed male medical records  
available from the retrospective analysis of data and the percentage of 
completed male medical records reported as seen by clinicians. 
3. To determine if there is a statistically significant relationship among the 
opinions of clinicians who participated in the voluntary male infertility 
survey on topics such as; data availability and gender based ethical 




Materials and Methods 
Research Design 
The primary purpose of this study was to gain further insight on 
controversial male infertility factors from the unique perspective of reproductive 
clinicians. There is so much variability in practices and procedures throughout 
the infertility industry that a general consensus of which is the most effective 
remains unknown. The study was designed to collect clinical data in an 
unconventional method through the analysis of infertility professionals’ 
responses. After a review of the literature, the researcher developed a series of 
questions based on current disputed male infertility factors. Gender related 
ethical practices present in today’s industry were also addressed in an 
anonymous survey mailed to reproductive professionals.  
The goal of the survey was to gauge male infertility factors from a different 
perspective. Collecting observations from existing professionals in the fertility 
industry, directed the survey identification of male infertility factors from a first-
hand perspective. Survey results served to enhance research in this area by 
acknowledging the personal experiences of professionals. Combining multiple 
methods of evaluation; such as the clinician survey study in this chapter and the 
retrospective study in the previous chapter, we believe the results will help to 
create a better foundation for the basis of future research studies.    
The unique approach of surveying scientists and physicians, through 
social science research techniques, while subsequently comparing their opinions 
to scientific data helped to create a more comprehensive method for data 
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collection. The first two objectives of this study were specifically identified by the 
researcher to describe the nature of the relationship between clinician opinions 
and the statistical data collected from the review of literature and retrospective 
study. This section of the research was designed to gain a broad sense of where 
the issues of male infertility stand currently.  
While, the deficient amount of research in this area provides a limitless 
requirement for cause and effect studies to be performed. The approach of this 
portion of the study was to gain knowledge on the important male variables that 
are currently being observed in the industry. The next step on the continuum of 
research can then be based off of the results obtained from the clinician survey.   
By addressing clinicians directly, the study had two goals in mind. First, to 
identify the variables of importance that practicing clinicians have reported from 
their treatment experiences of male infertility patients. The second was to gather 
information on the practices in male infertility treatment currently observed in the 
industry today. As the topic has continued to spread, a number of unknowns 
have been brought into the conversation. Not only is it important to identify the 
detrimental cause and affect variables on male reproductive success. It is also 
important to appreciate that the industry will be forced to re-evaluate ethical 






The researcher designed the following objectives and research hypothesis 
to describe study sample characteristics and to identify correlation data:  
1. To describe the level of importance of male infertility variables that 
clinicians report as the most commonly observed in their professional 
experiences in comparison to the retrospective male response data 
collected on those same male infertility variables.   
2. To describe the percentage of completed male medical records  
available from the retrospective analysis of data and the percentage of 
completed male medical records reported as seen by clinicians. 
3. Clinicians who participated in the voluntary male infertility survey will 
demonstrate a negative correlation among their opinions of infertility topics 
such as; data availability and gender based ethical treatment of patients. 
Approval to conduct this study was obtained from the Louisiana State 
University Institutional Review Board, IRB# E8894 (Appendix D). Exemption was 
granted under the compliance of the following guidelines; that participants cannot 
be identified, directly or statistically, and the responses/observations could not 
harm participants if made public. A waiver of signed consent was granted, with 
the inclusion of the survey instructions stating that participation is voluntary. The 
participants were informed that by completing the survey they were providing and 
documenting their consent.   
Population and Sample 
The population of the study was defined as clinical professionals who are 
currently associated with the human infertility industry. One outlet for survey 
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distribution, EmbryoMail, is a national human infertility membership group. 
Correspondence is directed through the group moderator and then forwarded on 
to members of the group. Membership is strictly for professionals within the 
infertility industry. Using this network, the researcher invited all qualified 
members to complete the IRB approved male infertility clinician survey (Appendix 
E).  
In addition, approximately 20 Louisiana State University Alumni, currently 
working in the human reproductive industry, were used as another sample 
source. Members were emailed the same anonymous survey participation 
invitation. Results came from random voluntary participation. The researcher had 
no way of identifying participant personal information that was not asked by 
specific survey questions.  
The study sample consisted of 53 voluntarily and anonymous survey 
participants. Clinicians who participated in the survey included 50.9% male 
professionals and 49.1% female professionals within the industry. Of the 
professionals that made up the study sample; 5.7% were Reproductive 
Endocrinologists, MD; 24.5% were Reproductive Physiologists, PhD; 9.4% were 
Andrologists; 56.6% were Embryologists; 1.9% were Urologists, MD; and 1.9% 









Figure 4.1.  Percentage of occupations held by reproductive professionals who 
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Instrumentation and Research Procedure 
 The researcher used the program SurveyMonkey® to design and publish 
a 36 multiple choice questionnaire. Male infertility questions were based on 
topics from a review of the current literature. A pilot survey test was sent out to 
various colleagues in the area whose answers were not to be included in the 
results. On January 26, 2015, after positive confirmation of the instrument, an 
email invitation was sent to the EmbryoMail moderator and the group of LSU 
Reproductive Alumni.  
Survey instructions were stated as follows: You are invited to participate in 
the 20 to 25 minute brief online survey. If you only have experience with some of 
the questions feel free to skip the ones that do not pertain to you and/or record 
an alternative answer. Any and all input is welcome in order to gain as much data 
from the human clinician side of the industry. Feel free to forward the survey link 
to other colleagues you think may be interested in participating. Thank you in 
advance for your assistance. To complete the survey click on the link below or 
copy and paste into browser: Please complete by February 16, 2015. 
https://www.surveymonkey.com/s/clinicalmaleinfertility. 
As of February 16, 2015, survey data had been collected from 46 
respondents. In a successful attempt to increase sample size, the researcher 
sent out a reminder e-mail extending the deadline to March 13, 2015. An 
additional seven participants were included. The final survey sample size totaled 
at 53 respondents.    
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Open ended answers and the suggestion for additional comments were 
offered in 14 of the survey questions. These questions were incorporated to gain 
additional feedback from the professionals on clinical practices that may not have 
been included in the survey answer options.  
Survey responses and e-mails received by the investigator were opened 
with a secured internet connection. Participant information was received under 
an identification number with no way for the researcher to identify a participants’ 
name or location. Additionally, a secure login was created by the researcher to 
upload, edit, and obtain results of the survey.  
Data Collection 
Participant responses were collected and identified by the order in which 
the survey was submitted. For example, the only information for Respondent #1 
was that the participant began the survey 7:25 p.m. on January 26, 2015 and 
completed the survey at 7:40 p.m.; a total time of 15:19 minutes.  
The researcher was able evaluate response data for each participant 
individually or as a whole sample group through the survey site. Both methods 
provided useful in monitoring progress and allowed for the researcher to identify 
additional comments from specific participants on their individual page(s). Survey 
results were recorded by gender, occupation, and specific question response, 
accessed only by the researcher. 
The survey publisher program provided graphs based on descriptive data. 
However, to meet the objectives of the study, the researcher reviewed each 
survey sample and recorded their answers linking their profession and gender. 
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This allowed the researcher to focus on specific relationships that otherwise 
could not have been evaluated based on the design of the survey.  
The researcher wanted address specific comparisons focused on 
occupation in relation to data accessibility and gender in relation to ethical 
questions. These survey questions can be viewed below in Table 4.1. In addition, 
the researcher wanted to evaluate the clinicians’ opinions on, specific male 
infertility factors, patient information gathered by the specific clinic, and male 
infertility evaluation tests. The results of these questions were compared to 
corresponding data from the retrospective.  
After realizing the amount of male data missing in the retrospective study 
patients, the researcher wanted to compare the clinicians’ personal experience 
with this same issue. Percentages of completed male medical records were 
compared for both study samples. Comparing the results for association or 
disagreement allowed the researcher to evaluate the importance of missing male 
data from two separate perspectives.   
Male medical chart completion percentage was evaluated for the 
observations given by the clinicians participating in the survey in percentage 
completions. In addition, the researcher evaluated the retrospective study 
medical charts for the amount of data missing. If an evaluation was completely 
missing that sample was considered 100% incomplete. If the evaluation was 
incomplete and/or missing data for three to five variables it was considered 25.0 
to 50.0% complete. Complete evaluations and evaluations missing only one data 
point were considered greater than 75.0% complete. 
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Table 4.1.  Male infertility clinician survey questions evaluated in relation to      
                  occupation and gender.  
 
   Survey  
 Question (#)      Male Infertility Clinician Survey Questions 
 
 Question 1 What role do you play in reproductive health? 
 
 Question 2 Gender: Male or Female? 
 
 Question 4 In your current position, do you have access to and               
                                     review all descriptive data for each male patient  
                                     per cycle? 
 
 Question 7 In your current position, do you have access to      
                                     and review all semen data for each male patient    
                                     per cycle? 
 
 Question 16                 In your current position, do you have access to  
                                     and review all urological data for each male patient  
                                     per cycle? 
 
 Question 19                 In your current position, do you have access to   
                                     and review all exposure data in each male patient   
                                     per cycle? 
 
 Question 25   In your current position, do you have access to and  
                                     review all medical history data in each male patient    
                                     per cycle? 
 
 Question 32                 Does reproductive healthcare need a better  
                                     communication system allowing the physician and  
                                     the laboratory physiologist to have equal access to  
                                     the all of the male patient’s exposure/environmental   
                                     and past medical information per cycle? 
 
 Question 34                 In your professional opinion do you find it unethical  
                                     to provide fertility treatment for males after a certain  
                                     age? 
 
 Question 35                 In your professional opinion, do you find that we are  
                                     adequately providing significant clinical information  
                                     to older male patients on the risks and ethical issues  






The main unit of observation for this study was reproductive clinicians who 
voluntarily participated in an online survey. In some instances, these 
observations were also compared to results from the previous retrospective 
study. With Microsoft Excel 2010, descriptive statistics were used to determine 
the mean percentages of the most commonly seen male infertility variables 
observed by the professionals who participated in the survey. The percentage 
means were then used to rank the top five variables that were reported by 
clinician observations as important factors in male infertility. 
Frequency rates and descriptive statistics were also used, in IBM SPSS 
Statistics 22, to identify percentage means of male data response rates from the 
retrospective study. The variables of importance identified by the clinician 
observations were then compared to the mean percentages of the same 
variables from the retrospective study. Since the study was measuring different 
rates/ranks, there were no statistical procedures performed other than descriptive 
statistics. Still, the researcher wanted to visualize the difference between what 
variables are of importance to clinicians and what variables are actually being 
reported by male patients. 
In addition, descriptive statistics were used to determine the mean 
percentages of male record completion that were reported by survey participants. 
To compare the rates being observed by professionals in the industry and actual 
study data collected on completed male records, retrospective completion data 
was evaluated in association. Descriptive statistics had been previously applied 
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in the retrospective study to determine the frequency and percentages of 
completed male records reported. This allowed for a side by side comparison of 
industry observations and retrospective clinic data to be loosely and cautiously 
evaluated for similarities. 
The researcher used Cramer’s V correlation coefficient, in SPSS, to 
determine if there was a significant relationship between occupation and gender. 
In addition, Cramer’s V coefficient was used to evaluate for a correlation between 
data access and clinician occupation. Data accessibility was examined for five 
different areas; descriptive data, semen evaluation data, urological data, 
exposure data, and medical data.  
Again in IBM SPSS, the researcher used Cramer’s V correlation 
coefficient to examine the relationship between gender and ethical male 
treatment practices such as; the need of a better clinician communication system 
and adequate information provided on advanced age male reproductive risks. 
When evaluating occupation and the need for a better clinical communication 
system, the researcher also used Cramer’s V to determine a correlation. A Phi 
correlation coefficient was used to determine if there was a significant 
relationship between clinician gender and treatment cutoff age for males.   
Results 
  
This section begins with the results of survey questions that were not 
addressed in the statistical analysis. No statistical implications were made for 
these additional comparisons. However, the researcher thought it would be 
beneficial to the exploratory nature of the research design to evaluate clinicians’ 
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opinions on these particular questions. In addition, response percentages from 
the survey study are compared, side by side, to analogous results from the 
retrospective study. The results of correlational analyses are then reported, 
implicating the type of relationship between surveyed clinicians’ opinions, gender, 
and occupation for the dependent and independent variables.  
Figure 4.2 demonstrates the opinion percentage means of surveyed 
clinicians on the effectiveness of basic semen analysis as a predictor of male 
infertility. Out of 53 participants, 67.9% responded that basic semen analysis was 
an effective predictor most of the time. Clinicians who reported semen analysis 
as only occasionally effective totaled 26.4% of the response group. Notably, only 
a small percentage of survey participants, 5.7%, reported that this analysis was 
effective all of the time. 
Participating clinicians’ opinions on the importance of DNA fragmentation 
as a predictor of male infertility are exhibited in Figure 4.3. The mean 
percentages of 52 respondents describe the professional opinions of those 
surveyed on this male infertility factor. Result demonstrated that 32.7% have no 
idea if DNA fragmentation was a predictor, 26.9% reported that occasionally it 
was a predictor, 23.1% rarely thought DNA fragmentation was a predictor of male 
infertility, 11.5% thought that most of the time this variable was an indicator, 3.8% 





Figure 4.2.  Percentage means of clinician responses on the importance of basic 
semen analysis as a male infertility predictor demonstrated by the response 
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Figure 4.3. Percentage means of clinician responses on the importance of DNA 
fragmentation as a male infertility predictor demonstrated by the response ranks 
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However, when asked what semen parameters the clinic tested for, DNA 
fragmentation exemplified one of the lowest statics. The response rate for this 
survey question was 100%. As shown in Table 4.2, clinicians reported semen 
parameters tested at their clinics in the following order; volume, sperm count, 
sperm motility, and progressive motility were tested by 100% of the clinics. 
Progressive motility was reported to be tested by 90.6% of the clinics, while white 
blood cell count was tested 88.7% of the clinics. Less than half of the clinics, 
30.2%, tested for DNA fragmentation and 13.2% tested for acrosome integrity. 
 
Table 4.2.  Percentages of semen parameters routinely evaluated as reported by     
                  the professional experience of surveyed clinicians.   
 





   Volume 100.0% 53 
   Sperm Count 100.0% 53 
   Sperm Motility 100.0% 53 
   Progressive Motility 90.6% 48 
   Sperm Morphology 100.0% 53 
   White Blood Cell Count 88.7% 47 
   Acrosome Integrity 13.2% 7 
   DNA Fragmentation 30.2% 16 




The results of participant opinions on the significance of male age on 
impaired semen and/or sperm cells are presented in Figure 4.4. Approximately 
six percent (5.7%) of clinicians admitted to having no idea on the effects of male 
age as it related to impaired semen samples and no respondent (0%) believed 
male age was completely responsible. However, 58.5% were in agreement that 
male age had a somewhat significant effect on the integrity of semen and/or 
sperm cells. The remaining participant responses were closely divided, with 
18.9% of clinicians believing that male age had a lot to do with impaired semen 
samples. On the other hand, 17.0% of clinicians believed that male age was a 
factor of little significance.   
When clinicians were surveyed on the significance of genetic and 
epigenetic changes in sperm DNA, the results demonstrated an increased 
agreement in contribution on male infertility (Figure 4.5). Approximately 80.1% of 
professionals responded that genetics and/or epigenetics displayed somewhat or 
a lot of significance on male infertility, 41.5% and 39.6%, respectively. Additional 
results demonstrated that 9.4% of clinicians assumed that this variable had a 
little significance on male infertility, 7.5% believed that these changes were 
completely responsible for male infertility, and 1.9% had no idea of the 









Figure 4.4.  Percentage means of clinician responses on the significance of male 
age contribution on impaired semen and/or sperm cells demonstrated by the 
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Figure 4.5.  Percentage means of clinician responses on the significance of 
genetic/epigenetic changes in sperm DNA on impaired semen and/or sperm cells 









A Little Somewhat A Lot Completely
Responsible
No Idea

















n = 53 
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Male exposure and environmental factors were thought to have a lot of 
significance on impaired semen and/or sperm cells as reported by 58.5% of 
clinicians surveyed (Figure 4.6). Approximately, 32.0% of the participants 
responded that male exposure and environmental factors were believed to have 
somewhat of a significant effect on normal sperm production. Lastly, 5.7% of the 
remaining opinion results demonstrated the belief that these factors had little 
significance on impaired semen samples and 3.8% of clinicians reported having 
no idea. 
Considerably, when asked if access to more male patient lifestyle 
information would enable the clinician to provide better care, 53.9% of survey 
participants answered yes, 19.2% stated no, and 26.9% were undecided 
(Appendix F.8). Survey participants also responded to the need of a better 
clinical communication system for access to male records with 53.8% 
professional agreement, 42.3% thought the current system was sufficient, and 
3.9% were undecided about the need for a better clinical communication system 
(Appendix F.9).  
Objective 1  
To describe the level of importance of male infertility variables that 
clinicians report most commonly observed in their professional experiences in 
comparison to the retrospective male response data collected on those same 






Figure 4.6.  Percentage means of clinician responses on the significance of male 
exposure and environmental factor(s) contributed to sperm impairments as cells 
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 The most commonly seen descriptive variables that clinical professionals 
reported in connection with male infertility were infertility length with current 
partner at 70.8%, age at 45.8%, BMI at 29.2%, and weight at 16.7% (Table 4.3). 
Height was added to the table because of its response rate in the retrospective 
study. Seventy percent of male infertility patients evaluated in the retrospective 
study reported data on height. Interestingly, only 2.1% of the clinicians surveyed 
listed height as an important descriptive variable. However, BMI was ranked third 
by survey responders, at 29.2%, among common variables associated with male 
infertility. Therefore, one would assume that height should be just as important as 
weight since BMI can be calculated if male patient records contain data on both.  
 
Table 4.3.  Percentages of the response rank of clinicians on the importance of  
                  male infertility variable and the response rate of retrospective study         
                  male infertility patients.  
 
         Male                                     Survey                           Retrospective    
  Factor Variable                    Response Rank %            Response Rate % 
                                                          
                                                              n = 53                       n = 83 
      
     ILCP                      70.8%              59.0%  
     Age                      45.8%              98.0% 
     BMI                      29.2%                                  60.0% 
     Weight                      16.7%                        65.0% 
     Height*                        2.1%                        71.0% 
     




As mentioned above, ILCP was the most commonly reported variable by 
survey participants at 70.8%. Retrospective data response rate for ILCP was 
lower at 59.0%. However, the retrospective percentage needs to be considered 
with caution, since some of the ILCP data was obtained from female partner 
charts in order to have more data samples. By having done this the researcher 
may have suppressed a larger difference that is not being expressed.  
The most important semen characteristics that clinical professionals 
reported in correlation to male infertility was sperm count at 84.6%, sperm 
motility at 76.9%, sperm morphology at 75.0%, progressive motility at 46.2%, and 
volume at 17.3%. Retrospective response rates were considered to be available 
one hundred percent of the time (Table 4.4).  
 
Table 4.4.  Percentages of the response rank of clinicians on the importance of  
                  semen evaluation characteristics and the response rate of             
                  retrospective study male infertility patients.  
 
 
                                      Survey                   Retrospective  
   Variable          Response Rank %          Response Rate %  
                                                           
                                                                  n = 52           n = 104 
   Sperm Count/Concentration              84.6%                        100%   
   Sperm Motility                76.9%                        100%  
   Sperm Morphology               75.0%    100%*     
   Progressive Motility               46.2%              100%**   
   Volume                 17.3%    100%  
 
 **n = 100 
   *n = 90  
140 
 
It should be noted that the semen sample data listed for the retrospective 
response rate did not come from patient responses. Semen evaluations are 
routinely recorded in the male infertility patients’ medical charts by their 
clinicians. Thus, with the exception of a few characteristics that are not evaluated 
after a sample is frozen and thawed, semen data should be routinely available for 
male infertility patients. 
Data based on urology variables usually comes from the male patients’ 
personal responses or medical records from a prior urological evaluation. In the 
clinician survey study, the most commonly seen urological variables reported in 
correlation to male infertility were vasectomy at 77.8%, hormone treatment at 
60.0%, surgery to testicles at 33.3%, undescended testicles at 33.3%, and 
impotence at 28.9% (Table 4.5).  
In the retrospective study, the researcher observed a number of missing 
data points for these specific variables. When evaluating impotence, the 
response rate was 54.0% of male patients in the retrospective study and the 
clinicians surveyed rated it lowest in importance. However, it was noted by the 
researcher that 15.0% of the retrospective patients had specifically skipped the 
same question dealing with impotence while completing all other remaining 
questions on the evaluation. Table 4.5 demonstrates the retrospective response 
rates as they compared to the clinicians’ survey opinions. The retrospective 
results demonstrated a male patient completion response rate for vasectomy at 
66.0%, for hormone treatment 61.0%, for surgery to testicle(s) 63.0%, and for 
undescended testicle(s) 63.0%.  
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Table 4.5.  Urological male infertility variables of importance. Survey percentages  
                  describe response rank and retrospective percentages describe     
                  response rate. 
 
                                     Survey                      Retrospective  
     Variable          Response Rank %         Response Rate %   
 
            n = 48                                  n = 83 
 
     Vasectomy          77.8%       66.0%  
     Hormone Treatment              60.0%       61.0% 
     Surgery to Testicle(s)                33.3%       63.0% 
     Undescended Testicle(s)               33.3%                 63.0% 
     Impotence           28.9%       54.0%  
 
The most commonly seen environmental exposure variables that clinical 
professionals reported in correlation to male infertility were smoking at 74.5%, 
steroids for body building at 70.6%, recreational drug use at 58.8%, exposure to 
chemicals at 51.0%, recent high fever at 39.2%, and alcohol use at 39.2% (Table 
4.6).  
Again the male patient retrospective response rate was listed in Table 4.6 
to be viewed in relation to the survey responses. Smoking resulted in the largest 
percent of retrospective data acquired at 66.0%; followed by steroids for body 
building at 62.0%, recreational drug use at 61.0%, exposure to chemicals 60.0%, 






Table 4.6.  Environmental exposure male infertility variables of importance.  
                  Survey percentages describe response rank and retrospective   
                  percentages describe response rate. 
 
                                      Survey             Retrospective            
     Variable            Response Rank %         Response Rate % 
 
       
           n = 52               n = 83 
 
     Smoking                74.5%                                   66.0% 
     Steroids for Body Building             70.6%                          62.0% 
     Recreational Drug Use                 58.8%                   61.0% 
     Exposure to Chemicals                        51.0%                                   60.0% 
     Recent High Fever                        39.2%                61.0% 
     Alcoholic Use                         39.2%                59.0% 
 
Survey results revealed that the most commonly seen medical variables 
encountered by clinicians in correlation to male infertility were medication use at 
84.8%, recent illness/infection at 50.0%, BMI at 37.0%, and birth defects at 
21.7% (Table 4.7). Results for the response rate of the retrospective study 
showed 14.0% of the sample reporting medication use for high blood pressure. 
This was the highest frequency of type of medication retrospectively collected 
from male patient records. The complete percentage of patient data for 
medication use was 60.2%. In addition, 62.7% reported a recent illness and 





Table 4.7.  Medical male infertility variables of importance. Survey percentages  
                  describe response rank and retro percentages describe response  
                  rate. 
 
                                Survey                    Retrospective  
     Variable                    Response Rank %            Response Rate %      
 
                                                                   n = 52               n = 83 
      
     Medication Use                 84.8%                60.2%         
     Recent Illness/Infection                50.0%                62.7%   
     BMI                  37.0%                65.1% 
     Birth Defects                            21.7%                 N/A 
   
2. To describe the relationship between the amounts of completed male 
medical records available from the retrospective analysis of data in 
comparison with the amount of completed male medical records reported 
as seen by clinicians and measured by an anonymous national online 
survey.  
  Clinician survey participants described that 39.1% of their charts were 
less than 25.0% completed, 34.8% of their charts were 25.0 to 50.0% completed, 
and 26.1% of male chart data was considered greater than 75.0% completed. 
Results of male patient chart completion evaluated in the retrospective study 
reported that 45.0% were less than 25.0% completed, 23.0% was 25.0 to 50.0% 
completed, and 32.0% were recorded as greater than 75.0% complete (Figure 
4.7). These results are consistent with the observations of a number of current 
research studies. In a 2011 study, Billari et al. reported that survey response 




Figure 4.7.  Percentage of retrospective study male patient chart completion 
levels (%) compared with percentage of male patient chart completion levels (%) 
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n = 46 
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3. Clinicians who participated in the voluntary male infertility survey will 
demonstrate a negative correlation among their opinions of infertility topics 
such as; data availability and gender based ethical treatment of patients. 
Results analyzed from a Cramer’s V correlation coefficient found no  
significant relationship between gender and occupation with an r value,  r = .326 
(Table 4.8 and 4.9). 
 
Table 4.8.  Frequency distribution of the survey participants’ gender and    
                  occupation presented in a Cramer’s V correlation coefficient   
                  contingency table.  
 











Male 2 9 12 3 1 0 27 
Female 1 4 18 2 0 1 26 




Table 4.9.  Cramer’s V correlation coefficient exhibits a non-significant  
                  relationship between gender and occupation.  
 
 Cramer’s V Correlation Coefficient Value Approx. Sig. 
Nominal by Nominal 
Phi .326 .343 
Cramer's V .326 .343 
N of Valid Cases 53  
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Using a Cramer’s V correlation, there was no significant correlation found 
between occupation and access to any of the data variables; descriptive at  
r = .351 (Appendix F.10a, F.10b), semen at r = .235 (Appendix F.11a, F.11b), 
urological at r = .317 (Appendix F.12a, F.12b), exposure at r = .251 (Appendix 
F.13a, F.13b), or medical data r = .306 (Appendix F.14a, F.14b). The results of 
this analysis were a bit surprising and contradictory to the participants’ response 
of needing more data. Although, the researcher did not come across any 
published research studies based on infertility patient record availability, personal 
observation in the industry has indicated a difference.  
The expected results for this correlation were that occupation status would 
have a significant relationship when compared with access to patient data. The 
results were expected to more closely reflect the respondents’ opinion of needing 
a better communication system, which 53.8% of the professionals agreed upon. 
Using a Cramer’s V correlation coefficient there was no significant 
correlation found between gender and the need for a better clinical 
communication system with a value of r = .284 (Table 4.10 and 4.11). 
Furthermore, a non-significant relationship was identified when Cramer’s V was 
used to analyze occupation and the need for a better communication system 










Table 4.10.  Frequency distribution of survey participants’ gender and opinions  
                    on the need for a better communication system presented in a  
                    Cramer’s V correlation coefficient contingency table.  
 
Gender*Clinical Communication System Contingency Table 
 Clinical Communication System  
 
 






Male 8 16 2 26 
Female 14 12 0 26 




Table 4.11.  Cramer’s V correlation coefficient exhibits a non-significant   
                    relationship between gender and the need for a better clinical    
                    communication system.  
 
Cramer’s V Correlation Coefficient Value Approx. Sig. 
Nominal by Nominal 
Phi .284 .122 
Cramer's V .284 .122 







Table 4.12.  Cramer’s V correlation coefficient exhibits a non-significant   
                    relationship between occupation and the need for a better clinical    
                    communication system.  
 















Repro Endo 2 1 0 3 
Repro Phys 3 9 1 13 
Embryologist 14 15 1 30 
Andrologist 3 1 0 4 
Urologist 0 1 0 1 
Repro Tech 0 1 0 1 




Table 4.13.  Cramer’s V correlation coefficient exhibits a non-significant     
                    relationship between occupation and the need for a better clinical  
                    communication system.  
 
 Cramer’s V Correlation Coefficient Value Approx. Sig. 
Nominal by Nominal 
Phi .359 .752 
Cramer's V .254 .752 
N of Valid Cases 52  
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As expected, when addressing the ethical topic of male infertility patient  
cutoff age responses varied among the clinicians. In reference to the loose 
establishment of female cutoff ages, survey participants were questioned on their 
experiences with male cutoff ages. Regarding their own personal clinics, 94.2% 
of survey participants responded that they did not enforce a male cutoff age for 
infertility treatment. Furthermore, responses demonstrated that only 5.8% of the 
professionals implemented a clinical male cutoff age as shown in Figure 4.8. 
If participants responded yes to the previous question they were asked to 
specify a male cutoff age. With a 10.0% response rate, clinicians reported 
inconsistent guidelines on the need to set an age. In addition, the actual male 
cutoff age currently enforced by their clinic was also highly variable. Responses 
ranged from a suggested male age of 40 years old for semen donors only, to a 
60 and/or 65 year old male patient age treatment limit. In addition, 2.0% of those 
that responded explained that male patients over 40 years of age at their clinic 
were only counseled on the increased risks of advanced male reproductive age.  
Although these limited responses were not analyzed for significant 
differences, it is important to note the response variation that existed among such 
a small population. Since it is believed that the study sample is a normal 
representation of the infertility industry population, the researcher found that 
these results were reasonably generalizable to the industry as a whole. The 
previous review of literature supported these results, as well, by citing examples 





Figure 4.8.  Percentage of clinics that enforce a male infertility treatment cutoff 
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When clinicians were asked their ethical opinion of providing fertility 
treatment for males after a certain age, 35.0% responded it was unethical and 
64.0% responded it was not unethical (Table 4.14). Using a Phi correlation 
coefficient, a significant relationship was not found among clinician gender and 
their opinion to enforce a male treatment cutoff age, with an r value of r = .162 
(Table 4.15). 
 
Table 4.14.  Frequency distribution of survey participants’ gender and opinions  
                    on unethical treatment of advanced age male patients presented in  
                    a Phi correlation coefficient contingency table.  
 
 Gender*Unethical Advanced Age Male Treatment Contingency Table 
 Unethical Advanced Age  Male Treatment 
Gender 
Total Female Male 
 
No 19 15 34 
Yes 7 11 18 




Table 4.15.  Phi correlation coefficient exhibits a non-significant relationship  
                    between gender and opinions on unethical treatment of advanced  
                    age male patients.   
 
 Phi Correlation Coefficient Value Approx. Sig. 
Nominal by Nominal 
Phi .162 .244 
Cramer's V .162 .244 
N of Valid Cases 52  
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As previously stated, male infertility is a considerably understudied area of 
research. In alignment with this circumstance and the low male response rates 
reported in both studies; the researcher wanted to evaluate clinicians’ opinions in 
regards to the ethical question of adequate information being provided. As a 
whole, survey participants responded to the issue as expected (Table 4.16). An 
impressive 63.0% of clinicians acknowledged that the industry was not providing 
enough information to patients on the risks associated with advanced male age 
reproductive treatments (Figure 4.9). As demonstrated in Table 4.17, a Cramer’s 
V analysis, reported a p value of r = .120. The results from this correlation 
established that clinician gender did not influence clinicians’ opinions on 
adequate male information being provided to patients.  
By comparing these two variables the researcher wanted to determine if a 
relationship existed between clinician gender and the response to a gender 
based question on ethical treatment. The researcher expected the results to 
show that this variable was, in fact, a significant positive or negative factor, due 
to the gender sensitivity of this question. 
To identify the possible existence of a relationship between occupation 
and adequate male information provided, the researcher again used a Cramer’s 
V correlation coefficient. With an established p value of r = .310, survey results 
demonstrated that clinician occupation did not influence the clinicians’ opinions of 





Table 4.16.  Frequency distribution of survey participants’ gender and opinions  
         on adequate male data provided presented in a Cramer’s V     
         correlation coefficient contingency table.  
 
 Gender*Adequate Male Data Provided Contingency Table  
 Gender 
Adequate Male Data Provided 
Total No Yes Undecided 
 
Male 15 7 4 26 
Female 18 5 3 26 




Table 4.17.  Cramer’s V correlation coefficient exhibits a non-significant  
                    relationship between gender and adequate male data provided.  
 
Cramer’s V Correlation Coefficient  Value Approx. Sig. 
Nominal by Nominal 
Phi .120 .688 
Cramer's V .120 .688 




























Figure 4.9.  Percentages of clinicians’ survey opinions on adequately providing  










Yes No Undecided 
n = 53 
Adequate Male Patient Information 
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Table 4.18.  Frequency distribution of survey participants’ occupation and     
                    adequate male data provided presented in a Cramer’s V correlation   
                    coefficient contingency table.  
 
 Occupation*Adequate Male Data Contingency Table 
 Occupation 
Adequate Male Information Provided 
Total No Yes Undecided 
 
Repro Endo 2 1 0 3 
Repro Phys 9 4 0 13 
Embyologist 18 5 7 30 
Andrologist 3 1 0 4 
Urologist 0 1 0 1 
Reproductive Tech 1 0 0 1 




Table 4.19.  Cramer’s V correlation coefficient exhibits a non-significant  
                    relationship between occupation and adequate male data provided. 
  
 Cramer’s V Correlation Coefficient  Value Approx. Sig. 
Nominal by Nominal 
Phi .438 .441 
Cramer's V .310 .441 








 The main purpose of including the clinician survey into this research 
project was to gain a more realistic grasp on controversial issues in the male 
infertility industry. Although, not much statistical significance can be taken from 
this design, it gives the reader an idea of what is happening in the industry daily. 
In addition, it highlights new areas of ideas on male infertility research. The key is 
to connect what the clinicians are currently observing and the areas that need to 
be researched.  
The goal of this objective was to view the two rates, clinician response and  
retrospective male patient data, side by side and evaluate for any possible 
relationships. Survey percentages describe the response rank of clinicians and 
retrospective percentages describe the response rate of male infertility patients. 
Further research can be developed based upon variables that clinicians think 
acknowledge as important to male reproductive success. Those variables can 
also be compared with their availability from male patient responses to clinical 
questionnaires, to assess question sensitivity.  
While only 45.8% of the survey participants regarded male age as an 
infertility indicator; the previous chapter study reported data that found a 
significant correlation between male age and biochemical pregnancy rates. 
Retrospective data also revealed a significant correlation between male age and 
IVF pregnancy rates. However, it is important to observe from the survey results 
that clinicians are not focused only on male age as an infertility factor. The 
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results suggested that clinicians are observing additional male infertility and 
environmental factors; just as current research has begun to demonstrate.  
 Participating clinicians reported that the variable of highest average of 
male infertility factor importance observed from their perspective was infertility 
length with current partner. However, the results from the retrospective study of 
male patients were so variable that it provided no significance. These contrasting 
results may be the expression of the difference in study design. A possible 
suggestion is that clinicians obtain altered data from face to face patient care 
when compared with the patient responses gathered from a questionnaire.  
It is safe to assume that the missing retrospective data on ILCP in combination 
with the already small sample size was a limiting factor in the previous study. 
This may prove to be an important difference when comparing the results of the 
two studies. Substantial research studies in this area should be designed around 
the most effective methods of gathering patient data on infertility length.    
Additionally, this may be an area where patients need access to more 
fertility information. In their 2007 paper, Robinson and Ellis reported that one of 
the probable causes for failure to conceive appeared to be mistiming of 
intercourse. One way for clinicians to address this issue would be to provide 
patients with increased knowledge on fertilization and ovulation in an effort to 
reduce infertility length in some cases.  
When comparing semen evaluation characteristics, the results of the two 
studies expressed different main variables. Results from the retrospective study 
reported semen volume and progressive motility as negatively correlated to male 
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age. These age related variables are commonly reported among semen 
evaluation research studies, as recognized in the review of literature. However, 
only 17.3% of survey participants reported volume as an important semen 
characteristic and the second to lowest importance rating was for progressive 
motility (46.2%). 
In the retrospective study, smoking was reported to have multiple 
significant correlations with semen characteristics. Similarly, survey participants 
reported smoking as the top variable affecting male fertility in their experience. A 
number of research studies, such as Linsten et al. (2005), reported both smoking 
and overweight to unfavorably affect male reproductive success after IVF cycles. 
Linsten and colleagues (2005) went on to report that the negative impact of 
smoking on the live birth rate in IVF treatment is comparable to an increase in 
female age >10 years.  
Vasectomy was listed as the most common seen urological factor in 
relation to male infertility. However, out of 83 responses in the retrospective 
study only six percent of male patients reported having a vasectomy. Two 
percent reported having had hormone treatment as compared with 60.0% of 
clinicians reporting its importance. One percent reported having surgery to 
testicles as compared with 33.0% percent of clinicians reporting its importance. 
One percent of the male patients reported having undescended testicle as 
compared with 33.3% and 8.0% percent reported impotence as compared with 
28.9% of clinicians reporting its importance.  
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When participating clinicians were asked about the role DNA 
fragmentation plays in male infertility, the majority, 33.0% reported having no 
idea. In addition, DNA fragmentation represented one of the lowest semen 
variables that clinicians reported testing. At 30.2%, less than half of the clinics 
actually reported to testing for DNA fragmentation. Due to limited research on 
DNA fragmentation, the opinions of clinicians may be reflecting the lack of 
knowledge on alternative semen characteristics effecting male fertility. Further 
analytical studies are needed to identify the relationship between DNA, semen 
characteristics, and biochemical pregnancy rates.   
Not all infertility researchers agree on the same ‘normal’ characteristics for 
a semen analysis. The review of literature explained how most of the semen 
variables tested for fertility are controversial. In the current survey clinicians 
reported that semen quality is a high predictor of reproductive success. However, 
66.0% of the group reported that a better diagnostics test is needed for semen 
analyses. Sousa et al. (2011) are among some of the researchers that have 
demonstrated advanced techniques to evaluate semen samples. Yet, a 
subpopulation containing only fertile sperm has never been isolated. The 
researchers explained that this was mainly due to the fact that we still cannot 
completely describe what makes a competent spermatozoon (Sousa, et al., 
2011).  
Although the researcher expected to see a difference in reporting based 
on gender; the results of the current survey showed no correlation between male 
and female clinicians as they responded to specific gender based questions. 
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These results were in agreement with a 2011 human fertility age limit study 
published by Billari and colleagues. When evaluating participants, gender of the 
respondent was not a statistically different indicator in the perception of female or 
male age deadlines (Billari et al., 2001). Some researchers have suggested that 
as society advances, gender equality plays a role in the notion of fertility equality.   
The majority of clinicians surveyed were in agreement that more male 
information would be beneficial in the treatment process. Study results 
demonstrated similar percentages between the experiences of clinicians and the 
amount of retrospective data reported when analyzing the issue of missing male 
data. A 2014 CDC consensus illustrated that the percentage of male data 
reported to analyze was much less than the amount of female data available 
(Center for Disease Control and Prevention, 2014).  
A likely factor contributing to insufficient reporting is the stigma associated 
with certain male medical conditions. In a 2003 review, Dudgeon and Inhorn 
concluded that for men, infertility is a potentially humiliating and emasculating 
stigma that had a more profound adverse impact on men than the same 
diagnosis did for women. The group argued that in contemporary Western 
societies, stereotyped masculinity denies vulnerability, promotes an appearance 
of toughness and emotional control, minimizes the need for assistance from 
others, and suggests a preoccupation with sex, which virtually leads men to view 
male infertility the same as male impotence (Dudgeon and Inhorn, 2003). 
Another proposed reason for so much missing data is the male patients’ 
lack of fertility knowledge on the importance of the question. For example, some 
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clinics in the industry provide professional consultations to advanced age female 
patients, while similar programs are not nearly as often provided for males. 
Additionally, outside of the fertility world, reproductive problems and prenatal 
care are generally associated with human females. 
This raises the question, is the fertility industry providing adequate 
information on male risk factors, such as advanced age and exposure. In 
addition, are patients aware of the ethical issues associated with advanced age 
fertility treatments? The response data from this survey suggests that 63.5% of 
the professionals surveyed do not think adequate male infertility information is 
being addressed with infertility couples.  Although, this was not statistically 
analyzed for significance, it can be viewed as a current evaluation describing the 
professional practices in today’s human infertility clinics.  
There are fertility clinicians within the industry who have a strong opinion 
about paternal age and others that do not. Ultimately, it is up to the clinic and the 
patient to decide upon treatment. Currently, few federal laws interfere with U.S. 
citizens becoming parents. In the U.S. there is not one federal law in place that 
enforces an age limit on becoming a parent. Therefore, it is not required but 
some clinics practice female cutoff ages, while very few have male cutoff ages.  
Surveying the views of clinicians in the current study provided an example 
of industry practices. Ninety-four percent of professionals responded that they do 
not have a male cutoff age. However, when asked if it was unethical to provide 
fertility treatment for males after a certain age the percentage of clinicians who 
responded yes rose to 35.0%, while 65.0% responded no. More research on 
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advanced male age factors will help to provide additional needed clarity to the 
issue of ethical patient treatment. 
Due to the exploratory nature of the study, no significant conclusions were 
drawn from the comparison of relationships among this data. Although the 
sample size of the clinician survey study was small, the researcher felt that the 
sample population was normally distributed. Therefore, opinions reported can be 
generalized as comparable to those of clinicians throughout the industry. 
Additionally, since there are so few industry standards enforced, gaining any 
information on the current practices will be beneficial. The current study results 
will contribute to the foundation of future male infertility research. Feedback from 
the clinicians provided researchable information on the amount of male risk 
factors and lifestyle factors currently being addressed with infertility couples. By 
reporting patient data and performing new studies like the current survey, 
valuable exposure can be added to the area of male infertility research.  
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CHAPTER V:  CONCLUSION 
Summary 
The focus of this research was the evaluation of male reproductive 
success in regard to age, as well as environmental lifestyle exposures. 
Biochemical pregnancy rate and semen parameters were the specific 
concentrations of the study. In 2010, Sartorius and Nieschlag reported that lower 
fertility rates and pregnancy-associated complications should not only be 
associated with advanced maternal age but also with increased paternal.  
Much controversy about male infertility and the influential factors can be 
found among the current collection of literature. The present study was designed 
as a two part evaluation. A retrospective collection of male data from a private 
fertility clinic was combined with a national survey of infertility clinicians. The 
strategy of using these two approaches was to gather information about male 
infertility from different angles. The retrospective study served as an analysis of 
patient data, while the clinician survey functioned as an exploration of opinions 
within the industry. Combining the results of the two studies will provide 
investigators with additional data to determine relevant areas of research to 
investigate.  
In 2011, Billari and colleagues pointed out that in light of the recent 
increase in fertility at advanced ages, it is important to understand both the 
factors that drive this increase and the factors that limit this increase. Biology and 
reproductive technology have set ultimate limits on fertility, especially for females 
(Billari et al., 2011). Male limits, on the other hand, are much less defined.  
Recent research has shown that men do in fact have biological clocks affecting 
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hormone levels, fertility, and sperm quality (Lambert et al., 2006; Lewis et al., 
2006). Although, opposed to females, male reproductive function alters slowly 
over a period of years, albeit with age dependent alterations (Sartorius and 
Nieschlag, 2010). 
Increasing research on the topic of male fertility brings investigators closer 
to defining the factors that improve male reproductive success and the factors 
that hinder male reproductive success. With each study, the role of male infertility 
becomes more clarified in its recognition as a dual contributor to a couple’s 
reproductive success.   
Implications, Recommendations, Limitations 
Retrospective Study 
Conclusion 1 
 It was concluded that advanced age males who participate in clinical ART 
treatment cycles at a private human fertility clinic will have lower biochemical 
pregnancy rates and lower IVF pregnancy rates. These results are supported by 
a number of research studies. In a 2004 study, Kϋhnert and Nieschlag showed 
increasing evidence that advanced paternal age is associated with changes in 
reproductive functions on different levels; semen production, fertility, and 
pregnancy outcome to name a few. These results are also in agreement with the 
2006 study performed by de La Rochenbrochard and colleagues where the 




It was also concluded that advanced age males who participate in clinical 
ART treatment cycles at a private human fertility clinic will have decreased 
seminal volume and reduced progressive motility. Similarly, Rolf and colleagues 
(1996) demonstrated that seminal volume and seminal fructose concentration 
decreased with age, possibly due to a seminal vesicle insufficiency, since the 
seminal vesicle contributes most to ejaculate volume. In 2006, Gagnon and de 
Lamirande explained that factors leading to decreased sperm motility could be 
found in altered functions of post-testicular glands such as the prostate and, 
more probable, the epididymis, as the swimming ability of spermatozoa is 
acquired during epididymal transit and motility is dependent on dilution into 
seminal plasma.  
Additionally, age-dependent alterations of the epididymis might lead to 
disturbed mitochondrial functioning. An important part of epididymal sperm 
maturation is the activation of sperm mitochondria (Aitken et al., 2007). The 
mitochondria are essential for energy production and storage, which enables the 
sperm to remain motile. In 2011, Sousa et al. suggested that differences in 
sperm fertilization ability between ejaculates can be attributed to the number of 
sperm in the ejaculate with functioning mitochondria.  
The current study results concluded that advanced age males who 
participate in clinical ART treatment cycles at a private human fertility clinic did 
not experience unsuccessful semen characteristics for concentration, motility, 
percent normal, and total motile sperm per specimen. These results are not in 
agreement with prior research data from the same fertility clinic. The clinic 
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previously concluded that sperm concentration, motility, and morphology 
decreased as male age increased. The difference between the current study and 
the previous clinical research was the sample size of male patients and the 
length of time male patients were evaluated. The current study contained a 
sample size of 104 male patients and evaluated cycles over a four year period. 
The previous research contained a sample size of 16,156 male patients and 
evaluated cycles over a nine year period.  
Although no significant correlations were found when advanced male age 
was compared with the patient’s response for difficulty with ejaculation, the 
results led the researcher to believe that there is a definite need for further 
studies in this area. It is believed that an abnormally high amount of male 
patients specifically skipped the two questions related to difficulty with erection 
and ejaculation. The amount missing data strongly suggests that this may be a 
sensitive question for males to answer. Additionally, it raises the question of the 
accuracy of the results in studies that included this variable.  
Previous female studies have associated advanced age with decreased 
implantation rates and pregnancy rates (Yarali et al., 2010; Jiao et al., 2002; Ishii 
et al., 2012). In a 2010 study, Yarali and colleagues found that increased 
miscarriages as well as decreased implantation rate were mainly responsible for 
the poor performance of patients with advanced female age. Duran and 
colleagues reported that although they observed a decrease in semen volume, 
sperm motility, and fertilization rate with advanced male age, embryo quality, 
clinical pregnancy, implantation, miscarriage, and live birth rates were not 
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affected (Duran et al., 2010). The current study results demonstrated an altered 
outcome.  
This study was different in that it evaluated pregnancy rates and not 
fertilization rates. It is important to point out that all of the embryos transferred in 
the retrospective study cycles were fertilized. The detrimental effects were 
expressed at implantation or at the early stages of pregnancy development. The 
current study results found that advanced male age affected semen volume and 
progressive motility, as well as, biochemical pregnancy rates. The study went a 
step further by not only reporting decreased semen quality with advanced male 
age but also reporting decreased pregnancy rates after embryo transfer with 
advanced male age.  
 A recommendation for further retrospective research would be to obtain a 
larger sample size. The same variables should be addressed, with the inclusion 
of additionally identified factors. However, retrospective studies should be 
performed independently for variables associated with embryo quality, semen 
characteristics, and pregnancy outcome.  Another recommendation for further 
research would be to perform a prospective research study at a human fertility 
clinic, addressing the same variables. Again a larger sample size would be 
needed, but the advantage of having present access to the patients could clear 
up some of the problems of missing data.  
Conclusion 2 
It was concluded that those male patients who reported to smoke more 
than 5 to 10 cigarettes per day showed a decrease in sperm concentration and 
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progressive motility. Additionally, it was concluded that male patients who 
reported smoking were also associated with ejaculation difficulty. Previous 
studies that have examined environmental factors and paternal fertility have also 
demonstrated an association between cigarette smoke and sperm concentration. 
 In a 1992 review of semen quality studies conducted over a 50 year 
period, Carlsen et al. reported that mean sperm concentration worldwide fell by 
half. Giwercman and colleagues (1993) concluded that such a fast decline in 
semen quality was probably due to environmental, rather than genetic factors. 
The group suggested that in utero exposure to environmental oestrogens, 
pollution, and lifestyle exposures, including cigarette smoking were possible 
causes of this decline in quality (Giwercman et al., 1993). In an additional review, 
Vine (1996) revealed that smokers’ sperm concentration was on average about 
15.0% lower than that of non-smokers. 
 The current study results concluded that male patients who participate in 
clinical ART treatment cycles at a private human fertility clinic demonstrated no 
decline in biochemical pregnancy rate when reported to consume 1 to 5 drinks 
socially. However, it was concluded that male patient alcohol usage of 1 to 5 
drinks socially caused a decline in semen volume as well as total motile sperm 
per specimen.  
The results of male consumption of alcohol in association with decreased 
semen volume are in agreement with the results of a 2014 study performed by 
Jurewicz and colleagues. Previous reviews were also in agreement that higher 
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age, smoking, and alcohol consumption were risk factors for poor semen quality 
(Li et al., 2011; Sadeu et al., 2010).  
Sartorius and Nieschlag (2010) claimed that although a contribution of 
environmental factors to the deterioration of human semen parameters in 
advancing age is readily accepted, solid evidence does not exist. Future studies 
should take this into consideration. Larger study samples should be a major goal 
in future research. Due to the amount of missing data and the variability of male 
factors, such as semen characteristics, small samples may not be as effective in 
exposing significant male infertility factors.  
Conclusion 3 
It was concluded that advanced age males who participate in clinical ART 
treatment cycles at a private human fertility clinic will not have lower reproductive 
success rates as male BMI levels increase. Conversely, Kort and colleagues 
(2006) previously reported an inverse relationship between BMI and the total 
number of normal-motile sperm cells per subject observed. Interestingly, the 
group of men with a BMI greater than 25 kg/m2 had fewer normal chromatin-
intact motile sperm cells per ejaculate.  
In the current study we evaluated for common semen characteristics and 
biochemical pregnancy. However, other studies have suggested that BMI 
affected all parts of male reproduction, the effect commonly seen in the 
developing embryo. In 2014, Simon and colleagues showed that increased 
sperm DNA damage adversely affected embryo quality starting at day 2 of early 
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embryonic development and continuing after embryo transfer. This resulted in 
reduced implantation rates and pregnancy outcome.  
Rato and colleagues (2014) reported that testicular metabolic alterations 
induced by increased adipose tissue may also lead to mitochondrial dysfunction, 
which is closely associated to reactive oxygen species (ROS) overproduction, 
and oxidative stress. ROS easily targets spermatozoa DNA and lipids, 
contributing to decreased sperm quality (Rato et al., 2014).  
Therefore, it can be assumed, that embryo production is compromised 
because of sperm fertilization from a male with a high BMI level. Additionally 
suggesting that if BMI plays a factor in decreased semen quality it is possibly 
seen through DNA damage. In 2004, Tesarik et al., described how the sperm 
activates its genome at the time of embryo genomic activation and this crucial 
step determines the development of the embryo until the blastocyst stage. This is 
quite possibly where the BMI factor presents itself. 
The current study did not evaluate for DNA damage or embryo quality. 
However, when erectile dysfunction was re-evaluated because of the amount of 
intentionally skipped questions the researcher noticed a trend in increased male 
patient BMI levels. Further research is needed to perform correlation studies on 
the relationships of these variables. Using the same variables, with the addition 
of embryo development and DNA damage, further studies should evaluate 
variables from a larger sample size of male patients. In the meantime, to ensure 





It was concluded that advanced age males who participated in clinical 
ART treatment cycles at a private human fertility clinic will have a decline in the 
percent of normal sperm as infertility length with their current partner increases. 
These results are in agreement with previous studies which suggested that the 
older a man was, the longer it may take his partner to conceive, regardless of her 
age (Ford et al., 2000). More recent studies have emerged stating that underlying 
infertility and time to pregnancy is another risk factor for adverse pregnancy 
outcomes, independent of maternal age (Zhu et al., 2006).  
Unlike the small sample size of the current study, Ford and colleagues 
(2000) found significant correlation among older men and ILCP by performing a 
large population study. The current sample size for ILCP was not only small but 
extremely variable. Therefore, these results are to be considered with caution. 
There is an extremely limited amount of research in this area. Further studies 
need to pursue larger sample sizes and more accurate data responses.   
Limitations 
In addition to the limitations of a retrospective study design, there may 
also be unidentified correlations due to the small sample size of the study. 
Missing data contributed to another limitation of the study, correlation analyses 
were carried out for sub-samples, further reducing the sample sizes. To try and 
lesson these affects the researcher incorporated statistical procedures that 
exhibited normal distribution and an absence of significant differences in means 
when compared to the national population. Another limitation was the design of 
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the study only looking at couples biochemical pregnancy rates and semen 
characteristics. Researchers say the findings may actually underestimate the 
effect of male age on infertility and future studies should also include embryo 
development and live birth rates.  
The small size of the sample can be considered a limitation to the current 
study. Due, in part, to such a small study sample the results cannot be 
adequately compared to previous studies that claimed paternal occupation 
(Kenkel et al., 2001; Magnusdottir et al., 2005) and lifestyle factors (Jensen et al., 
2004; Povey et al., 2012; Sallmén et al., 2006) have an impact on semen 
parameters.  
Using only one clinic for the sample strengthened the internal validity of 
the study but it came with limitations of getting a large enough sample size. 
Larger samples are usually obtained by a retrospective survey over a number of 
years. In that instance, the available data, complete or incomplete is all that the 
researcher has available to record.  
Another limitation may be the increased success rate of the clinic. 
However, the researcher took measures to make sure that the sample was not 
significantly different from the national population. When clinical samples were 
statically compared to national population means there was no difference found. 
Advanced success of the study clinic may act as another limitation by 
overcoming some of the subtleties of male infertility factors. Even though 




Additionally, the researcher extensively reviewed both patient medical 
records of the sample couple to obtain as much information as possible. For 
example, missing male ILCP was obtained from female partner records when 
available. This was not done often, but it does contribute to the hindrance of the 
true response rate of the male. In addition, there were a number of discrepancies 
among male data, such as; males that listed different ages in separate 
documents, males and females that listed different ILCP, males that changed 
height and weight from one document to another, and the number of questions 
skipped.  
Finally, another limitation to consider would be the generalizability of the 
study sample. However, the research group felt that securing internal validity was 
of greater importance. In addition, the study clinic routinely provides treatment to 
a large variety of patients from a large and diverse area among the southwestern 
region of the U.S. 
Clinician Survey Study 
Objective 1 and 2 
As anticipated, results of the clinician survey suggested areas of concern 
for further research on male variables and practices within the industry based on 
their experiences with male infertility patients. Specific male variables of 
importance were identified from the opinion results of clinicians. Data for these 
variables had also been collected in the retrospective study. By comparing the 
results of the two studies, the researcher feels confident in suggesting that the 
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variables clinicians identified as important, on average, only contained 50.0% of 
complete male patient data.    
The results are in agreement with a 2014 Centers for Disease Control and 
Prevention consensus which illustrated that the percentage of male data reported 
to analyze was much less than the amount of female data available. Therefore, it 
is proposed that analogous research studies be performed to determine an 
enhanced collection method for these specifically identified variables.  
The current study also suggested that there is a notable lack of patient 
knowledge regarding the importance and contribution of male infertility factors. 
One possible theory for the reduced amount of male data is that patients are 
unaware of the actual percentage of the male’s reproductive role. Therefore, both 
males and females might assume it is unnecessary to provide complete 
information on male patient questionnaires.  
Another theory behind the missing data is the sensitive nature of 
discussing male infertility. Researchers have explained that male patients 
appeared to be more likely to confide in and desire information and emotional 
support from infertility clinicians rather than from friends or mental health 
professionals (Glover et al., 1994; Hammarberg et al., 2010; Brucker and 
McKenry, 2004). Therefore, if patients are not getting adequate information on 
male infertility factors from their doctor visits they are highly unlikely to learn 
about fertility issues and lifestyle exposure factors through additional resources.   
Results suggest that forthcoming studies use a combined method to 
increase data collection, while providing increased patient knowledge on male 
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infertility variables. For example, future clinical research surveys should be more 
specific by individually labeling male reproductive threats. The proposed design 
would also include the specific effects of each of these threats on male 
reproduction.    
Exploratory studies are one suggested design to further analyze the issue 
of missing male data. Performing a retrospective study would help to identify the 
response rate but would limit further analysis. A prospective clinical study could 
also be designed to identify the response rate and then follow up with the male 
patients on the reasons behind the missing data.   
Although the researcher expected this finding, at such a large scope was 
not intentional. The study was designed to protect for this by collecting as many 
variables as possible; in the case that some might not provide a large enough 
sample size. It was not expected for the researcher to find such a significant 
amount of missing data. In addition, gathering data from male electronic medical 
records was extremely inefficient and more time consuming than expected. The 
original design of the retrospective data included a larger sample and was 
confounded by the collection process of male data. The results for the clinician 
survey suggest that professionals in the industry are observing similar response 
rates from male patients.   
Conclusion 1 
 It was concluded that reproductive infertility clinicians who participated in a 
voluntary male infertility survey did not demonstrate a significant difference of 
opinions on topics such as; data availability and gender based ethical treatment 
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of patients. However, gender and the need of better communication system for 
patient data was extremely close to having a significant correlation. Further 
research should definitely be designed to address this relationship. Experimental 
studies need to be performed on the comparison of male data access in each 
occupation.  
Limitations 
 The biggest limitation of this study was that the researcher was not in 
complete control of who was selected to participate. Although the group invited to 
participate in the survey were professionals in the infertility industry, the 
researcher was reliant on a third party, EmbryoMail, to verify the legitimacy of 
their credentials.  
 Another study limitation was the inability to identify the sample response 
rate of survey participants, creating an extraneous variable threat. A review of the 
literature demonstrated that previous survey studies have reported extremely 
variable response rates. In a European social survey on fertility age limits, Billari 
et al. (2011) reported a 46.0% response rate from one sample and a 73.0% 
response rate from another. To overcome this and the fact that a specific group 
was addressed, the researcher utilized descriptive statistics to prove normal 
distribution among the sample. In addition, descriptive statistics were used to 
show no significant difference from the national population. Still, another 
limitation of descriptive research is that it cannot identify a cause and effect 
relationship.   
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 As with the retrospective study, survey sample size is a limitation. 
Although normally distributed, small variances may be hidden by the small 
sample size studied. Another limitation is that the survey was only exploratory. 
Further research needs to be performed to investigate qualitative and 
quantitative clinical studies.  
 Evaluating the influence of age on reproduction has proven to be 
extremely difficult and controversial. Conclusions remain vulnerable due to many 
possible confounding cofactors. Sartorius and Nieschlag (2010) explained that 
not only do individual subjects age at different rates, but effects of age on male 
reproduction bay be caused by aging, or by mediators generated secondarily by 
age-related cofactors.  
 As long as couples continue to advance with the current trend of delayed 
childbearing, male infertility factors need to remain on the forefront. The 
opportunities for research topics in the area are endless. Just as important, is the 
opportunity to inform and educate reproductive age males on the risks and 
benefits associated with their personal fertility. Although this is not expected to be 
easily overcome, the stigma of males and their infertility need to be put aside to 
better treat the infertility couple.  
In a 25 European country survey male and female age limits were equally 
associated by the opposite sex, when it came to their reproductive capabilities 
(Billari et al., 2011). Billari and collaborators (2011) suggested one reason for this 
may be that young people in Europe are more aware of recent medical insight 
into the biological limits to childbearing for both males and females. Another 
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reason may be that, for young people, notions of gender equality in their lives 
may be of greater importance so they apply similar reproductive expectations to 
women and men alike. For them, it is late parenthood rather than late 
motherhood that should be avoided for reasons physical or otherwise (Billari et 
al., 2011). This suggestion is promising for the continued acknowledgement of 
male infertility factors.  
There is a strong need for further research studies in all areas of male 
reproductive physiology. The results of the current study and the review of 
literature strongly suggest that this is not just a biological issue. Future research 
needs to address male infertility in an all-encompassing manner including; 
societal stigmas, religious beliefs, industry ethics, age limits, and a host of 
environmental and lifestyle factors.  
The design of the study should take into consideration the large amount of 
patients that will be needed and the excess time required to evaluate records on 
each patient. The present results suggest that researchers should expect to get 
data from approximately 25.0% of the male records reviewed. Additional 
research should focus on describing the nature of the missing data. New 
collection methods should be attempted in an effort to get as much male data as 
possible.  
The researcher submitted a third study to the LSU IRB as a part of this 
proposal that has not yet been pursued. The approved study is designed around 
the creation and real time administration of a clinician survey. The instrument 
would be similar to the study clinic questionnaire, except that patients would be 
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administered the instrument by a professional. Information would be collected on 
specific variables, such as the names of specific exposure chemicals.  
In addition, this method could meet a second issue that needs to be 
addressed, properly providing male infertility information to patients. Couples 
would be informed on the types of fertility treatments available and what lifestyle 
factors to be addressed promoting increased male reproductive success.  
However, still to be determined is the correct provision of privacy or 
anonymity for male patients. The results of the current study suggested that there 
are a number of sensitive questions that receive no response from male patients. 
Future research would need to determine the best way to get the most accurate 
and available responses from male patients.  
 In a systematic review of research concerning patients’ perspectives on 
fertility care, Dancet et al. (2010) demonstrated that only three of the 51 studies 
had focused specifically on male experiences. The authors concluded that there 
was a lack of data regarding men’s perceptions of care, particularly with regard to 
invasive procedures (Dancet et al, 2010).   
In their 2012 review, Dudgeon and Inhorn, evaluated 92 publications 
through a search of available literature on the psychological and social aspects of 
infertility in men. Although psychological and social aspects of infertility, fertility 
treatment with assisted reproductive technologies, and infertility-related 
childlessness have been investigated comprehensively in women, the 
psychosocial consequences of infertility for men are less well understood (Greil 
et al., 2010). Previously reported in a 2010 publication, Greil and colleagues 
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explained that most of the participants in each male study were recruited from 
clinical services and little was known about men who do not seek treatment. The 
group also pointed out that among those who do in fact pursue treatment; a 
number of male behavioral factors still remain unknown.  
Data gained by the researcher from the current 2015 study supports both 
statements in the above paragraph. Reflecting the 2010 Greil et al. review, the 
2015 retrospective study samples were also comprised of a male patient 
population that received clinical infertility services. In addition, the researcher’s 
observations from the current study was consistent with Greil and colleagues’ 
2010 account, confirming that there are still a large number of unknowns and 
incomplete information available for males who do participate in clinical services. 
There are a number of past and present reasons that have led to the lack 
of male patient information. However, results from the current study led the 
researcher to focus on two of the possible current issues; male fertility stigma 
and lack of contribution knowledge.  
Based on their review of biological and cultural anthropological theories on 
masculinity and human reproduction, Dudgeon and Inhorn (2012) concluded that 
male infertility is more stigmatizing for men than it is for women. The authors 
argued that infertility is potentially humiliating and emasculating to many men. As 
a male, any association with infertility, virility, and sexual potency can lead to 
perceived personal inadequacy (Dudgeon and Inhorn, 2012). 
In Sweden, Hjelmstedt et al. (1999) found that 50.0% more men, than 
women had not shared their infertility problems with others. The authors 
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interpreted these results as reflecting the inherent frustrations of being in a 
situation that is poorly understood and in which assured treatments are not 
guaranteed (Hjelmstedt et al., 1999). While there is an emerging body of 
evidence focused on the psychological and social aspects of infertility for men, 
significant knowledge gaps remain (Greil, et al., 2010; Sherrod, 2006).  
The current study results provided valuable information for further 
research. Additionally, some of the results can be utilized by fertility clinicians 
and infertility patients participating in clinical ART treatment cycles. These results 
also support the growing body of research that is examining the effect of 
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CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT 
THIS CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT (the “Agreement”) is 
made and entered into as of ___________ between Fertility Specialists of Texas (“Company”) 
and Jeanne L. Glaser, MS (“Researcher”). 
1. PURPOSE 
Company and Researcher wish to collaborate in a retrospective patient research study. Company 
may disclose to Researcher certain confidential technical and patient information which Company 
desires Researcher to treat as confidential. 
2. CONFIDENTIAL INFORMATION 
 
“Confidential Information” means any information disclosed to Researcher by Company, either 
directly or indirectly in writing, orally or by inspection of tangible objects, including without 
limitation patient records or personal information of patients, electronic records, images, 
ownership information.  Confidential Information shall also include without limitation the items 
set forth in the Appendix attached hereto.  
3. NON-USE AND NON-DISCLOSURE 
Researcher agrees not to use any Confidential Information for any purpose except to fulfill 
retrospective research data requirements as listed in Appendix. In addition, specific measures will 
be taken to protect patient anonymity and all records in Researcher’s possession will be destroyed 
at the completion of the study.  Researcher shall not use any Confidential Information in any 
manner detrimental to the business interests of Company.  Researcher agrees not to disclose any 
Confidential Information to any third parties. Researcher shall not disclose Confidential 
Information to advisors of Researcher. 
4. MAINTENANCE OF CONFIDENTIALITY 
Researcher agrees that it shall take all reasonable measures to protect the secrecy of and avoid 
disclosure and unauthorized use of the Confidential Information. Without limiting the foregoing, 
Researcher shall take at least those measures that Researcher takes to protect its own most highly 
confidential information. Researcher shall not make any copies of Confidential Information 
unless the same are previously approved in writing by the Company. Researcher shall reproduce 
Company’s proprietary rights notices on any such approved copies, in the same manner in which 
such notices were set forth in or on the original. Researcher shall immediately notify Company in 
the event of any unauthorized use or disclosure of the Confidential Information. 
5. NO OBLIGATION 
Nothing herein shall obligate Company or Researcher to proceed with any transaction between 
them, and each party reserves the right, in its sole discretion, to terminate the discussions 
contemplated by this Agreement concerning the business opportunity. 
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6. NO WARRANTY 
ALL CONFIDENTIAL INFORMATION IS PROVIDED “AS IS.” COMPANY MAKES NO 
WARRANTIES, EXPRESS, IMPLIED OR OTHERWISE, REGARDING ITS ACCURACY, 
COMPLETENESS OR PERFORMANCE.  
7. RETURN OF MATERIALS 
All documents and other tangible objects containing or representing Confidential Information and 
all copies thereof which are in the possession of Researcher shall be and remain the property of 
Company and tangible objects shall be promptly returned to Company. All electronic patient 
records will be destroyed by Researcher. 
8. NO LICENSE 
Nothing in this Agreement is intended to grant any rights to Researcher under any patent, mask 
work right or copyright of Company, nor shall this Agreement grant Researcher any rights in or 
to Confidential Information except as expressly set forth herein. 
9. TERM 
This Agreement shall survive indefinitely, not just upon the completion of the study.  
10. REMEDIES 
Researcher agrees that any violation or threatened violation of this Agreement will cause 
irreparable injury to the Company, entitling Company to obtain injunctive relief in addition to all 
legal remedies. 
11. MISCELLANEOUS 
This Agreement shall bind and inure to the benefit of the parties hereto and their successors and 
assigns, except that Researcher may not assign or transfer this Agreement, by operation of law or 
otherwise, without Company’s prior written consent. THIS AGREEMENT SHALL BE 
GOVERNED BY THE LAWS OF THE STATE OF LOUISIANA, WITHOUT REFERENCE 
TO CONFLICT OF LAWS matter hereof. If any provision of this Agreement is found to be 
illegal or unenforceable, the other provisions shall remain effective and enforceable to the 
greatest extent permitted by law. Any failure to enforce any provision of this Agreement shall not 
constitute a waiver thereof or of any other provision hereof. This Agreement may not be 
amended, nor any obligation waived, except by a writing signed by both parties hereto. The 
parties may execute this Agreement in counterparts, each of which is deemed an original, but all 











Fertility Specialists of Texas Jeanne L. Glaser, MS 
Signature: __________________________ Signature: __________________________ 
Title: ______________________________ University: _________________________ 
Date Signed:________________________ Title: ______________________________ 




List of other additional, particular items subject to confidentiality and non-disclosure: 
1. See LSU Institutional Review Board Action on Exemption Approval Request. 
2. See Brief Summary of the Project, A Retrospective Study: Examining the Male 
Infertility Factor; The Association Between Age, Environment and Reproductive 
Success.  
3. See LSU Institution Review Board Application for Exemption from Institutional 
Oversight. 
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2. One-sample t-test analysis of the retrospective study sample average  
pregnancy rate (44.0%) compared to the national ART pregnancy rate 




National ART Pregnancy Rate Average = .39 













3.   One-sample t-test analysis of the retrospective study sample average 




National Male BMI Average = 29 
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4.   Point-biserial correlation coefficient scatter/dot plot exhibiting negative 





















5.   Point-biserial correlation coefficient scatter/dot plot exhibiting negative 





6.  Retrospective male patient alcohol usage. 
 
Descriptive Statistics 
       Mean    Std. Deviation           N 
Social Alcohol Usage .6250 .48925 48 
Volume 2.429 1.6007 83 




7a. Point-biserial correlation coefficient scatter/dot plot exhibiting negative 






















7b. Point-biserial correlation coefficient scatter/dot plot exhibiting negative 






















Would access to more male patient lifestyle information improve 






  Yes 53.8% 28 
  No 19.2% 10 
  Undecided 26.9% 14 






Does reproductive healthcare need a better communication system 
allowing the physician and the laboratory physiologist to have equal 






  Need a better system 53.8% 28 
  Current system is sufficient 42.3% 22 
  Undecided 3.9% 2 













Occupation*Descriptive Data Access Contingency Table 
 Occupation 
Descriptive Data Access 
   Total Always Mostly Occasionally Rarely 
 
Repro Endo 3 0 0 0 3 
Repro Phys 4 1 4 4 13 
Embryologist 17 7 3 3 30 
Andrologist 4 1 0 0 5 
Urologist 1 0 0 0 1 
Reproductive Tech 0 0 0 1 1 






 Cramer’s V Correlation Coefficient  
 Occupation*Descriptive Data Access Value Approx. Sig. 
 
Nominal by Nominal 
Phi .608 .187 
Cramer's V .351 .187 







Occupation*Semen Data Access Contingency Table  
 Occupation 
Semen Data Access  
Always Mostly Occasionally Rarely Never  Total 
 
Repro Endo 3 0 0 0 0 3 
Repro Phys 8 3 1 0 1 13 
Embryologist 20 8 0 1 1 30 
Andrologist 5 0 0 0 0 5 
Urologist 1 0 0 0 0 1 
Reproductive Tech 0 1 0 0 0 1 






 Cramer’s V Correlation Coefficient  
 Occupation*Semen Data Access Value Approx. Sig. 
 
Nominal by Nominal 
Phi .470 .926 
Cramer's V .235 .926 






Occupation*Urology Data Access Contingency Table  
 Occupation 
Urology Data Access 
Total Always Mostly Occasionally Rarely Never 
 
Repro Endo 2 0 1 0 0 3 
Repro Phys 4 1 7 1 0 13 
Embryologist 10 8 6 3 1 28 
Andrologist 1 1 3 0 0 5 
Urologist 1 0 0 0 0 1 
Reproductive Tech 0 0 0 1 0 1 






 Cramer’s V Correlation Coefficient  
 Occupation*Urology Data Access Value Approx. Sig. 
 
Nominal by Nominal 
Phi .634 .427 
Cramer's V .317 .427 








Occupation*Exposure Data Access Contingency Table 
 Occupation 
Exposure Data Access 
Total Always Mostly Occasionally Rarely Never 
 
Repro Endo 2 0 1 0 0 3 
Repro Phys 3 2 4 4 0 13 
Embryologist 8 8 6 6 1 29 
Andrologist 2 1 2 0 0 5 
Urologist 1 0 0 0 0 1 
Reproductive Tech 0 0 0 1 0 1 






Cramer’s V Correlation Coefficient 
Occupation*Exposure Data Access Value Approx. Sig. 
Nominal by Nominal 
Phi .501 .874 
Cramer's V .251 .874 







Occupation*Medical Data Access Contingency Table 
 Occupation 
Medical Data Access 
  
Total Always Mostly Occasionally Rarely Never 
 Repro Endo 2 0 1 0 0 3 
Repro Phys 3 0 4 5 1 13 
Embryologist 10 7 7 2 2 28 
Andrologist 1 1 2 0 0 4 
Urologist 1 0 0 0 0 1 
Reproductive Tech 0 0 1 0 0 1 






 Cramer’s V Correlation Coefficient  
 Occupation*Medical Data Access Value Approx. Sig. 
 
Nominal by Nominal 
Phi .613 .537 
Cramer's V .306 .537 
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